<SEC-DOCUMENT>0000950103-22-002304.txt : 20220209
<SEC-HEADER>0000950103-22-002304.hdr.sgml : 20220209
<ACCEPTANCE-DATETIME>20220209163955
ACCESSION NUMBER:		0000950103-22-002304
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20220208
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220209
DATE AS OF CHANGE:		20220209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTERNATIONAL FLAVORS & FRAGRANCES INC
		CENTRAL INDEX KEY:			0000051253
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		IRS NUMBER:				131432060
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04858
		FILM NUMBER:		22607790

	BUSINESS ADDRESS:	
		STREET 1:		521 W 57TH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		2127655500

	MAIL ADDRESS:	
		STREET 1:		521 W 57TH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VANAMERIGEN HAEBLER INC
		DATE OF NAME CHANGE:	19680426
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>dp166855_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:IFF="http://iff.com/20220208">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_IFF_iff.com_20220208 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20220208_20220208 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0000051253 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_12/31 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-02-08to2022-02-08" name="dei:EntityCentralIndexKey">0000051253</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-02-08to2022-02-08" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-02-08to2022-02-08" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate">12/31</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="iff-20220208.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-02-08to2022-02-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-08</xbrli:startDate>
        <xbrli:endDate>2022-02-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-082022-02-08_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-08</xbrli:startDate>
        <xbrli:endDate>2022-02-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-082022-02-08_custom_Sec1.75PercentSeniorNotesDue2024Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">IFF:Sec1.75PercentSeniorNotesDue2024Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-08</xbrli:startDate>
        <xbrli:endDate>2022-02-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-082022-02-08_custom_Sec1.800PercentSeniorNotesDue2026Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">IFF:Sec1.800PercentSeniorNotesDue2026Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-08</xbrli:startDate>
        <xbrli:endDate>2022-02-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>



<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, DC 20549</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_905_edei--DocumentType_c20220208__20220208_zQHsSzn4fRtg"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>



<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;<b>Pursuant
to Section 13 OR 15(d)</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of The Securities Exchange Act of 1934</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of report (Date of earliest event reported):
February 9, 2022 (<span id="xdx_90F_edei--DocumentPeriodEndDate_c20220208__20220208_zetlRItGjZp8"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">February 8, 2022</ix:nonNumeric></span>)</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_900_edei--EntityRegistrantName_c20220208__20220208_zpUAF5PyEeYc"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" name="dei:EntityRegistrantName">INTERNATIONAL FLAVORS &amp; FRAGRANCES INC.</ix:nonNumeric></span></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its
charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; font-size: 12pt; text-align: center; width: 33%"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20220208__20220208_zWDAErVCMvI1"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">New York</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; font-size: 12pt; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-size: 12pt; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_90B_edei--EntityFileNumber_c20220208__20220208_zpnpqp8JHuR9"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" name="dei:EntityFileNumber">1-4858</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; font-size: 12pt; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-size: 12pt; text-align: center; width: 33%"><span style="font-size: 10pt"><b><span id="xdx_901_edei--EntityTaxIdentificationNumber_c20220208__20220208_zxg43gwZTQph"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" name="dei:EntityTaxIdentificationNumber">13-1432060</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top">
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(State or
other jurisdiction</b></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of incorporation)</b></p>
</td>
    <td style="vertical-align: bottom; font-size: 12pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: top">
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Commission</b></p>

    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>File Number)</b></p>
</td>
    <td style="vertical-align: bottom; font-size: 12pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: top">
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(I.R.S. Employer</b></p>

    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Identification No.)</b></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>
</td></tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; width: 33%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressAddressLine1_c20220208__20220208_zFwQ4Q6to9Sh"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" name="dei:EntityAddressAddressLine1">521 West 57th Street</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressCityOrTown_c20220208__20220208_zQ8y7m4VMjEk"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20220208__20220208_zSsW8LZa28Ei"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric> </span></b></span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center; width: 33%"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressPostalZipCode_c20220208__20220208_zNltkRhMRoj8"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" name="dei:EntityAddressPostalZipCode">10019</ix:nonNumeric></span></b></span></td>
    </tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 8pt"><b>(Address of principal executive offices)</b></span></td>
    <td style="vertical-align: bottom"><span style="font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 8pt"><b>(Zip Code)</b></span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_906_edei--CityAreaCode_c20220208__20220208_ziXeTyZtUdQ8"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" name="dei:CityAreaCode">212</ix:nonNumeric></span>) <span id="xdx_906_edei--LocalPhoneNumber_c20220208__20220208_z2qp66MOKtd2"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" name="dei:LocalPhoneNumber">765-5500</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Registrant&#8217;s telephone number, including
area code)</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Former name or former address, if changed since
last report)</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--WrittenCommunications_c20220208__20220208_zsOkRASegLF7"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--SolicitingMaterial_c20220208__20220208_zavHd6USEH5"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20220208__20220208_zwm2KL4CHEu8"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20220208__20220208_zMVdusrFUUqc"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 34%">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="width: 32%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="width: 32%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><span style="font-size: 8pt"><b>Title of each class</b></span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid">
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Trading</b></p>

    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Symbol(s)</b></p>
</td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid">
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Name of each exchange</b></p>

    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>on which registered</b></p>
</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_909_edei--Security12bTitle_c20220208__20220208__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zg6WIeb1JMt7"><ix:nonNumeric contextRef="From2022-02-082022-02-08_us-gaap_CommonStockMember" name="dei:Security12bTitle">Common Stock, par value 12 1/2&#162; per share</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_902_edei--TradingSymbol_c20220208__20220208__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zrzRvpXQdsxb"><ix:nonNumeric contextRef="From2022-02-082022-02-08_us-gaap_CommonStockMember" name="dei:TradingSymbol">IFF</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90B_edei--SecurityExchangeName_c20220208__20220208__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYdWlLKRDs4d"><ix:nonNumeric contextRef="From2022-02-082022-02-08_us-gaap_CommonStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_904_edei--Security12bTitle_c20220208__20220208__us-gaap--StatementClassOfStockAxis__custom--Sec1.75PercentSeniorNotesDue2024Member_zCo81g53Q0Yg"><ix:nonNumeric contextRef="From2022-02-082022-02-08_custom_Sec1.75PercentSeniorNotesDue2024Member" name="dei:Security12bTitle">1.75% Senior Notes due 2024</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--TradingSymbol_c20220208__20220208__us-gaap--StatementClassOfStockAxis__custom--Sec1.75PercentSeniorNotesDue2024Member_z2uxYJ5EJ9u"><ix:nonNumeric contextRef="From2022-02-082022-02-08_custom_Sec1.75PercentSeniorNotesDue2024Member" name="dei:TradingSymbol">IFF 24</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_901_edei--SecurityExchangeName_c20220208__20220208__us-gaap--StatementClassOfStockAxis__custom--Sec1.75PercentSeniorNotesDue2024Member_zNwclu0kqOA2"><ix:nonNumeric contextRef="From2022-02-082022-02-08_custom_Sec1.75PercentSeniorNotesDue2024Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--Security12bTitle_c20220208__20220208__us-gaap--StatementClassOfStockAxis__custom--Sec1.800PercentSeniorNotesDue2026Member_zYZupYG5nKC5"><ix:nonNumeric contextRef="From2022-02-082022-02-08_custom_Sec1.800PercentSeniorNotesDue2026Member" name="dei:Security12bTitle">1.800% Senior Notes due 2026</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_900_edei--TradingSymbol_c20220208__20220208__us-gaap--StatementClassOfStockAxis__custom--Sec1.800PercentSeniorNotesDue2026Member_zpgvAh3ygr85"><ix:nonNumeric contextRef="From2022-02-082022-02-08_custom_Sec1.800PercentSeniorNotesDue2026Member" name="dei:TradingSymbol">IFF 26</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_901_edei--SecurityExchangeName_c20220208__20220208__us-gaap--StatementClassOfStockAxis__custom--Sec1.800PercentSeniorNotesDue2026Member_znHuKOOTux03"><ix:nonNumeric contextRef="From2022-02-082022-02-08_custom_Sec1.800PercentSeniorNotesDue2026Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the Registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20220208__20220208_z4k80YVcxAI4"><ix:nonNumeric contextRef="From2022-02-08to2022-02-08" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the Registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<div style="border-bottom: black 0.75pt solid; padding: 0in">

</div>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 0.75pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->










<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 11%"><span style="font-size: 10pt"><b>Item 1.01</b></span></td>
    <td><span style="font-size: 10pt"><b>Entry into a Material Definitive Agreement. </b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 8, 2022, International Flavors &amp; Fragrances, Inc. (the
&#8220;<span style="text-decoration: underline">Company</span>&#8221;) entered into a Cooperation Agreement (the &#8220;<span style="text-decoration: underline">Agreement</span>&#8221;) with Carl C. Icahn and the persons
and entities listed therein (collectively, the &#8220;<span style="text-decoration: underline">Icahn Group</span>&#8221;), pursuant to which the Company agreed to (i) increase
the size of the board of directors of the Company (the &#8220;<span style="text-decoration: underline">Board</span>&#8221;) to fourteen directors and (ii) appoint Barry Bruno
(the &#8220;<span style="text-decoration: underline">Independent Director</span>&#8221;) to the Board to fill the resulting vacancy. In addition, the Company has agreed to include
the Independent Director as part of the Company&#8217;s slate of nominees (collectively, the &#8220;<span style="text-decoration: underline">2022 Slate</span>&#8221;) for election
to the Board at the 2022 annual meeting of stockholders (the &#8220;<span style="text-decoration: underline">2022 Annual Meeting</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">In connection with his appointment
to the Board, the Board determined that Mr. Bruno qualifies as an independent director under the listing rules of New York Stock Exchange.
Under the terms of the Agreement, the Icahn Group agreed that it will not enter into any agreement with, or compensate, the Independent
Director with respect to his role or service as a director of the Company. In addition, the Icahn Group confirmed that Mr. Bruno is not
associated with the Icahn Group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, under the terms of the Agreement, in the event the Independent
Director resigns or for any reason fails to serve or is not serving as a director (subject to exceptions set forth in the Agreement, including
as a result of such director not being nominated by the Company to stand for election at an annual meeting of stockholders subsequent
to the 2022 Annual Meeting, following which the Icahn Group&#8217;s replacement rights shall terminate), then a new independent director
that is mutually acceptable to the Board and the Icahn Group shall be added to the Board or as a nominee on the 2022 Slate, as applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">So long as the Independent Director is a member of the Board, any Board
consideration of appointment and employment of the Company&#8217;s chief executive officer and chief financial officer, mergers, acquisitions
of material assets, dispositions of material assets, or similar extraordinary transactions, and voting with respect thereto, will take
place only at the full Board level or in committees at which the Independent Director is a member.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">So long as the Icahn Group holds a &#8220;Net Long Position&#8221;,
as defined in the Agreement, in at least 2,154,552 shares of the Company&#8217;s common stock (the &#8220;<span style="text-decoration: underline">Common Shares</span>&#8221;),
the Company will not adopt a Rights Plan, as defined in the Agreement, with an &#8220;Acquiring Person&#8221; beneficial ownership threshold
below 15.0% of the then-outstanding Common Shares, unless (x) such Rights Plan provides that, if such Rights Plan is not ratified by the
Company&#8217;s stockholders within 270 days of such Rights Plan being adopted, such Rights Plan shall automatically expire and (y) the
&#8220;Acquiring Person&#8221; definition of such Rights Plan exempts the Icahn Group up to a beneficial ownership of 9.9% of the then-outstanding
Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Agreement also includes other customary voting, standstill and
non-disparagement provisions. The Agreement, including the standstill restrictions on the Icahn Group, will terminate upon the earlier
of (x) 35 calendar days before the advance notice deadline set forth in the bylaws of the Company (the &#8220;<span style="text-decoration: underline">Bylaws</span>&#8221;) for
the Company&#8217;s 2023 annual meeting of stockholders and (y) the day that is the seventh calendar day after the Icahn Group gives written
notice to the Company (which notice shall not be given before May 31, 2022) of the Icahn Group&#8217;s election to terminate the Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing description is qualified in its entirety by reference
to the full text of the Agreement, a copy of which is attached hereto as Exhibit 10.1 and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the entry into the Agreement, the Company and the
Icahn Group will also enter into a Confidentiality Agreement, the form of which is included as Exhibit B to the Agreement, which is attached
hereto as Exhibit 10.1 and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 11%"><span style="font-size: 10pt"><b>Item 5.02</b></span></td>
    <td><span style="font-size: 10pt"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The description of the matters included under Item 1.02 are incorporated
into this Item 5.02 by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 11%"><span style="font-size: 10pt"><b>Item 5.03</b></span></td>
    <td><span style="font-size: 10pt"><b>Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the entry into the Agreement, on February 8, 2022,
the Board approved and adopted an amendment to Article II, Section 2 of the Bylaws, effective immediately, to increase the size of the
Board to fourteen directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing description of the amended Bylaws is qualified in its
entirety by reference to the full text of the Bylaws, a copy of which is attached hereto as Exhibit 3.1 and is incorporated by reference
herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 11%"><span style="font-size: 10pt"><b>Item 7.01</b></span></td>
    <td><span style="font-size: 10pt"><b>Regulation FD Disclosure.</b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 9, 2022, the Company issued a press release announcing
the Company&#8217;s entry into the Agreement with the Icahn Group. A copy of the press release is furnished with this Current Report on
Form 8-K as Exhibit 99.1 and incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information in this item (including Exhibit 99.1) is being &#8220;furnished&#8221;
and shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;<span style="text-decoration: underline">Securities
Act</span>&#8221;), is not subject to the liabilities of that section and is not deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 11%"><span style="font-size: 10pt"><b>Item 9.01</b></span></td>
    <td><span style="font-size: 10pt"><b>Financial Statements and Exhibits. </b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) <span style="text-decoration: underline">Exhibits</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="text-align: right"><span style="font-size: 10pt"><a href="dp166855_ex0301.htm">3.1</a></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="width: 92%"><span style="font-size: 10pt"><a href="dp166855_ex0301.htm">Bylaws of International Flavors &amp; Fragrances Inc., effective as of February 8, 2022</a></span></td></tr>
  <tr>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: right"><span style="font-size: 10pt"><a href="dp166855_ex1001.htm">10.1</a></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="dp166855_ex1001.htm">Cooperation Agreement, dated as of February 8, 2022, by and among International Flavors &amp; Fragrances Inc. and the Icahn Group</a></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: right"><span style="font-size: 10pt"><a href="dp166855_ex9901.htm">99.1</a></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="dp166855_ex9901.htm">Press release issued by International Flavors &amp; Fragrances Inc. dated February 9, 2022</a></span></td></tr>
  <tr>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: right"><span style="font-size: 10pt">&#160;&#160;104</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;&#160;</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>









<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 60%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="3" style="vertical-align: bottom"><span style="font-size: 10pt"><b>INTERNATIONAL FLAVORS &amp; FRAGRANCES INC.</b></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">By:</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top">
    <p style="border-bottom: black 0.75pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Jennifer Johnson&#160;</p></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Name:</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Jennifer Johnson </span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Title:</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Executive Vice President and General Counsel</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Dated:</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">February 9, 2022</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJyNkdFOwjAUhp+AdzhZ4h2BtoKQ3elUYgSyMEK8rdtBF7aepe1QXsc739Kuk3ghU5omTXP+7/9PzgmCfjCj+7xADU83qzmssawKaRFWuEWNKkWniB4eQ3DvCl9yY7VU1n+PYESOQceMB1xIV/DSfW4wC4GJIZsOhQA2DdklxIug19QjUts8Q2VzWYBUGcSaKp2jlfrQOqzlOykqDz5qg9rkpELgA9aWP0EwLmBJe/lGemdgPo+CXt+fXjDTVFdNTG0slXBXYOmyTIv+XN9K6jVhgikfTBlLUOWkl2TR3NYomLhaYPmM2ik5Ey70+rsDr76AVg8egKxGaJAu/8n4l/2o034yPu0+OuHudlCSSiylu1jqjSxq5IKLGHXyKjV2ZLQUeKwPldSwb0hwg+VD8QGV265p+PMTo2bO/8R2T8eBqTM4e0h/7LHLqmudR6svlOPhRQ== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>dp166855_ex0301.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 3.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.45pt 0pt 141.9pt; text-align: center">BY-LAWS</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.45pt 0pt 141.9pt; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.45pt 0pt 141.9pt; text-align: center">of</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.45pt 0pt 141.9pt; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.55pt 0pt 141.9pt; text-align: center">INTERNATIONAL FLAVORS &amp; FRAGRANCES
INC.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.55pt 0pt 141.9pt; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.8pt 0pt 141.9pt; text-align: center">(a New York corporation)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.8pt 0pt 141.9pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.7pt 0pt 141.9pt; text-align: center">(as adopted March 10, 1964, including
all amendments adopted as of February 8, 2022)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.7pt 0pt 141.9pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE
I</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 197.5pt 0pt 196.65pt; text-align: left; text-indent: 48.1pt"></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MEETINGS OF SHAREHOLDERS</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 197.5pt 0pt 196.65pt; text-align: left; text-indent: 48.1pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">SECTION 1 <B>Annual Meeting</B>. The annual meeting of
the shareholders of International Flavors &amp; Fragrances Inc. (the &ldquo;Corporation&rdquo;) for the election of directors and for
the transaction of such other business as may properly come before the meeting shall be held at such place, on such date and at such time
as shall be designated from time to time by the Board of Directors.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">SECTION 2 <B>Special Meetings</B>. Special meetings of the shareholders,
unless otherwise prescribed by the New York</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">Business Corporation Law (the &ldquo;Business Corporation
Law&rdquo;), may be called at any time by the Chair of the Board, the Chief Executive Officer or by a majority of the Board of Directors.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt; text-align: left"><FONT STYLE="font-weight: normal">SECTION
3 </FONT>Notice of Meetings; Business to be Presented at Meeting<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.9pt 0pt 5pt">(a)&nbsp;&nbsp;Notice of
Meeting. Written notice of each meeting of shareholders stating the place, date and hour of the meeting shall be sent to each shareholder
entitled to vote at the meeting not less than ten (10) nor more than sixty (60) days before the date of the meeting. To the extent that
the meeting is a special meeting, such notice shall also indicate the person or persons calling the meeting, or the person(s) directing
that the meeting be so called, and shall state the purpose or purposes for which the meeting has been called. Notice of any meeting of
shareholders may be sent either in written or electronic form and shall comply with Section 505 of the Business Corporation Law. No business
shall be conducted at a meeting of the shareholders except in accordance with the procedures set forth in this Section 3.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.5pt 0pt 5pt">(b)&nbsp;&nbsp;Nature of
Business at Annual Meetings of Shareholders. No business may be transacted at an annual meeting of shareholders other than business that
is either (i) specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Board of Directors (or
any duly authorized committee thereof), (ii) otherwise properly brought before an annual meeting, by or at the direction of the Board
of Directors (or any duly authorized committee thereof), (iii) otherwise properly brought before an annual meeting by any shareholder
of the Corporation (A) who is a shareholder of record (x) on the date the shareholder provides the shareholder notice required by Section
3(d), (y) on the record date for the determination of shareholders entitled to vote at such meeting and (z) on the date of such meeting
and (B) who complies with the advance notice procedures set forth in Section 3(d) or (iv) otherwise properly brought before an annual
meeting pursuant to Section 4.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.5pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.55pt 0pt 5pt; text-indent: 0.5in">Notwithstanding anything in these
By-Laws to the contrary, no business shall be conducted at an annual meeting of shareholders except business brought before such meeting
in accordance with the procedures set forth</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.55pt 0pt 5pt; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 21.85pt 0pt 5pt">in this Section 3; provided, however, that, once business
has been properly brought before the meeting in accordance with such procedures, nothing in this Section 3 shall be deemed to preclude
discussion by any shareholder of any such business. If the chair of an annual meeting determines that business was not properly brought
before such meeting in accordance with the foregoing procedures, the chair shall declare to the meeting that the business was not properly
brought before the meeting and such business shall not be transacted.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 21.85pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 34.8pt 0pt 5pt">(c)&nbsp;&nbsp;Director Nominations.
Nominations of persons for election to the Board of Directors may be made at any annual meeting of shareholders, or at any special meeting
of shareholders called for the purpose of electing directors:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 34.8pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 33.75pt 0pt 5pt; text-indent: 0.75in">(i)&nbsp;&nbsp;subject
to Article II, Section 14, by or at the direction of the Board of Directors (or any duly authorized committee thereof),</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 33.75pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.75pt 0pt 5pt; text-indent: 0.75in">(ii)&nbsp;&nbsp;by
any shareholder of the Corporation (A) who is a shareholder of record (x) on the date the shareholder provides the shareholder notice
required by Section 3(d), (y) on the record date for the determination of shareholders entitled to vote at such meeting and (z) on the
date of such meeting and (B) who complies with the advance notice procedures set forth in this Section 3; or</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.75pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.75pt 0pt 5pt; text-indent: 0.75in">(iii) by any Eligible Shareholder
or Eligible Shareholder Group (each as defined in Section 4 of this Article I) with respect to any director nomination to be included
in the Corporation&rsquo;s proxy statement for an annual meeting who satisfies the requirements set forth in Section 4 of this Article
I.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.15pt 0pt 5pt">Notwithstanding anything in these By-Laws to the contrary,
except as set forth in Article II, Section 6, no person shall be eligible for election as a director of the Corporation unless nominated
in accordance with the procedures set forth in this Section 3 or Section 4. If the chair of the meeting determines that a nomination was
not made in accordance with the procedures set forth in this Section 3 or Section 4, the chair shall declare to the meeting that the nomination
was defective and such defective nomination shall be disregarded.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.15pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.8pt 0pt 5pt">(d)&nbsp;&nbsp;Required Notice
for Director Nomination or Submission of Other Proposal. In addition to any other applicable requirements, in order for a shareholder
to present any business to be transacted at an annual meeting of shareholders, including any nomination for a director to be made by a
shareholder (whether pursuant to Section 3(c)(ii) or Section 3(c)(iii) of this Article I above), such shareholder must provide the Secretary
of the Corporation notice thereof that (A) complies with the time requirements set forth in clause (1) below and (B) includes the information
required by this Section 3 or Section 4 of this Article I. The provisions of this Section 3 shall be the exclusive means for a shareholder
to make nominations or submit other business (other than matters properly brought under Rule 14a-8 of the Securities Exchange Act of 1934,
as amended (the &ldquo;Exchange Act&rdquo;)).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.8pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.9pt 0pt 5pt; text-indent: 0.75in">(i)&nbsp;&nbsp;<U>Timely
Notice</U>. To be timely, a shareholder&rsquo;s notice to the Secretary must be delivered to or mailed and received at the principal executive
offices of the Corporation (i) in the case of an annual meeting, not less than ninety (90) days nor more than one-hundred and twenty (120)
days prior to the anniversary date of the immediately preceding annual meeting of shareholders; provided, however, that in the event that
the annual meeting is called for on a date that is not within thirty (30) days before or after such anniversary date, notice by the shareholder
in order to be timely must be so received not later than the close of business on the tenth (10th) day following the day on which such
notice of the date of the annual meeting was mailed or such public disclosure of the date of the annual meeting was made, whichever first
occurs; and (ii) in the case of a special meeting of shareholders called for the purpose of electing directors, not later than the close
of business on the tenth (10th) day</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.9pt 0pt 5pt; text-indent: 0.75in"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.9pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 17.65pt 0pt 5pt">following the day on which notice of the date of the special
meeting was mailed or public disclosure of the date of the special meeting was made, whichever first occurs.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 17.65pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 20.6pt 0pt 5pt; text-indent: 0.75in">(ii)&nbsp;&nbsp;<U>Notice
Requirements for Nomination of any Director by a Shareholder</U>. For nominations to be properly brought before a meeting by a Shareholder
pursuant to Article I, Section 3(c)(ii) or Section 3(c)(iii), the shareholder&rsquo;s notice must set forth the following information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 20.6pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 24.35pt 0pt 5pt; text-indent: 1in">(A)&nbsp;&nbsp;as
to each person whom the shareholder proposes to nominate for election as a director the following information:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 24.35pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.55pt 0pt 5pt; text-indent: 1.25in">1) the
name, age, business address and residence address of the proposed nominee;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.55pt 0pt 5pt; text-indent: 1.25in">2) a complete biography or statement
of the proposed nominee&rsquo;s qualifications, including principal occupation or employment of such person (present and for the past
five (5) years), education, work experience, knowledge of the Corporation&rsquo;s industry, membership on the board of directors of any
other corporation currently held or held within the past five (5) years and civic activity;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 41.5pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.55pt 0pt 5pt; text-indent: 1.25in">3)&nbsp;&nbsp;the class or series
and number of shares of capital stock of the Corporation which are &ldquo;beneficially owned&rdquo; (as such term is defined by Section
13(d) of the Exchange Act ) or held of record by the proposed nominee and any other ownership interest in shares of the Corporation,
whether economic or otherwise, including any option, warrant, convertible security, stock appreciation right, or similar right with an
exercise or conversion privilege or a settlement payment or mechanism at a price related to any class or series of shares of the Corporation
or with a value derived in whole or in part from the value of any class or series of shares of the Corporation, whether or not such instrument
or right shall be subject to settlement in the underlying class or series of shares of the Corporation or otherwise directly or indirectly
beneficially owned by such person and any other direct or indirect opportunity to profit or share in any profit derived from any increase
or decrease in the value of the shares of the Corporation (&ldquo;Derivative Interests&rdquo;) (which information shall be supplemented
not later than ten (10) days after the record date for the meeting to disclose such ownership as of the record date);</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.55pt 0pt 5pt; text-indent: 1.25in">4) the date any shares or Derivative
Interests were acquired and the investment intent of such acquisition;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 17.95pt 0pt 5pt; text-indent: 1.25in">5)&nbsp;&nbsp;a
description of all arrangements or understandings between the shareholder and the proposed nominee and/or any other person or persons
pursuant to which the nomination is to be made by the shareholder;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 17.95pt 0pt 5pt; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 18.2pt 0pt 5pt; text-indent: 1.25in">6)&nbsp;&nbsp;any other information
relating to the proposed nominee that would be required to be disclosed in a proxy statement or other filings required to be made in
connection with solicitations of proxies for election of directors pursuant to Section 14 of the Exchange Act, and the rules and regulations
promulgated thereunder; including information with respect to a proposed nominee&rsquo;s independence as defined under the rules and
regulations promulgated by the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) and New York Stock Exchange and information
regarding the proposed nominee&rsquo;s attributes that the Nominating and Governance Committee of the Board of Directors would need to
consider in order to assess whether such proposed nominee would qualify as an &ldquo;audit committee financial expert&rdquo; as defined
by the rules and regulations promulgated by the SEC; and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.4pt 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 78.5pt 0pt 5pt; text-indent: 1.25in">7)&nbsp;&nbsp;a
copy of the completed and signed Questionnaire and the Statement of Representations and Agreements described in Section 3(e) below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 78.5pt 0pt 5pt; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 41.1pt 0pt 5pt; text-align: justify">The Corporation may require any proposed
nominee to furnish such other information as may reasonably be required by the Corporation to determine the eligibility of such proposed
nominee to serve as director of the Corporation.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 41.1pt 0pt 5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 77.05pt"></TD><TD STYLE="width: 18pt">(B)</TD><TD>as to the shareholder giving the notice the following information:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 19.2pt 0pt 5pt; text-indent: 1.25in">1)&nbsp;&nbsp;the
name and address of such record shareholder and the beneficial owner, if any, on whose behalf the nomination is made;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 19.2pt 0pt 5pt; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 20.95pt 0pt 5pt; text-indent: 1.25in">2)&nbsp;&nbsp;the
class or series and number of shares of capital stock of the Corporation which are owned beneficially or of record by such shareholder
and the beneficial owner, if any;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 20.95pt 0pt 5pt; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.3pt 0pt 5pt; text-indent: 1.25in">3)&nbsp;&nbsp;the
class or series and number of shares of capital stock of the Corporation which are owned beneficially or of record and any other Derivative
Interests owned by the shareholder (which information shall be supplemented not later than ten (10) days after the record date for the
meeting to disclose such ownership as of the record date);</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.3pt 0pt 5pt; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.3pt 0pt 5pt; text-indent: 1.25in">4) the date any shares or Derivative
Interests were acquired and the investment intent of such acquisition;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.65pt 0pt 5pt; text-align: justify; text-indent: 1.25in">5)&nbsp;&nbsp;a
description of all arrangements or understandings between such shareholder and each proposed nominee and any other person or persons (including
their names) pursuant to which the nomination(s) are to be made by such shareholder;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.65pt 0pt 5pt; text-align: justify; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.3pt 0pt 5pt; text-indent: 1.25in">6) a representation that such shareholder
intends to appear in person or by proxy at the meeting to nominate the persons named in such shareholder&rsquo;s notice;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.85pt 0pt 5pt; text-indent: 1.25in">7)&nbsp;&nbsp;a
representation as to whether the shareholder or the beneficial owner, if any, intends, or is part of a group which intends, to (a) deliver
a proxy statement and/or form of proxy to holders of at least the percentage of the Corporation&rsquo;s outstanding stock required to
elect the nominee and/or (b) otherwise solicit proxies from shareholders in support of such nomination; and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.85pt 0pt 5pt; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 5pt; text-indent: 1.25in">8)&nbsp;&nbsp;any
other information relating to such shareholder or the beneficial owner, if any, that would be required to be disclosed in a proxy statement
or other filings required to be made in connection with solicitations of proxies for election of directors pursuant to Section 14 of the
Exchange Act and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 5pt; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.15pt 0pt 5pt; text-indent: 0.75in">(iii)&nbsp;&nbsp;
<U>Notice Requirements for Nomination of a Director Included in Corporation&rsquo;s Proxy Statement</U>. For nominations to be properly
brought before a meeting by a Shareholder pursuant to Article I, Section 3(c)(iii) and to be in proper written form, the shareholder&rsquo;s
notice must provide the information required by Section 4 of this Article I and satisfy all other requirements of Section 4 of this Article
I (the &ldquo;Nomination Notice&rdquo;).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.15pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.15pt 0pt 5pt; text-indent: 0.75in">(iv) <U>Notice Requirements for
Other Shareholder Proposals</U>. To the extent that the shareholder&rsquo;s notice relates to a matter other than the nomination of a
director, to be in proper written form, a shareholder&rsquo;s</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 28.9pt 0pt 0; text-align: right">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 39pt 0pt 5pt">notice to the Secretary must set forth as to each matter
such shareholder proposes to bring before an annual meeting, the following:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 39pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 18.4pt 0pt 5pt; text-indent: 1in">(A)&nbsp;&nbsp;a
brief description of the business desired to be brought before such meeting and the reasons for conducting such business at such meeting;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 18.4pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 23.65pt 0pt 5pt; text-indent: 1in">(B)&nbsp;&nbsp;the
name and address of such record shareholder and the beneficial owner, if any, on whose behalf the proposal is made;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 23.65pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15.25pt 0pt 5pt; text-indent: 1in">(C)&nbsp;&nbsp;the
class or series and number of shares of capital stock of the Corporation which are owned beneficially or of record and any other Derivative
Interests owned by the shareholder and the beneficial owner, if any (which information shall be supplemented not later than ten (10) days
after the record date for the meeting to disclose such ownership as of the record date);</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15.25pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15.25pt 0pt 5pt; text-indent: 1in">(D) the date such shares or Derivative
Interests were acquired and the investment intent of such acquisition;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.55pt 0pt 5pt; text-indent: 1in">(E)&nbsp;&nbsp;a
description of all arrangements or understandings between such shareholder and any other person or persons (including their names) in
connection with the proposal of such business by such shareholder and any material interest of such shareholder in such business;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.55pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15.8pt 0pt 5pt; text-indent: 1in">(F)&nbsp;&nbsp;a
representation that such shareholder intends to appear in person or by proxy at the meeting to bring such business before such meeting;
and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15.8pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 26.15pt 0pt 5pt; text-indent: 1in">(G)&nbsp;&nbsp;a representation as
to whether the shareholder or the beneficial owner, if any, intends, or is part of a group which intends, to (a) deliver a proxy statement
and/or form of proxy to holders of at least the percentage of the Corporation&rsquo;s outstanding stock required to approve or adopt
the proposal and/or (b) otherwise solicit proxies from shareholders in support of such proposal.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.2pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.65pt 0pt 5pt">Notwithstanding the foregoing provisions of this Section
3, a shareholder seeking to have a proposal included in the Corporation&rsquo;s proxy statement shall comply with the requirements of
Section 14 of the Exchange Act, including, but not limited to, Rule 14a-8 promulgated thereunder or its successor provision. The Corporation
may require any shareholder to furnish such other information as may reasonably be required by the Corporation to determine if the business
shall be properly brought before an annual meeting of the shareholders.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.65pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.2pt 0pt 5pt">(e)&nbsp;&nbsp;<U>Director
Nominee Questionnaire; Representation and Agreement Requirement</U>. To be eligible to be a nominee for election or reelection as a director
of the Corporation pursuant to Section 3(c) of this Article I, each proposed nominee must deliver to the Secretary of the Corporation</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.2pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 52.05pt 0pt 5pt; text-indent: 0.75in">(i) a written questionnaire with
respect to the background and qualification of such person in the form provided by the Secretary upon written request (a &ldquo;Questionnaire&rdquo;);</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 52.05pt 0pt 5pt; text-indent: 0.75in">(ii)&nbsp;&nbsp;a
statement of representations and agreements (a &ldquo;Statement of Representations and Agreements&rdquo;) executed by the proposed nominee
that he or she:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 52.05pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15.45pt 0pt 5pt; text-indent: 1in">(A)&nbsp;&nbsp;is
not and will not become a party to any agreement, arrangement or understanding with any person or entity that has not been disclosed to
the Corporation (1) relating to how such proposed nominee will act</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15.45pt 0pt 5pt; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 21.2pt 0pt 5pt">or vote on any issue in his or her role as a director of
the Corporation, (2) that could limit or interfere with such proposed nominee's ability to comply with his or her fiduciary duties as
a director of the Corporation or (3) with respect to any direct or indirect compensation, reimbursement or indemnification in connection
with service as a director;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 21.2pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.9pt 0pt 5pt; text-indent: 1in">(B)&nbsp;&nbsp;has
read and agrees, if elected, to adhere to the Corporation&rsquo;s Corporate Governance Guidelines and Directors&rsquo; Code of Conduct
and any other Corporation policies and guidelines applicable to directors, including, but not limited to, those relating to corporate
governance, conflict of interest, confidentiality, stock ownership and trading policies;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.9pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.9pt 0pt 5pt; text-indent: 1in">(C) agrees
to be named as a nominee and to serve as a director if elected; and</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.4pt 0pt 5pt; text-indent: 1in">(D)&nbsp;&nbsp;will,
if elected, promptly following any subsequent re-election in which such proposed nominee does not receive the required vote, tender an
irrevocable resignation in accordance with Article II, Section 5 of these By-Laws.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.4pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt; text-align: left"><FONT STYLE="font-weight: normal">SECTION
4 </FONT>Shareholders Nominations Included in the Corporation&rsquo;s Proxy Statement</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.3pt 0pt 5pt">(a)&nbsp;&nbsp;<U>Inclusion
of Nominee in Proxy Statement</U>. Whenever the Board of Directors solicits proxies with respect to the election of Directors at an annual
meeting of shareholders, subject to the provisions of this Section 4, the Corporation shall include in its proxy materials for such annual
meeting:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.3pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.45pt 0pt 5pt; text-indent: 0.75in">(i)&nbsp;&nbsp;the
names of any persons nominated for election (each, a &ldquo;Shareholder Nominee&rdquo;) by any Eligible Shareholder (as defined below)
or group of up to twenty (20) Eligible Shareholders that has (individually or, in the case of a group, each member of the shareholder
group) satisfied, as determined by the Board of Directors, acting in good faith, all applicable conditions and complied with all applicable
procedures set forth in this Section 4 (such Eligible Shareholder or Eligible Shareholders being a &ldquo;Nominating Shareholder&rdquo;);</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.45pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 20.8pt 0pt 5pt; text-indent: 0.75in">(ii)&nbsp;&nbsp;disclosure
about each Shareholder Nominee and Nominating Shareholder required under the rules of the SEC or other applicable law to be included in
the proxy statement;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 20.8pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.85pt 0pt 5pt; text-align: justify; text-indent: 0.75in">(iii)&nbsp;&nbsp;a
Statement (as defined below in Section 4(e)) in support of each of the Shareholder Nominee&rsquo;s election to the Board of Directors
included by the Nominating Shareholder in the Nomination Notice for inclusion in the proxy statement (subject to the Corporation&rsquo;s
rights set forth in Section 4(e)); and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.85pt 0pt 5pt; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13pt 0pt 5pt; text-indent: 0.75in">(iv)&nbsp;&nbsp;any
other information that the Corporation or the Board of Directors determines, in their discretion, to include in the proxy statement relating
to the nomination of the Shareholder Nominee(s), including, without limitation, any statement in opposition to the nomination and any
of the information provided pursuant to this Section 4.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.3pt 0pt 5pt">(b) <U>Maximum
Number of Shareholder Nominees</U>.</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.75pt 0pt 5pt; text-indent: 0.75in">(i)&nbsp;&nbsp;The maximum number
of Shareholder Nominees appearing in the Corporation&rsquo;s proxy materials with respect to an annual meeting shall not exceed twenty
percent (20%) of the number of directors in office as of the last day on which a Nomination Notice may be delivered pursuant to this
Section 4, or if such amount is not a whole number, the closest whole number below twenty percent (20%) (the &ldquo;Maximum Number&rdquo;);
provided, however, that this number shall be reduced by (1) any Shareholder Nominee whose name was submitted by an</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.4pt 0pt 5pt">Eligible Shareholder for inclusion in the Corporation&rsquo;s
proxy materials pursuant to this Section 4 but either is subsequently withdrawn or that the Board of Directors decides to nominate as
a Board of Directors nominee and (2) the number of incumbent directors who had been Shareholder Nominees at any of the preceding two annual
meetings and whose election at the upcoming annual meeting is being recommended by the Board of Directors. In the event that one or more
vacancies for any reason occurs on the Board of Directors after the deadline set forth in Section 3(d) above but before the date of the
annual meeting and the Board of Directors resolves to reduce the size of the board in connection therewith, the Maximum Number shall be
calculated based on the number of directors in office as so reduced.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.4pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt; text-indent: 0.75in">(ii)&nbsp;&nbsp;Any
Eligible Shareholder submitting more than one Shareholder Nominee for inclusion in the Corporation&rsquo;s proxy materials pursuant to
this Section 4 shall rank such Shareholder Nominees based on the order in which the Eligible Shareholder desires such Shareholder Nominees
be selected for inclusion in the Corporation&rsquo;s proxy materials. If the number of Shareholder Nominees submitted by Eligible Shareholders
pursuant to this Section 4 exceeds the Maximum Number, the highest ranking Shareholder Nominee who meets the requirements of this Section
4 of each Eligible Shareholder will be selected for inclusion in the Corporation&rsquo;s proxy materials until the maximum number is reached,
going in order by the number (largest to smallest) of shares of common stock of the Corporation each Eligible Shareholder disclosed as
Owned in its respective Nomination Notice. If the Maximum Number is not reached after the highest ranking Shareholder Nominee who meets
the requirements of this Section 4 of each Eligible Shareholder has been selected, this process will continue with the next highest ranked
nominees as many times as necessary, following the same order each time, until the Maximum Number is reached.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.05pt"></TD><TD STYLE="width: 21.6pt">(c)</TD><TD><U>Eligibility of Nominating Shareholder</U></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.55pt 0pt 5pt; text-indent: 0.75in">(i)&nbsp;&nbsp;An
&ldquo;Eligible Shareholder&rdquo; is a person who has either (A) been a record holder of the shares of common stock used to satisfy the
eligibility requirements in this Section 4(c) continuously for the three-year period specified in paragraph (ii) below or (B) provides
to the Secretary of the Corporation, within the time period referred to in Section 3(d)(i), evidence of continuous Ownership of such shares
for such three-year period from one or more securities intermediaries in a form that the Board of Directors or its designee, acting in
good faith, determines would be deemed acceptable for purposes of a shareholder proposal under Rule 14a-8(b)(2) under the Exchange Act
(or any successor rule).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.55pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.25pt 0pt 5pt; text-indent: 0.75in">(ii)&nbsp;&nbsp;An Eligible Shareholder
or group of up to twenty (20) Eligible Shareholders (an &ldquo;Eligible Shareholder Group&rdquo;) may submit a nomination in accordance
with this Section 4 only if the person or group (in the aggregate) has continuously Owned at least the Required Shares throughout the
three-year period preceding and including the date of submission of the Nomination Notice, on the record date and continues to Own at
least the Required Shares through the date of the annual meeting. For the avoidance of doubt, in the event of a nomination by an Eligible
Shareholder Group, any and all requirements and obligations for an individual Eligible Shareholder that are set forth in this Section
5, including the minimum holding period, shall apply to each member of such group; provided, however, that the Required Shares shall
apply to the Ownership of the Eligible Shareholder Group in the aggregate. Should any shareholder cease to satisfy the eligibility requirements
in this Section 4, as determined by the Board of Directors or its designee, acting in good faith, or withdraw from an Eligible Shareholder
Group at any time prior to the annual meeting of shareholders, the Eligible Shareholder Group shall only be deemed to Own the shares
held by the remaining members of the group. For this purpose, two or more funds or trusts that are (A) under common management and investment
control, (B) under common management and funded primarily by the same employer, or (C) a &ldquo;group of investment companies,&rdquo;
as such term is defined in Section 12(d)(1)(G)(ii) of the</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.75pt 0pt 5pt">Investment Corporation Act of 1940, as amended (each, a
&ldquo;Qualifying Fund&rdquo;), shall be treated as one shareholder or beneficial owner.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.75pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.4pt 0pt 5pt; text-align: justify; text-indent: 0.75in">(iii)&nbsp;&nbsp;The
&ldquo;Required Shares&rdquo; means 3% of the number of outstanding shares of common stock of the Corporation as of the most recent date
for which such amount is given in any filing by the Corporation with the SEC prior to the submission of the Nomination Notice.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.4pt 0pt 5pt; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.1pt 0pt 5pt; text-indent: 0.75in">(iv)&nbsp;&nbsp;For purposes of this
Section 4, an Eligible Shareholder &ldquo;Owns&rdquo; only those outstanding shares of the Corporation as to which the Eligible Shareholder
possesses both: (A) the full voting and investment rights pertaining to the shares and (B) the full economic interest in (including the
opportunity for profit and risk of loss on) such shares; provided, that the number of shares calculated in accordance with clauses (A)
and (B) shall not include any shares: (1) sold by such Eligible Shareholder or any of its affiliates in any transaction that has not
been settled or closed, (2) borrowed by such Eligible Shareholder or any of its affiliates for any purpose or purchased by such Eligible
Shareholder or any of its affiliates pursuant to an agreement to resell, or (3) subject to any option, warrant, forward contract, swap,
contract of sale, other derivative or similar agreement entered into by such Eligible Shareholder or any of its affiliates, whether any
such instrument or agreement is to be settled with shares or with cash based on the notional amount or value of outstanding shares of
the Corporation, in any such case which instrument or agreement has, or is intended to have, the purpose or effect of: (x) reducing in
any manner, to any extent or at any time in the future, such Eligible Shareholder&rsquo;s or any of its affiliates&rsquo; full right
to vote or direct the voting of any such shares, and/or (y) hedging, offsetting, or altering to any degree, gain or loss arising from
the full economic ownership of such shares by such Eligible Shareholder or any of its affiliates. An Eligible Shareholder &ldquo;owns&rdquo;
shares held in the name of a nominee or other intermediary so long as the Eligible Shareholder retains the right to instruct how the
shares are voted with respect to the election of directors and possesses the full economic interest in the shares. An Eligible Shareholder&rsquo;s
ownership of shares shall be deemed to continue during any period in which the Eligible Shareholder has delegated any voting power by
means of a proxy, power of attorney, or other similar instrument or arrangement that is revocable at any time by the Eligible Shareholder.
An Eligible Shareholder&rsquo;s ownership of shares shall be deemed to continue during any period in which the Eligible Shareholder has
loaned such shares provided that the Eligible Shareholder has the power to recall such loaned shares on three business days&rsquo; notice
and has recalled such shares upon notification that it&rsquo;s nominees would be included in the proxy statement. The terms &ldquo;Owned,&rdquo;
&ldquo;Owning&rdquo; and other variations of the word &ldquo;Own&rdquo; shall have correlative meanings. Whether outstanding shares of
the Corporation are &ldquo;Owned&rdquo; for these purposes shall be determined by the Board of Directors or its designee.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.4pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 22.5pt 0pt 5pt; text-indent: 0.75in">(v)&nbsp;&nbsp;No
person shall be permitted to be in more than one Eligible Shareholder Group, and if any person appears as a member of more than one Eligible
Shareholder Group, it shall be deemed to be a member of the Eligible Shareholder Group that has the largest ownership position as reflected
in the Nomination Notice.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 22.5pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.6pt 0pt 5pt">(d)&nbsp;&nbsp;<U>Information
to be Provided by Nominating Shareholder</U>. Within the time period specified in Section 3(d)(i), each Nominating Shareholder must provide
the following information in writing to the Secretary of the Corporation:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.6pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 16.9pt 0pt 5pt; text-indent: 0.75in">(i)&nbsp;&nbsp;a
copy of the Schedule 14N that has been filed by such Eligible Shareholder with the Securities and Exchange Commission as required by Rule
14a-18 under the 1934 Act, as such rule may be amended;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 16.9pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.9pt 0pt 5pt; text-indent: 0.75in">(ii)&nbsp;&nbsp;one
or more written statements from the record holder of the shares of capital stock of the Corporation (and from each intermediary through
which the shares are or have been held during the requisite three</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.9pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.9pt 0pt 5pt; text-indent: 0.75in"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.9pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.15pt 0pt 5pt">(3)-year holding period) specifying the number of shares
of capital stock of the Corporation that the Nominating Shareholder Owns, and has continuously Owned for three (3) years preceding the
date of the Nomination Notice, and the Nominating Shareholder&rsquo;s agreement to provide, within five (5) business days after the record
date for the annual meeting, written statements from the record holder and intermediaries verifying the Eligible Shareholder&rsquo;s continuous
Ownership of the Required Shares through the record date;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.15pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 29.3pt 0pt 5pt; text-indent: 0.75in">(iii)&nbsp;&nbsp;a
written notice by each Nominating Shareholder (including each member of an Eligible Shareholder Group), including the information required
with respect to the nomination of directors pursuant to Section 3(d)(ii) of this Article I;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 29.3pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.1pt 0pt 5pt; text-indent: 0.75in">(iv)&nbsp;&nbsp;a
written notice by each Nominating Shareholder (including each member of an Eligible Shareholder Group), in a form deemed satisfactory
by the Board of Directors or its designee, acting in good faith, in which each the Nominating Shareholder represents and warrants to the
Corporation the following:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.1pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.85pt 0pt 5pt; text-indent: 1in">(A)&nbsp;&nbsp;that
the Nominating Shareholder acquired the securities of the Corporation in the ordinary course of business and did not acquire, and is not
holding, securities of the Corporation for the purpose or with the effect of influencing or changing control of the Corporation;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.85pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.65pt 0pt 5pt; text-indent: 1in">(B)&nbsp;&nbsp;that
the Shareholder Nominee&rsquo;s candidacy or, if elected, Board membership would not violate applicable state or federal law or the rules
of any national securities exchange on which the Corporation&rsquo;s securities are traded;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.65pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.95pt 0pt 5pt; text-indent: 1in">(C)&nbsp;&nbsp;that
the Shareholder Nominee: (A) does not have any direct or indirect relationship with the Corporation that will cause the Shareholder Nominee
to be deemed not independent pursuant to the Corporation&rsquo;s Corporate Governance Guidelines as most recently published on its website
prior to the submission of the Nomination Notice and otherwise qualifies as independent under the rules of any national securities exchange
on which the Corporation&rsquo;s shares of common stock are traded; (B) is a &ldquo;non-employee director&rdquo; for the purposes of Rule
16b-3 under the Exchange Act (or any successor rule); (C) is an &ldquo;outside director&rdquo; for the purposes of Section 162(m) of the
Internal Revenue Code (or any successor provision); and (D) is not and has not been subject to any event specified in Rule 506(d)(1) of
Regulation D (or any successor rule) under the Securities Act of 1933 or Item 401(f) of Regulation S-K (or any successor rule) under the
Exchange Act, without reference to whether the event is material to an evaluation of the ability or integrity of the Shareholder Nominee;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.95pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 21.75pt 0pt 5pt; text-indent: 1in">(D)&nbsp;&nbsp;that
the Nominating Shareholder satisfies the eligibility requirements set forth in Section 4(c) and has provided evidence of ownership to
the extent required by Section 4(c)(i)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 21.75pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 22.1pt 0pt 5pt; text-indent: 1in">(E)&nbsp;&nbsp;that
the Nominating Shareholder agrees to Own the Required Shares through the date of the annual meeting and satisfy the eligibility requirements
described in Section 4(c) through the date of the annual meeting;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 22.1pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.8pt 0pt 5pt; text-indent: 1in">(F)&nbsp;&nbsp;that
the Nominating Shareholder has not engaged and will not engage in, and has not and will not be a &ldquo;participant&rdquo; in another
person&rsquo;s, &ldquo;solicitation&rdquo; within the meaning of Rule 14a-1(l) under the 1934 Act in support of the election of any individual
as a director at the annual meeting other than its Shareholder Nominee or a nominee of the Board of Directors;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.8pt 0pt 5pt; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.5pt 0pt 5pt; text-indent: 1in">(G) that the Nominating Shareholder
will not use any proxy card other than the Corporation&rsquo;s proxy card in soliciting shareholders in connection with the election
of a Shareholder Nominee at the annual meeting;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.5pt 0pt 5pt; text-indent: 1in">(H)&nbsp;&nbsp;that
the facts, statements and other information in all communications with the Corporation and its shareholders are and will be true and correct
in all material respects and do not and will not omit to state a material fact necessary in order to make the statements made, in light
of the circumstances under which they were made, not misleading, and will otherwise comply with all applicable laws, rules and regulations
in connection with any actions taken pursuant to this Section 4; and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.5pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 25.15pt 0pt 5pt; text-indent: 1in">(I)&nbsp;&nbsp;in
the case of a nomination by an Eligible Shareholder Group, the designation by all group members of one group member that is authorized
to act on behalf of all group members with respect to matters relating to the nomination, including withdrawal of the nomination;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 25.15pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.6pt 0pt 5pt; text-indent: 0.75in">(v)&nbsp;&nbsp;an
executed agreement, in a form deemed satisfactory by the Board of Directors or its designee, acting in good faith, pursuant to which the
Nominating Shareholder (including each group member) agrees:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.6pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 28.45pt 0pt 5pt; text-indent: 1in">(A)&nbsp;&nbsp;to
comply with all applicable laws, rules and regulations in connection with the nomination, solicitation and election;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 28.45pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.7pt 0pt 5pt; text-indent: 1in">(B)&nbsp;&nbsp;to
file any written communication with the Corporation&rsquo;s shareholders relating to one or more of the Corporation&rsquo;s directors
or director nominees or any Shareholder Nominee with the SEC, regardless of whether any such filing is required under any rule or regulation
or whether any exemption from filing is available for such materials under any rule or regulation;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.7pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 19.6pt 0pt 5pt; text-indent: 1in">(C)&nbsp;&nbsp;to
assume all liability stemming from an action, suit or proceeding concerning any actual or alleged legal or regulatory violation arising
out of any communication by the Nominating Shareholder or any of its Shareholder Nominees with the Corporation, its shareholders or any
other person in connection with the nomination or election of directors, including, without limitation, the Nomination Notice;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 19.6pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.7pt 0pt 5pt; text-indent: 1in">(D)&nbsp;&nbsp;to
indemnify and hold harmless (jointly with all other group members, in the case of a group member) the Corporation and each of its directors,
officers and employees individually against any liability, loss, damages, expenses or other costs (including attorneys&rsquo; fees) incurred
in connection with any threatened or pending action, suit or proceeding, whether legal, administrative or investigative, against the Corporation
or any of its directors, officers or employees arising out of or relating to a failure or alleged failure of the Nominating Shareholder
or any of its Shareholder Nominees to comply with, or any breach or alleged breach of, its respective obligations, agreements or representations
under this Section 4; and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.7pt 0pt 5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.05pt 0pt 5pt; text-indent: 1in">(E)&nbsp;&nbsp;in the event that any
information included in the Nomination Notice ceases to be true and accurate in all material respects (or omits a material fact necessary
to make the statements made not misleading), or that the Nominating Shareholder (including any group member) has failed to continue to
satisfy the eligibility requirements described in Section 4(c), to promptly notify the Corporation of the misstatement or omission in
such previously provided information and of the information that is required to correct the misstatement or omission (it being understood
that providing any such notification shall not be deemed to cure any such defect or limit the Corporation&rsquo;s right to omit a Shareholder
Nominee from its proxy materials pursuant to this Section 4); and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 35.4pt 0pt 5pt">(e)&nbsp;&nbsp;<U>Representations
and Agreement of the Shareholder Nominee</U>. Within the time period specified in Section 3(d)(i), each Shareholder Nominee must deliver
to the Secretary of the Corporation the following:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 35.4pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 20pt 0pt 5pt; text-indent: 0.75in">(i)&nbsp;&nbsp;a
completed Questionnaire and Statement of Representations and Agreements as set forth in Section 3(e) of Article I; and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 20pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.4pt 0pt 5pt; text-indent: 0.75in">(ii)&nbsp;&nbsp;a
letter of resignation signed by the Shareholder Nominee, which letter shall specify that such Shareholder Nominee&rsquo;s resignation
is irrevocable and that it shall become effective upon a determination by the Board of Directors or any committee thereof (excluding,
for purposes of such determination, such Shareholder Nominee) that (x) any of the information provided to the Corporation by the Eligible
Shareholder or the Shareholder Nominee in respect of the nomination of such Shareholder Nominee pursuant to this Section 4 is or was untrue
in any material respect or omitted to state a material fact necessary in order to make the statement made, in light of the circumstances
under which it was made, not misleading or (y) the Eligible Shareholder shall have breached any of its obligations under this Section
4.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.4pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.15pt 0pt 5pt">(f)&nbsp;&nbsp;<U>Statement</U>. In addition to the items
required pursuant to Section 4(d) of this Article I, the Eligible Shareholder may provide to the Secretary of the Corporation, at the
time the information required by this Section 4 is provided, a written statement for inclusion in the Corporation&rsquo;s proxy statement
for the annual meeting, not to exceed five hundred (500) words, in support of the Shareholder Nominee&rsquo;s candidacy (the &ldquo;Statement&rdquo;).
Notwithstanding anything to the contrary contained in this Section 4, the Corporation may omit from its proxy materials any information
or Statement (or portion thereof) that it, in good faith, believes would violate any applicable law, rule, regulation or listing standard.
Nothing in this Section 4 shall limit the Corporation&rsquo;s ability to solicit against and include in its proxy materials its own statements
relating to any Eligible Shareholder or Shareholder Nominees.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.4pt 0pt 5pt">(g)&nbsp;&nbsp;<U>Limitation
on Shareholder Nominees</U>. Any Shareholder Nominee who is included in the Corporation&rsquo;s proxy materials for a particular annual
meeting but either (i) withdraws from or becomes ineligible or unavailable for election at such annual meeting, or (ii) does not receive
at least twenty five percent (25%) of the votes cast &ldquo;for&rdquo; the Shareholder Nominee&rsquo;s election, will be ineligible to
be a Shareholder Nominee pursuant to this Section 4 for the next two (2) annual meetings. Any Shareholder Nominee who is included in the
Corporation&rsquo;s proxy materials for a particular annual meeting, but subsequently is determined not to satisfy the eligibility requirements
of this Section 4 or any other provision of the Corporation&rsquo;s By-laws, Certificate of Incorporation, Corporate Governance Guidelines
or other applicable regulation at any time before the applicable annual meeting, will not be eligible for election at such annual meeting
and may not be replaced by the Eligible Shareholder that nominated such Shareholder Nominee. If, after the deadline for submitting a Nomination
Notice, a Nominating Shareholder ceases to satisfy, as determined by the Board of Directors or its designee, acting in good faith, the
eligibility requirements in this Section 4 or withdraws its nomination or a Shareholder Nominee ceases to satisfy the eligibility requirements
in this Section 4, as determined by the Board of Directors or its designee, acting in good faith, or becomes unwilling to serve on the
Board of Directors, whether before or after the mailing of the definitive proxy statement, then the nomination shall be disregarded, and
the Corporation (1) shall not be required to include in its proxy statement or on any ballot or form of proxy the disregarded Shareholder
Nominee or any successor or replacement nominee proposed by the applicable Nominating Shareholder or by any other Nominating Shareholder
and (2) may otherwise communicate to its shareholders, including without limitation by amending or supplementing its proxy statement or
ballot or form of proxy, that the Shareholder Nominee will not be included as a Shareholder Nominee in the proxy statement or on any ballot
or form of proxy and will not be voted on at the annual meeting.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.4pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.4pt 0pt 5pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.4pt 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.25pt 0pt 5pt">(h)&nbsp;&nbsp;<U>Exceptions</U>.
Notwithstanding anything to the contrary in this Section 4, the Corporation may omit from its proxy statement any Shareholder Nominee
and any information concerning such Shareholder Nominee (including a Nominating Shareholder&rsquo;s Statement) and no vote on such Shareholder
Nominee will occur (notwithstanding that proxies in respect of such vote may have been received by the Corporation), and the Nominating
Shareholder may not, after the last day on which a Nomination Notice would be timely, cure in any way any defect preventing the nomination
of the Shareholder Nominee, if:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.25pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.2pt 0pt 5pt; text-indent: 0.75in">(i)&nbsp;&nbsp;if
the Eligible Shareholder who has nominated such Shareholder Nominee has engaged in or is currently engaged in, or has been or is a &ldquo;participant&rdquo;
in another person&rsquo;s, &ldquo;solicitation&rdquo; within the meaning of Rule 14a-1(l) under the 1934 Act in support of the election
of any individual as a director at the meeting other than its Shareholder Nominee(s) or a nominee of the Board of Directors;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.2pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.9pt 0pt 5pt; text-indent: 0.75in">(ii)&nbsp;&nbsp;if
the Shareholder Nominee is not independent under the Applicable Independence Standards, as determined by the Board of Directors;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.9pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 28.45pt 0pt 5pt; text-indent: 0.75in">(iii)&nbsp;&nbsp;if
the Shareholder Nominee&rsquo;s nomination or election as a member of the Board of Directors would cause the Corporation to be in violation
of these By-Laws, the Certificate of Incorporation, the listing standards of the principal exchange upon which the Corporation&rsquo;s
shares of common stock are traded, or any applicable law, rule or regulation;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 28.45pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.55pt 0pt 5pt; text-indent: 0.75in">(iv)&nbsp;&nbsp;if
the Shareholder Nominee is or has been, within the past three years, an employee or director of a competitor, as defined in Section 8
of the Clayton Antitrust Act of 1914;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.55pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15.75pt 0pt 5pt; text-indent: 0.75in">(v)&nbsp;&nbsp;if
the Shareholder Nominee is, or becomes prior to the annual meeting, a named subject of a pending criminal proceeding (excluding traffic
violations and other minor offenses) or has been convicted in such a criminal proceeding within the past ten (10) years;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15.75pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 30.5pt 0pt 5pt; text-indent: 0.75in">(vi)&nbsp;&nbsp;if
the Shareholder Nominee is or becomes subject to any order of the type specified in Rule 506(d) of Regulation D promulgated under the
Securities Act of 1933, as amended;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 30.5pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.3pt 0pt 5pt; text-indent: 0.75in">(vii)&nbsp;&nbsp;if
any information provided by the Shareholder Nominee or any Nominating Shareholder to the Corporation was untrue in any material respect
or omitted to state a material fact necessary in order to make the statement made, in light of the circumstances under which it was made,
not misleading, as determined by the Board of Directors;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.3pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.9pt 0pt 5pt; text-indent: 0.75in">(viii)&nbsp;&nbsp;if
the Eligible Shareholder or applicable Shareholder Nominee otherwise contravenes any of the agreements or representations made by such
Eligible Shareholder or Shareholder Nominee or fails to comply with its obligations pursuant to this Section 4; or</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.9pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.2pt 0pt 5pt; text-indent: 0.75in">(ix)&nbsp;&nbsp;if
the Eligible Shareholder ceases to be an Eligible Shareholder for any reason, including but not limited to not Owning the Required Shares
through the date of the applicable annual meeting.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.2pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 16.8pt 0pt 5pt">(i)&nbsp;&nbsp;<U>Exclusion</U>.
Notwithstanding anything to the contrary set forth herein, if the Corporation (A) receives notice pursuant to Section 3(c)(ii) that any
shareholder intends to nominate any nominee for election at such meeting, or</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 16.8pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 17.85pt 0pt 5pt">(B) has entered into, or will enter into, an agreement
or other arrangement with one or more shareholder(s) to avoid any person being formally proposed as a director candidate pursuant to Article
I, Section 3(c)(ii) of these By-</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 17.85pt 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">Laws, no Shareholder Nominees will be included in the Corporation&rsquo;s
proxy materials with respect to such meeting pursuant to this Section 4.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">(j)&nbsp;&nbsp;<U>Disqualifications</U>.
Notwithstanding anything to the contrary set forth herein, the Board of Directors or the person presiding at the meeting shall declare
a nomination by an Eligible Shareholder to be invalid, and such nomination shall be disregarded notwithstanding that proxies in respect
of such vote may have been received by the Corporation, if (i) the Shareholder Nominee(s) and/or the applicable Eligible Shareholder shall
have breached its or their obligations, agreements or representations under this Section 4, as determined by the Board of Directors or
the person presiding at the annual meeting, or (ii) the Eligible Shareholder (or a qualified representative thereof) does not appear at
the annual meeting to present any nomination pursuant to this Section 4.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 27.5pt 0pt 5pt">(k)&nbsp;&nbsp;<U>Filing
Obligation</U>. The Eligible Shareholder (including any person who Owns shares of common stock of the Corporation that constitute part
of the Eligible Shareholder&rsquo;s Ownership for purposes of satisfying Section 4(e) hereof) shall file with the Securities and Exchange
Commission any solicitation or other communication with the</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 27.5pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.1pt 0pt 5pt">Corporation&rsquo;s shareholders relating to the meeting
at which the Shareholder Nominee will be nominated, regardless of whether any such filing is required under Regulation 14A of the 1934
Act or whether any exemption from filing is available for such solicitation or other communication under Regulation 14A of the 1934 Act.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.1pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.35pt 0pt 5pt; text-align: justify">SECTION 5 <B>Quorum</B>. At all meetings
of the shareholders of the Corporation, the holders of a majority of the shares of capital stock of the Corporation entitled to vote at
such meeting, present in person or by proxy, shall constitute a quorum for the transaction of any business except as otherwise provided
by law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.35pt 0pt 5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.65pt 0pt 5pt">SECTION 6 <B>Organization; Adjournment</B>. The Board
of Directors may prescribe an order of business for meetings of shareholders. The Chair of the Board, or in his or her absence, the Chief
Executive Officer, shall preside at meetings of the shareholders; provided, however, that the Board of Directors may for any meeting
of shareholders designate another officer or officers to preside. If a quorum, determined in accordance with Article I, Section 5 of
these By-Laws, shall not be present or represented at any meeting of the shareholders, the chair of the meeting, or if so requested by
the chair, the shareholders present in person or represented by proxy, shall have the power to adjourn the meeting from time to time,
without notice other than announcement at the meeting, until a quorum shall be present or represented. In addition, the chair of any
meeting of shareholders shall have the power to adjourn the meeting at the request of the Board of Directors if the Board of Directors
determines that adjournment is necessary or appropriate to enable shareholders to consider fully the information which the Board of Directors
determines has not been made sufficiently or timely available to shareholders.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.2pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">SECTION 7 <B>Voting</B>. At each meeting of the shareholders
every shareholder of record of the Corporation entitled to vote at such meeting shall be entitled to one vote for each share of Common
Stock standing in his or her name on the books of the Corporation; provided, however, that the Board of Directors may fix, in advance,
a date not more than sixty (60) nor less than ten (10) days prior to the date of such meeting as the date as of which shareholders entitled
to notice of, and to vote at, such meeting shall be determined, and in case the Board of Directors shall fix a date, only shareholders
of record on such date shall be entitled to notice of, and to vote at, such meeting. At any meeting of shareholders each shareholder having
the right to vote shall be entitled to vote in person or by proxy.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.95pt 0pt 5pt; text-align: justify">Except with respect to the election
of directors, which shall be governed by Article II, Section 3 of these By-Laws, and except as otherwise provided by law, in the Certificate
of Incorporation or these By-Laws, all matters will be</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.95pt 0pt 5pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">determined by the vote of the holders of a majority of
the votes cast in favor or against the matter. Abstentions and broker non-votes will not count as a vote cast.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.75pt 0pt 5pt">SECTION 8 <B>Inspectors of Election</B>. At any meeting
of the shareholders, an inspector or inspectors of election may be appointed as provided in the Business Corporation Law and shall have
duties as provided in the Business Corporation Law. An inspector of election need not be a shareholder of the Corporation, and any officer
of the Corporation may be an inspector of election on any question other than a vote for or against his or her election to any position
with the Corporation or any other question in which he or she may be directly interested.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.75pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE II</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">BOARD
OF DIRECTORS</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 214.8pt; text-align: left; text-indent: 28.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.55pt 0pt 5pt">SECTION 1 <B>General Powers</B>. Except as otherwise provided
in these By-Laws or in the Certificate of Incorporation, the property, business and affairs of the Corporation shall be managed by the
Board of Directors.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.55pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.6pt 0pt 5pt">SECTION 2 <B>Number and Term</B>. Subject to Article II,
Section 14, the number of directors shall be fourteen (14) but the number thereof may, from time to time, be diminished to not less than
six (6) by amendment of these By-Laws. As used in these By-Laws, the term &ldquo;entire Board of Directors&rdquo; shall mean the total
number of directors which the Corporation would have at the time if there were no vacancies. Directors shall be elected to serve until
the next annual meeting or until his or her successor shall be duly elected and qualified.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.6pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">SECTION 3 <B>Election of Directors.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.15pt 0pt 5pt">At each meeting of the shareholders for the election of
directors at which a quorum is present, the vote required for election of a director by the shareholders shall, except in a Contested
Election, be the affirmative vote of a majority of the votes cast &ldquo;for&rdquo; the election of a nominee. For purposes of this Section
3, the affirmative vote of a majority of the votes cast shall mean that the number of votes cast &ldquo;for&rdquo; a nominee&rsquo;s election
exceeds the number of votes cast &ldquo;against&rdquo; that nominee&rsquo;s election.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.15pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">In a Contested Election, the persons receiving a plurality
of the votes cast by the holders of shares of capital stock entitled to vote at such meeting shall be the directors. A &ldquo;Contested
Election&rdquo; means an election where, as of the record date for such meeting in which the election will be held, there are more nominees
for election than positions on the Board of Directors to be filled by election at the meeting; provided that with respect to any nominee
proposed or nominated by a shareholder, the Secretary of the Corporation shall have received proper notice under Article I, Section 3
of these By-Laws. For purposes of this Section 3, if plurality voting is applicable to the election of directors at any meeting, the
nominees who receive the highest number of votes cast &ldquo;for,&rdquo; without regard to votes cast &ldquo;against&rdquo; or &ldquo;withhold,&rdquo;
shall be elected as directors up to the total number of directors to be elected at that meeting. Abstentions and broker non-votes will
not count as a vote cast with respect to any election of directors.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.7pt 0pt 5pt">SECTION 4 <B>Organization</B>. The Board of Directors may
choose one of their number as Chair of the Board. At each meeting of the Board of Directors, the Chair of the Board, or, if there shall
be no Chair of the Board or if he or she shall be absent, the Chief Executive Officer of the Corporation, or in case of his or her absence,
a chair who shall be any director chosen by a majority of the directors present thereat, shall act as chair of such meeting and preside
thereat. The Secretary of the Corporation, or in the case of his or her absence, any person whom the chair shall appoint secretary of
such meeting, shall act as secretary of such meeting and keep the minutes thereof.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.7pt 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">SECTION 5 <B>Resignations.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.35pt 0pt 5pt">(a)&nbsp;&nbsp;Any director
of the Corporation may resign at any time by giving written notice of his or her resignation to the Board of Directors, the Chief Executive
Officer or the Secretary of the Corporation. Subject to Section 5(b), any such resignation shall take effect at the time specified therein
or, if the time when the resignation shall become effective is not specified therein, then it shall take effect immediately upon its receipt
by such Board of Directors, Chief Executive Officer or Secretary; and, unless otherwise specified therein or as otherwise required by
the Corporation&rsquo;s corporate governance policies, the acceptance of such resignation shall not be necessary to make it effective.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.35pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.8pt 0pt 5pt">(b)&nbsp;&nbsp;In an election
of directors that is not contested, any incumbent director nominee who is not re-elected by the shareholders shall immediately tender
his or her resignation to the Chair of the Nominating and Governance Committee, subject to acceptance or rejection by the Board of Directors
as provided in this Section 5(b). The Nominating and Governance Committee shall consider the resignation offer and make a recommendation
to the Board of Directors. The Board of Directors (excluding the subject director), in accordance with the procedures established by the
Board of Directors, shall decide whether to act on the Nominating and Governance Committee&rsquo;s recommendation within ninety (90) days
after the date the results of the election are certified and the Corporation shall promptly disclose and explain such decision in a document
furnished or filed with the SEC. An incumbent director who tenders his or her resignation in accordance with this Section 5(b) will not
participate in the deliberations by the Nominating and Governance Committee or Board of Directors with respect to such resignation. If
the Board of Directors does not accept the incumbent director&rsquo;s resignation, he or she shall continue to serve until the next annual
meeting of shareholders and until his or her successor is elected and qualified. If the Board of Directors accepts the resignation, or
if the nominee who failed to receive the required vote is not an incumbent director, the Board of Directors may fill the resulting vacancy
or decrease the size of the Board of Directors in accordance with these By-Laws.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.8pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.2pt 0pt 5pt">SECTION 6 <B>Vacancies</B>. Except as provided in Article
II, Section 14, vacancies occurring in the Board of Directors for any reason, except the removal of directors without cause by the shareholders,
may be filled by the affirmative vote of at least two-thirds (2/3) of the whole Board of Directors. A director elected to fill a vacancy
shall be elected to hold office for the unexpired term of his or her predecessor. Newly-created directorships resulting from an increase
in the number of directors may be filled by the vote of a majority of the directors then in office, although less than a quorum exists.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.2pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.45pt 0pt 5pt">SECTION 7 <B>Annual Organization Meeting</B>. After each
annual election of directors, the Board of Directors may hold a regular meeting for the purpose of organization and the transaction of
other business as soon as practicable on the same day, at the place where other regular meetings of the Board of Directors are held. Notice
of such meeting need not be given. Such meeting may be held at any other time or place which shall be specified in a notice given as hereinafter
provided for special meetings of the Board of Directors or in a consent and waiver of notice thereof signed by all the directors.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.5pt 0pt 5pt">SECTION 8 <B>Regular Meetings</B>. Regular meetings of the
Board of Directors shall be held at such times and at such places within or without the State of New York or the United States as the
Board of Directors shall from time to time determine.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.5pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.55pt 0pt 5pt">SECTION 9 <B>Special Meetings; Notice</B>. Special meetings
of the Board of Directors shall be held whenever called by the Chair of the Board, the Chief Executive Officer of the Corporation, or
by any two (2) of the</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.55pt 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.95pt 0pt 5pt">directors at the time in office. A notice of each such
special meeting stating the time and place thereof shall be given as provided in this Section 9. Except as otherwise provided by law,
notice of each meeting shall be given by first class mail, telephone, overnight delivery, electronic mail, facsimile or hand delivery
to each director, at his or her residence or usual place of business at least forty-eight (48) hours before the meeting is to be held.
Notice of any meeting of the Board of Directors need not, however, be given to any director, if waived by him or her in writing before
or after the meeting or if he or she shall attend the meeting without protesting, prior thereto or at its commencement, the lack of notice
to him or her. Neither notices of a meeting nor a waiver of notice need specify the purpose of any regular or special meeting of the Board
of Directors.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.95pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">SECTION 10 <B>Quorum and Manner of Acting.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.95pt 0pt 5pt">(a)&nbsp;&nbsp;<U>Quorum</U>.
A majority of the entire Board of Directors shall be present in person at any meeting of the Board of Directors in order to constitute
a quorum for the transaction of business at such meeting and, except as otherwise specifically provided by the Certificate of Incorporation,
these By-Laws or by law, the act of a majority of the directors present at any such meeting, at which a quorum is present, shall be the
act of the Board of Directors. In the absence of a quorum for any meeting, a majority of the directors present thereat may adjourn such
meeting from time to time until a quorum shall be present thereat. Notice of any adjourned meeting need not be given.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.95pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.85pt 0pt 5pt">(b)&nbsp;&nbsp;<U>Telephone
Meetings</U>. Unless otherwise restricted by the Certificate of Incorporation or these By-Laws, any one or more members of the Board of
Directors or any committee thereof may participate in a meeting of the Board of Directors or committee by means of a conference telephone,
video conference or similar communications equipment allowing all persons participating in the meeting to hear each other at the same
time. Participation by such means shall constitute presence in person at a meeting.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.85pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6pt 0pt 5pt">(c)&nbsp;&nbsp;<U>Action By
Written Consent</U>. Any action required or permitted to be taken by the Board of Directors may be taken without a meeting, provided that
all Board members individually provide written consent to that action (which may include consent by electronic means); and provided further
that if such consent is effected by electronic means, such consent shall include a description of the action being taken and the typed
name of the director, which shall constitute the legally binding electronic signature of the director. Such action by written consent
will have the same force and effect as a unanimous vote of the Board of Directors. Such written consent and any counterparts thereof will
be filed with the minutes of the proceedings of the Board of Directors.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.1pt 0pt 5pt">SECTION 11 <B>Committees</B>. By the affirmative vote of
a majority of the entire Board of Directors, the Board of Directors may designate from among its members an Executive Committee, an Audit
Committee, a Human Capital and Compensation Committee, a Nominating and Governance Committee and other committees, each consisting of
one or more members. If an Executive Committee is created, the Chair of the Board, shall be a member. The Executive Committee will have
all the authority of the Board of Directors except as otherwise provided by Section 712 of the Business Corporation Law or other applicable
statutes. Any other committees will have such authority as the Board of Directors may provide. The Board of Directors may designate one
or more directors as alternate members of any committee to replace absent members. Subject to Article II, Section 14, the members of all
committees shall be selected by and removed by the Board of Directors. Such committees may meet at stated times or, in accordance with
their charters, upon notice to all the members of the committee. Each committee shall keep regular minutes of its proceedings and report
the same to the Board of Directors when required.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.1pt 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.4pt 0pt 5pt">SECTION 12 <B>Removal</B>. Any director may be removed
with cause by the affirmative vote of at least two-thirds of the entire Board of Directors or with or without cause by vote of the shareholders
at a regular or special meeting, subject to the provisions of the Business Corporation Law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.4pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.45pt 0pt 5pt">SECTION 13 <B>Compensation</B>. The directors and the
members of any committee of the Board of Directors of the Corporation shall be entitled to be reimbursed for any expenses, including all
travel expenses, incurred by them on account of their attendance at any regular or special meeting of the Board of Directors or of such
committee, and the Board of Directors may at any time or from time to time by resolution provide that the Corporation shall pay each such
director or member of such committee such compensation for his or her services as may be specified in such resolution. Nothing in this
Section 13 shall be construed to preclude any director from serving the Corporation in any other capacity and receiving compensation therefore.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">SECTION 14 <B>Special Governance Matters.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 27.2pt 0pt 5pt">(a)&nbsp;&nbsp;<U>Board Composition</U>. As of the Effective
Time on February 1, 2021, the Board of Directors of the Corporation consisted of (i) six (6) directors designated by the board of directors
of DuPont de Nemours, Inc. (&ldquo;DuPont&rdquo;) (collectively, the &ldquo;DuPont Designees&rdquo;), and (ii) seven (7) directors designated
by the Board of Directors as of immediately prior to the Effective Time and who were members of the Board of Directors immediately prior
to the Effective Time (collectively, the &ldquo;IFF Designees&rdquo;). For purposes of this Article II in these By-Laws, the term &ldquo;Effective
Time&rdquo; shall have the meaning set forth in that certain Agreement and Plan of Merger (the &ldquo;Merger Agreement&rdquo;) dated
as of December 15, 2019, by and among DuPont, Nutrition &amp; Biosciences, Inc., the Corporation, and Neptune Merger Sub I Inc.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.3pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.3pt 0pt 5pt">(b)&nbsp;&nbsp;<U>Nomination</U>.
The Board of Directors shall nominate for election to the Board of Directors at the Corporation&rsquo;s 2022 annual meeting (i) the six
(6) DuPont Designees (or any replacements thereof pursuant to Article II, Section 14(d)) and (ii) six (6) IFF Designees (or any replacements
thereof pursuant to Article II, Section 14(d)). The Board of Directors may nominate for election at such meeting more than twelve (12)
directors in total, provided that the nomination of any additional directors shall require the approval by (i) the affirmative vote of
a majority of the IFF Designees and/or Continuing IFF Designees, as applicable, then in office and (ii) the affirmative vote of a majority
of the DuPont Designees and/or Continuing DuPont Designees, as applicable, then in office.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.3pt 0pt 5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.05pt"></TD><TD STYLE="width: 21.6pt">(c)</TD><TD><U>Vacancies</U>. Until the Corporation&rsquo;s 2022 annual meeting:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.3pt 0pt 5pt; text-indent: 0.75in">(i)&nbsp;&nbsp;if
there is a vacancy created by cessation of service of any DuPont Designee (whether as a result of illness, death, resignation, removal
or any other reason, but in each case, except as provided in clause (c)(iii) below), such vacancy shall be filled by the affirmative vote
of a majority of the remaining DuPont Designees then in office, even if less than a quorum, or by a sole remaining DuPont Designee (any
such replacement, a &ldquo;Continuing DuPont Designee&rdquo;); and if there is a vacancy created by cessation of service of any Continuing
DuPont Designee (whether as a result of illness, death, resignation, removal or any other reason, but in each case, except as provided
in clause (c)(iii) below), such vacancy shall be filled by the affirmative vote of a majority of the remaining DuPont Designees and/or
Continuing DuPont Designee, as applicable, then in office, even if less than a quorum, or by a sole remaining DuPont Designee and/or Continuing
DuPont Designee, as applicable;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.3pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7pt 0pt 5pt; text-indent: 0.75in">(ii)&nbsp;&nbsp;if
there is a vacancy created by cessation of service of any IFF Designee (whether as a result of illness, death, resignation, removal or
any other reason, but in each case, except as provided in clause (c)(iii) below), such vacancy shall be filled by the affirmative vote
of a majority of the remaining IFF Designees then in office, even if</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.7pt 0pt 5pt">less than a quorum, or by a sole remaining IFF Designee
(any such replacement, a &ldquo;Continuing IFF Designee&rdquo;); and if there is a vacancy created by cessation of service of any Continuing
IFF Designee (whether as a result of illness, death, resignation, removal or any other reason, but in each case, except as provided in
clause (c)(iii) below), such vacancy shall be filled by the affirmative vote of a majority of the remaining IFF Designees and/or Continuing
IFF Designees, as applicable, then in office, even if less than a quorum, or by a sole remaining IFF Designee and/or Continuing IFF Designee,
as applicable; provided that the identity of each Continuing IFF Designee shall be reasonably acceptable to the Board of Directors; and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10.7pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.85pt 0pt 5pt; text-indent: 0.75in">(iii)&nbsp;&nbsp;notwithstanding
the foregoing, if there is a vacancy created by the removal of a director without cause by the shareholders, any person nominated by the
Board of Directors for election by the shareholders to fill such vacancy shall be selected: (A) if such director was a DuPont Designee
or Continuing DuPont Designee, by the remaining DuPont Designees and/or Continuing DuPont Designees, as applicable; and (b) if such director
was an IFF Designee or a Continuing IFF Designee, by the remaining IFF Designees and/or Continuing IFF Designees, as applicable; provided
that in no event will the person nominated to fill such vacancy be the director who was so removed.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.85pt 0pt 5pt; text-indent: 0.75in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.05pt"></TD><TD STYLE="width: 21.6pt">(d)</TD><TD><U>Limitations</U>. Until the 2022 annual meeting of the Corporation, no more than one DuPont Designee or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.55pt 0pt 5pt">Continuing DuPont Designee shall be a member of DuPont&rsquo;s
board of directors and each DuPont Designee and Continuing DuPont Designee shall qualify as an independent director under the rules and
regulations governing the requirements of the companies listed on the New York Stock Exchange. For the avoidance of doubt, in the event
any DuPont Designee or Continuing DuPont Designee discontinues their service as a director of the Corporation, or is otherwise unable
to stand for election as a director of the Corporation, in connection with the pervious sentence, such vacancy shall be filled in accordance
with Article II, Section 14(c). In the event any vacancy is to be filled pursuant to Article II, Section 14(c), the identify of such person
selected to fill such vacancy shall be reasonably acceptable to the Board of Directors.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.55pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.85pt 0pt 5pt">(e)&nbsp;&nbsp;<U>Committees</U>.
At the Effective Time, at least one DuPont Designee or Continuing DuPont Designee, as applicable, shall be appointed to serve on each
committee of the Board of Directors, subject in all events to the requirements of applicable law. At least one DuPont Designee or Continuing
DuPont Designee, as applicable, shall serve on each committee of the Board of Directors, subject in all events to the requirements of
applicable law, until the end of the terms of the directors elected at the 2022 annual meeting of the Corporation.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.85pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE III</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">OFFICERS</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 238.45pt 0pt 3.3in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">SECTION 1 <B>Officers; Term of Office</B>. The officers
of the Corporation shall be a Chief Executive Officer, one or more Presidents, one or more Vice Presidents (which may include one of more
executive vice presidents, senior vice presidents or vice presidents), a Secretary, a Treasurer and such other officers as the Board of
Directors may deem necessary or desirable (including one or more assistant secretaries or assistant treasurers). The officers referred
to</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">in this paragraph (x) shall be elected annually by the
Board of Directors at the regular meeting of the Board of Directors held immediately after the annual meeting of shareholders. Any two
or more offices may be held by the same person. Each officer shall hold office until his or her successor shall have been duly chosen
and shall qualify, or until his or her death or until he or she shall resign, or shall have been removed in the manner hereinafter provided.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.55pt 0pt 5pt">SECTION 2 <B>Removal</B>. Any officer of the Corporation
may be removed by the Board of Directors with or without cause at any time.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.55pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">SECTION 3 <B>Resignations</B>. Any officer of the Corporation
may resign at any time by giving written notice of his or her resignation to the Board of Directors or to the Chief Executive Officer
or Secretary of the Corporation. Any such resignation shall take effect at the time specified therein, or, if the time when it shall become
effective shall not be specified therein, then it shall take effect immediately upon its receipt by such Board of Directors, Chief Executive
Officer or Secretary; and, unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">SECTION 4 <B>Vacancies</B>. A vacancy in any office due
to death, resignation, removal, disqualification or any other cause shall be filled for the unexpired portion of the term in the manner
prescribed in these By-Laws for regular appointments or elections to such office.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.55pt 0pt 5pt">SECTION 5 <B>The Chief Executive Officer</B>. The Chief
Executive Officer shall be the chief executive officer of the Corporation and shall have general supervision of the business of the Corporation
and over its several officers, subject, however, to the control of the Board of Directors. He or she shall, in the absence of the Chair
of the Board, preside at all meetings of the shareholders and at all meetings of the Board of Directors. He or she shall see that all
orders and resolutions of the Board of Directors are carried into effect. He or she may sign, execute and deliver in the name and on behalf
of the Corporation all deeds, mortgages, bonds, contracts or other instruments authorized by the Board of Directors except where the signing,
execution or delivery thereof shall be expressly delegated to some other officer or agent of the Corporation or where any of them shall
be required by law to be otherwise signed, executed or delivered, and he or she may affix the seal of the Corporation to any instrument
which shall require it. He or she shall perform all duties incident to the office of Chief Executive Officer and such other duties as
from time to time may be assigned to him or her by the Board of Directors.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.55pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.6pt 0pt 5pt">SECTION 6 <B>The Presidents and any Vice Presidents</B>.
The Presidents and any Vice Presidents shall assist the Chief Executive Officer and shall perform such duties as may be assigned to him
or her by the Chief Executive Officer, the Board of Directors or as may be prescribed by these By-Laws.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 12.6pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.25pt 0pt 5pt">SECTION 7 <B>The Treasurer</B>. The Treasurer shall have
the care and custody of all funds, securities, evidences of indebtedness and other personal property of the Corporation and shall deposit
the same in accordance with the instructions of the Board of Directors. If required by the Board of Directors, the Treasurer shall give
a bond for the faithful discharge of his or her duties in such sum and with such surety or sureties as the Board of Directors shall determine.
He or she shall perform all the duties incidental to the office of Treasurer and such other duties as may be assigned, from time to time,
to him or her by the Chief Executive Officer or the Board of Directors. Upon request of the Board of Directors, he or she shall make such
reports to it as may be required at any time.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.25pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 24.65pt 0pt 5pt">SECTION 8 <B>The Secretary</B>. The Secretary shall (i)
attend all meetings of the Board of Directors and of the shareholders and record all votes, (ii) keep the minutes of all proceedings of
the Board of Directors and of the shareholders in a book to be kept for that purpose and for the standing committees when required and
(iii) have</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 24.65pt 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.4pt 0pt 5pt">charge of the stock certificate book and stock ledger and
such other books and papers as the Board of Directors may direct. He or she shall give, or cause to be given, notice of all meetings of
the shareholders and any meetings the Board of Directors for which notice is required, and shall perform all other duties incident to
the office of Secretary and such other duties as may be assigned, from time to time, to him or her by the Chief Executive Officer or the
Board of Directors. He or she shall keep in safe custody the seal of the Corporation and, when properly authorized, affix the same to
any instrument requiring it and, when so affixed, it shall be attested by his or her signature or by the signature of the Treasurer or
an Assistant Secretary.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.4pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.5pt 0pt 141.9pt; text-align: center">ARTICLE IV</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.5pt 0pt 141.9pt; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.9pt 0pt 141.9pt; text-align: center"><B>CONTRACTS, CHECKS, DRAFTS,
BANK ACCOUNTS, ETC.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.9pt 0pt 141.9pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.2pt 0pt 5pt">SECTION 1 <B>Execution of Contracts, etc</B>. Except as
otherwise required by law or by these By-Laws, any officer or officers, agent or agents, may be authorized by the Board of Directors,
or in the case of an officer appointed by the Chief Executive Officer, by either the Board of Directors or the Chief Executive Officer
to execute and deliver any contract or other instrument in the name of the Corporation and on its behalf.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.2pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.75pt 0pt 5pt">SECTION 2 <B>Checks, Drafts, etc</B>. All checks, drafts
and other orders for the payment of money, bills of lading, warehouse receipts, obligations, bills of exchange and insurance certificates
shall be signed in the name and on behalf of the Corporation by such officer or officers, agent or agents of the Corporation and in such
manner as shall from time to time be authorized by the Board of Directors or authorized by the Treasurer acting together with any Elected
Officer of the Corporation, which authorization may be general or confined to specific instances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 11.75pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 5pt">SECTION 3 <B>Deposits</B>. All funds of the Corporation not
otherwise employed shall be deposited from time to time to the credit of the Corporation or otherwise as the Board of Directors, or any
officer of the Corporation to whom power in that respect shall have been delegated, shall direct in such banks, trust companies or other
depositories as said Board of Directors may select or as may be selected by any officer or officers or agent or agents of the Corporation
to whom power in that respect shall have been delegated. For the purpose of deposit and for the purpose of collection for the account
of the Corporation, checks, drafts and other orders for the payment of money which are payable to the order of the Corporation may be
endorsed, assigned and delivered by any officer or agent of the Corporation.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.7pt 0pt 5pt">SECTION 4 <B>General and Special Bank Accounts</B>. The
Board of Directors may from time to time authorize the opening and keeping of general and special bank accounts with such banks, trust
companies or other depositaries as the Board of Directors may select, or as may be selected by any officer or officers, agent or agents
of the Corporation to whom power in that respect shall have been delegated. The Board of Directors may make such special rules and regulations
with respect to such bank accounts, not inconsistent with the provisions of these By- Laws, as it may deem expedient.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.7pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.5pt 0pt 141.9pt; text-align: center">ARTICLE V</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.5pt 0pt 141.9pt; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.8pt 0pt 141.9pt; text-align: center"><B>SHARES AND THEIR TRANSFER</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 142.8pt 0pt 141.9pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.05pt 0pt 5pt">SECTION 1 <B>Certificates for Stock</B>. The shares of
stock of the Corporation will be represented by certificates, in such form as the Board of Directors may from time to time prescribe,
except that the Board of Directors may provide that some or all of any class or series of shares will be uncertificated shares. No decision
to have uncertificated shares will apply to shares represented by a certificate until that certificate has been surrendered to the Corporation.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.05pt 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.55pt 0pt 5pt">The certificates representing such shares shall be numbered
in the order in which they shall be issued and shall be signed in the name of the Corporation by the Chair of the Board, a President or
a Vice-President, and by the Treasurer or the Secretary or an Assistant Treasurer or Assistant Secretary of the Corporation and its seal
shall be affixed thereto; provided, however, that where such certificate is signed by a transfer agent or registered by a registrar other
than the Corporation itself or its employee, if the Board of Directors shall by resolution so authorize, the signatures of such Chair
of the Board, President, or Vice-President, Treasurer, Secretary, Assistant Treasurer or Assistant Secretary and the seal of the Corporation
may be by facsimile. In case any officer or officers of the Corporation who shall have signed, or whose facsimile signature or signatures
has been placed upon a certificate or certificates shall cease to be such officer or officers, whether by reason of death, resignation
or otherwise, before such certificate or certificates shall have been delivered by the Corporation, such certificate or certificates may
nevertheless be adopted by the Corporation and be issued and delivered as if the person or persons who signed such certificate or certificates
had not ceased to be such officer or officers. A record shall be kept of the respective names of the persons, firms or corporations owning
the shares represented by certificates for stock of the Corporation, the number of shares represented by such certificates, respectively,
and the respective dates thereof, and in case of cancellation, the respective dates of cancellation. Every certificate surrendered to
the Corporation for exchange or transfer shall be canceled and a new certificate or certificates shall not be issued in exchange for any
existing certificate, until such existing certificate shall have been so canceled except in cases provided for in Article V, Section 4
of these By-Laws.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 8.55pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.75pt 0pt 5pt">SECTION 2 <B>Stock Ledger; Transfers of Stock</B>. The
Secretary shall keep or cause to be kept a stock-book, which may be in electronic form, containing the names, alphabetically arranged,
of all persons who are shareholders of the Corporation, showing each shareholder&rsquo;s place of residence, the number of shares of capital
stock owned by each shareholder, and the date when each shareholder became the owner of such shares. Transfers of shares of the capital
stock of the Corporation shall be made on the books of the Corporation only by the registered holder thereof, or by his or her attorney
thereunto authorized by power of attorney duly executed and filed with the Secretary of the Corporation or with a transfer clerk or transfer
agent appointed as in Article V, Section 3 of these By-Laws, upon (1) surrender of the certificate or certificates for such shares properly
endorsed, to the extent that the shares were issued in certificated form or a properly endorsed stock power authorizing the transfer of
such shares, and (2) the payment of all taxes thereon. The person in whose name shares of capital stock stand on the books of the Corporation
shall be deemed the owner thereof for all purposes with regard to the Corporation.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.75pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">SECTION 3 <B>Regulations</B>. The Board of Directors may
make such rules and regulations, as it may be deem expedient, not inconsistent with these By-Laws, concerning the issue, transfer and
registration of shares of the capital stock of the Corporation. It may appoint, or authorize any elected officer or officers to appoint,
one or more Transfer Clerks or one or more Transfer Agents or one or more Registrars, and may require all certificates of stock to bear
the signature or signatures of any of them.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.6pt 0pt 5pt">SECTION 4 <B>Lost, Destroyed and Mutilated Certificates</B>.
The holder of any share of stock of the Corporation shall immediately notify the Corporation of any loss, destruction or mutilation of
the certificate therefor, and the Corporation may issue a new certificate of stock in the place of any certificate theretofore issued
by it, alleged to have been lost or destroyed, and the Board of Directors may, in its discretion, require the owner of the lost or destroyed
certificate or his or her legal representatives to give the Corporation a bond in such sum, limited or unlimited, and in such form and
with such surety or sureties, as the Board of Directors shall in its uncontrolled discretion determine, to indemnify the Corporation against
any claim that may be made against it on account of the alleged loss or destruction of any such certificate, or the issuance of such new
certificate. The Board of Directors,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.6pt 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15.25pt 0pt 5pt">however, may in its discretion refuse to issue any such
new certificate, except pursuant to legal proceedings under the laws of the State of New York in such case made and provided.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15.25pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE
VI</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">INDEMNIFICATION</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 223.95pt 0pt 223.05pt; text-align: center; text-indent: 0.15pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.6pt 0pt 5pt">SECTION 1 <B>Right To Indemnification</B>. The Corporation
shall indemnify any person made, or threatened to be made, a party to an action or proceeding, whether civil or criminal, by reason of
the fact that he or she, or a person of whom he or she is the legal representative, is or was a director or officer of the Corporation,
or was serving, at the request of the Corporation, as a director, officer, employee, fiduciary or agent of any other affiliated corporation,
partnership, joint venture, trust, employee benefit plan or other enterprise, against judgments, fines, amounts paid in settlement and
reasonable expenses, including attorney&rsquo;s fees, incurred by such person as a result of such action or proceeding, or any appeal
therein, unless a judgment or other final adjudication adverse to such person establishes that his or her acts, or the acts of the person
of whom he or she is the legal representative, were committed in bad faith or were the result of active and deliberate dishonesty and
were material to the cause of action so adjudicated, or that he or she, or the person of whom he or she is the legal representative,
personally gained in fact a financial profit or other advantage to which he or she, or the other person of whom he or she is the legal
representative, was not legally entitled. The Corporation shall advance to such person funds to pay for such expenses, including attorney&rsquo;s
fees, incurred by such person in defending against any such action or proceeding, or any appeal therein, upon receipt of an undertaking
by or on behalf of such person to repay such funds to the Corporation if a judgment or other final adjudication adverse to such person
establishes that his or her acts, or the acts of the person of whom he or she is the legal representative, were committed in bad faith
or were the result of active and deliberate dishonesty and were material to the cause of action so adjudicated, or that he or she, or
the person of whom he or she is the legal representative, personally gained in fact a financial profit or other advantage to which he
or she, or such person, was not legally entitled.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.55pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.65pt 0pt 5pt">SECTION 2 <B>Right Of Claimant To Sue</B>. If a claim under
Section 1 of this Article VI is not paid in full by the Corporation within thirty (30) days after a written claim has been received by
the Corporation, the claimant may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim
and, if successful in whole or in part, the claimant shall be entitled to be paid also the expenses of prosecuting such claim. It shall
be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in defending any proceeding in
advance of its final disposition where the required undertaking, if any is required, has been tendered to the Corporation) that the claimant,
or the person of whom he or she is the legal representative, has not met the standard of conduct established in Article VI, Section 1
of these By-Laws, but the burden of proving such defense shall be on the Corporation. Neither the failure of the Corporation (including
its Board of Directors, independent legal counsel, or its shareholders) to have made a determination prior to the commencement of such
action that indemnification of the claimant is proper because the claimant or such person has met the said standard of conduct, nor an
actual determination by the Corporation (including its Board of Directors, independent legal counsel, or its shareholders) that the claimant
or such person has not met such applicable standard of conduct, shall be a defense to action or create a presumption that the claimant
or such person has not met such standard of conduct.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.65pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.4pt 0pt 5pt">SECTION 3 <B>Non-Exclusivity Of Rights</B>. Subject to the
limitations contained in Section 1 of this Article VI, the right to indemnification and the payment of expenses conferred in this Article
VI shall not be deemed exclusive of any other right to which any person seeking indemnification or advancement or payment of expenses
may be entitled, whether under any statute, provision of the Certification of Incorporation, these By-Laws, agreement, vote of</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.4pt 0pt 5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 21.9pt 0pt 5pt; text-align: justify">shareholders or disinterested directors
or otherwise, and the Corporation is hereby authorized to provide further indemnification or advancement rights to any such person whether
by separate agreement or by resolution of its directors or shareholders or otherwise.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 21.9pt 0pt 5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt; text-align: justify">SECTION 4 <B>Contract Rights; Savings Clause.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.35pt 0pt 5pt">(a)&nbsp;&nbsp;<U>Contract
Rights</U>. The rights conferred by this Article VI shall be contract rights and shall vest at the time a person agrees to become a director
or officer of the Corporation. Such rights shall continue as to a person who has ceased to be a director or officer of the Corporation
and shall extend to the heirs and legal representatives of such person. Any repeal or modification of the Business Corporation Law or
the provisions of this Article VI shall not affect any right or obligation then existing with respect to any state of facts then or previously
existing or any action or proceeding previously or thereafter brought or threatened based in whole or in part upon any such state of facts.
Such a contract right may not be modified retroactively without the consent of such person, except as provided by law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.35pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.3pt 0pt 5pt">(b)&nbsp;&nbsp;<U>Savings
Clause</U>. Any repeal or modification of the provisions of this Article VI shall not adversely affect any right or protection hereunder
of any director or officer in respect of any act or omission occurring prior to the time of such repeal or modification. If any provision
of this Article VI is held to be invalid, illegal or unenforceable for any reason whatsoever (i) the validity, legality and enforceability
of the remaining provisions of this Article VI (including without limitation, all portions of any paragraphs of this Article VI containing
any such provision held to be invalid, illegal or unenforceable, that are not by themselves invalid, illegal or unenforceable) shall not
in any way be affected or impaired thereby and (ii) to the fullest extent possible, the provisions of this Article VI (including, without
limitation, all portions of any paragraph of this Article VI containing any such provision held to be invalid, illegal or unenforceable,
that are not themselves invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested by the provision
held invalid, illegal or unenforceable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 7.3pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 18.55pt 0pt 5pt; text-align: justify">SECTION 5 <B>Business Corporation
Law</B>. All references to the Business Corporation Law in this Article VI shall mean such Law as it may from time to time be amended.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 18.55pt 0pt 5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">SECTION 6 <B>Insurance</B>. The Corporation may purchase
and maintain insurance to indemnify officers, directors and others against costs or liabilities incurred by them in connection with the
performance of their duties and any activities undertaken by them for, or at the request of, the Corporation, to the fullest extent permitted
by the Business Corporation Law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.45pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE VII</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">SEAL</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 238.45pt 0pt 3.3in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 19.3pt 0pt 5pt; text-align: justify">The seal of the Corporation shall
be in the form of a circle, and shall bear the full name of the Corporation and the year of its incorporation.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 19.3pt 0pt 5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE VIII</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">FISCAL YEAR</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 238.45pt 0pt 3.3in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15.85pt 0pt 5pt; text-align: justify">The fiscal year of the Corporation
shall end with the thirty-first day of December in each year or such other date as the Board shall determine.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15.85pt 0pt 5pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 232.5pt 0pt 231.6pt; text-align: center; text-indent: 0.05pt">ARTICLE
IX</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 232.5pt 0pt 231.6pt; text-align: center; text-indent: 0.05pt">AMENDMENTS</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 232.5pt 0pt 231.6pt; text-align: center; text-indent: 0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.7pt 0pt 5pt">The Board of Directors shall have the power to amend, repeal
or adopt the By-Laws of the Corporation, and the By- Laws may be amended, repealed or adopted by the shareholders entitled at the time
to vote in the election of directors. Notwithstanding the previous sentence, until the 2023 annual meeting of the Corporation, any amendment
or repeal of any provision of Article II, Section 14 of these By-Laws or adoption of any additional provision therein, or any adoption,
amendment or repeal of any other By-Law that would result in terms contrary to or in conflict with any of the terms of Article II, Section
14 of these By-Laws shall, in each case, require the approval by (i) the affirmative vote of a majority of the IFF Designees and/or Continuing
IFF Designees, as applicable, then in office, even if less than a quorum, or by a sole remaining IFF Designee and/or Continuing IFF Designee,
as applicable, and (ii) the affirmative vote of a majority of the DuPont Designees and/or Continuing DuPont Designees, as applicable,
then in office, even if less than a quorum, or by a sole remaining DuPont Designee and/or Continuing DuPont Designee, as applicable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.7pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.7pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.7pt 0pt 5pt"></P>

<!-- Field: Page; Sequence: 24; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6.7pt 0pt 5pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>dp166855_ex1001.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">COOPERATION AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Cooperation Agreement,
dated as of February 8, 2022 (this &ldquo;<B>Agreement</B>&rdquo;), is by and among the persons and entities listed on Schedule A (collectively,
the &ldquo;<B>Icahn Group</B>&rdquo;, and each individually a &ldquo;<B>member</B>&rdquo; of the Icahn Group) and International Flavors
&amp; Fragrances Inc. (the &ldquo;<B>Company</B>&rdquo;). In consideration of and reliance upon the mutual covenants and agreements contained
in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties
agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><B>Board Representation and Board Matters.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Company and the Icahn Group agree as follows:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">On or prior to the date of this Agreement, the Company shall take or shall have taken all necessary action
to increase the size of the Board of Directors of the Company (the &ldquo;<B>Board</B>&rdquo;) by one (1) seat to fourteen (14), and to
appoint Barry Bruno (the &ldquo;<B>Independent Director</B>&rdquo;) to fill the resulting vacancy, effective as soon as practicable after
the date of this Agreement, with a term expiring at the 2022 annual meeting of stockholders of the Company (the &ldquo;<B>2022 Annual
Meeting</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">As long as the Icahn Group has not materially breached this Agreement and failed to cure such breach within
five (5) business days of written notice from the Company specifying any such breach, the Company agrees that the Company&rsquo;s slate
of nominees for election to the Board at the 2022 Annual Meeting will consist of no more than fourteen (14) individuals (collectively,
the &ldquo;<B>2022 IFF Slate</B>&rdquo;) and will include, subject to his willingness and consent to serve, the Independent Director.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">The Company shall use reasonable best efforts to cause the election of the Independent Director at the
2022 Annual Meeting (including by (x) recommending that the Company&rsquo;s stockholders vote in favor of the election of the Independent
Director, (y) including the Independent Director in the Company&rsquo;s proxy statement and proxy card for the 2022 Annual Meeting, and
(z) otherwise supporting the Independent Director for election in a manner no less rigorous and favorable than the manner in which the
Company supports its other nominees in the aggregate). The Icahn Group agrees not to conduct a proxy contest or engage in any solicitation
of proxies regarding any matter, including the election of directors, with respect to the 2022 Annual Meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">That as a condition to the Independent Director&rsquo;s (and any replacement Independent Director&rsquo;s)
appointment to the Board and subsequent nomination for election, the Independent Director will provide to the Company, prior to nomination
and appointment and on an on-going basis while serving as a member of the Board, such information and materials as the Company routinely
receives from other members of the Board or as is required to be disclosed in proxy statements under applicable law or as is otherwise
reasonably requested by the Company from time-to-time from all members of the Board in connection with the Company&rsquo;s legal, regulatory,
auditor or stock exchange requirements, including, but not limited to, a completed D&amp;O Questionnaire in the form separately provided
by the Company to the Icahn Group (the &ldquo;<B>Nomination Documents</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">That, subject to <B>Section 1(c)</B> below, should the Independent Director resign from the Board or be
rendered unable to, or refuse to, be appointed to, or for any other reason fail to serve or is not serving, on the Board (other than as
a result of not being nominated by the Company for election at an annual meeting of stockholders subsequent to the 2022 Annual Meeting,
following which the Icahn Group&rsquo;s replacement rights pursuant to this <B>Section 1(a)(v)</B> shall terminate), as long as the Icahn
Group has not materially breached this Agreement and failed to cure such breach within five (5) business days of written notice from the
Company specifying any such breach, the Company shall cause to be added as a member of the Board or as a nominee on the 2022 IFF Slate,
as applicable, a replacement independent director that is mutually acceptable to the Board and the Icahn Group, who will then be deemed
to be the Independent Director hereunder.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">For the avoidance of doubt, the Board&rsquo;s approval of a replacement director pursuant to <B>Section
1(a)(v)</B> shall require that such replacement does: (A) qualify as &ldquo;independent&rdquo; pursuant to the independence requirements
of the New York Stock Exchange, (B) have the relevant financial and business experience to be a director of the Company, (C) satisfy the
requirements set forth in the Company Policies (as defined below), in each case as in effect as of the date of this Agreement or such
additional or amended guidelines and policies approved by the Board that are applicable to all directors of the Company, (collectively
clauses (A) through (C), the &ldquo;<B>Director Criteria</B>&rdquo;); provided that (i) no new Director Criteria will be adopted that
would have prevented the Independent Director from becoming a director had such criteria been in effect today, and (ii) the Company acknowledges
that the Independent Director satisfies the requirements of <B>Section 1(a)(vi)(B)</B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vii)</TD><TD STYLE="text-align: justify">That (1) for any annual meeting of stockholders subsequent to the 2022 Annual Meeting during the term
of this Agreement, the Company shall notify the Icahn Group in writing no less than thirty-five (35) calendar days before the advance
notice deadline set forth in the Company&rsquo;s Bylaws whether the Independent Director will be nominated by the Company for election
as a director at such annual meeting and, (2) if the Independent Director is to be so nominated, shall use reasonable best efforts to
cause the election of the Independent Director so nominated by the Company (including by (x) recommending that the Company&rsquo;s stockholders
vote in favor of the election of the Independent Director, (y) including the Independent Director in the Company&rsquo;s proxy statement
and proxy card for such annual meeting and (z) otherwise supporting the Independent Director for election in a manner no less rigorous
and favorable than the manner in which the Company supports its other nominees in the aggregate), and the Icahn Group agrees not to conduct
a proxy contest or engage in any solicitation of proxies regarding any matter, including the election of directors, with respect to any
such annual meeting at which the Company has nominated the Independent Director and the Independent Director has consented to being named,
and is named, in the proxy statement relating to such annual meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(viii)</TD><TD STYLE="text-align: justify">That as of the date of this Agreement, the Company represents and warrants that, (y) prior to the Board
appointing the Independent Director as a director, the Board is composed of thirteen (13) directors and that there are no vacancies on
the Board, and (z) immediately after the Board appoints the Independent Director as a</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">director, the Board
will be composed of fourteen (14) directors and that there will be no vacancies on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ix)</TD><TD STYLE="text-align: justify">That from and after the date of this Agreement, so long as the Independent Director is a member of the
Board, any Board consideration of appointment and employment of the Company&rsquo;s chief executive officer and chief financial officer,
mergers and acquisitions of material assets, or dispositions of material assets, or similar extraordinary transactions, such consideration,
and voting with respect thereto shall take place only at the full Board level or in committees of which the Independent Director is a
member.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(x)</TD><TD STYLE="text-align: justify">Concurrently with the appointment to the Board pursuant to <B>Section 1(a)(i)</B> and subject to compliance
with all stock exchange rules, the Board will consider appropriate appointments for the Independent Director to applicable Board committees
as they would consider such appointments for other Board candidates. Notwithstanding the foregoing, the Company acknowledges that for
so long as the Independent Director is a member of the Board, the Independent Director shall have the same rights as any other director
with respect to being permitted to attend (as an observer and without voting rights) any committee meeting regardless of whether the Independent
Director is a member of such committee, except in cases where privileged matters will be discussed or reviewed (unless the Independent
Director commits, in writing, on terms reasonably satisfactory to the Company, not to share information relating to such matters with
the Icahn Group, including its Affiliates, Associates and representatives), where the matters under consideration involve an actual conflict
of interest between the Company and the Icahn Group or its Affiliates or Associates, or where, upon advice of outside counsel to the Company,
the Independent Director&rsquo;s attendance would jeopardize any legal privilege.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">At all times from the date of this Agreement through the termination of his service as a member of the
Board, the Independent Director will need to comply with all written policies, procedures, processes, codes, rules, standards and guidelines
applicable to all non-employee Board members, including the Corporate Governance Guidelines, Code of Conduct, Code of Conduct for Directors,
Insider Trading Policy, Window Period Policy for the Purchase and Sale of Company Securities, Section 16 and Rule 144 Reporting Obligations
Policy, Regulation FD Policy, Rule 10(b)(5) Guidelines, Share Retention Policy, and Related Person Transactions Policy (collectively,
the &ldquo;<B>Company Policies</B>&rdquo;), and shall preserve the confidentiality of Company business and information, including discussions
or matters considered in meetings of the Board or Board committees (except to the extent permitted in the Confidentiality Agreement (as
defined below) to be entered into pursuant to <B>Section 5</B> of this Agreement). For the avoidance of doubt, the Parties agree that
notwithstanding the terms of any Company Policies, in no event shall any Company Policy apply to the Icahn Group. The Icahn Group confirms
that the Independent Director is not employed by or a consultant of, and is not otherwise an Affiliate or Associate of, any member of
the Icahn Group. The Icahn Group confirms that the Company may require the replacement of the Independent Director pursuant to <B>Section
1(a)(v)</B> if he or she becomes an employee, consultant, Affiliate or Associate of any member of the Icahn Group.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">The Icahn Group, upon request, shall keep the Company regularly apprised of the Net Long Position of the
Icahn Group and the Icahn Affiliates to the extent that such position differs</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">from the ownership
positions publicly reported by the Icahn Group in any public filing with the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">For purposes of this
Agreement: the term &ldquo;Net Long Position&rdquo; shall mean: such outstanding common shares of the Company (&ldquo;<B>Common Shares</B>&rdquo;)
beneficially owned, directly or indirectly, that constitute such person&rsquo;s net long position as defined in Rule 14e-4 under the Securities
Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;) <I>mutatis mutandis</I>, provided that &ldquo;Net Long Position&rdquo;
shall not include any shares as to which such person does not have the right to vote or direct the vote, or as to which such person has
entered into a derivative or other agreement, arrangement or understanding that hedges or transfers, in whole or in part, directly or
indirectly, any of the economic consequences of ownership of such shares; and the terms &ldquo;person&rdquo; or &ldquo;persons&rdquo;
shall mean any individual, corporation (including not-for-profit), general or limited partnership, limited liability or unlimited liability
company, joint venture, estate, trust, association, organization or other entity of any kind or nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">So long as the Icahn Group, together with the Icahn Affiliates, beneficially owns an aggregate Net Long
Position in at least 2,154,552 of the total outstanding Common Shares (as adjusted for any stock dividends, combinations, splits, recapitalizations
or similar type events), the Company shall not adopt a Rights Plan with an &ldquo;Acquiring Person&rdquo; beneficial ownership threshold
below 15.0% of the then-outstanding Common Shares, unless (x) such Rights Plan provides that, if such Rights Plan is not ratified by the
Company&rsquo;s stockholders within 270 days of such Rights Plan being adopted, such Rights Plan shall automatically expire and (y) the
&ldquo;Acquiring Person&rdquo; definition of such Rights Plan exempts the Icahn Group up to a beneficial ownership of 9.9% of the then-outstanding
Common Shares. The term &ldquo;<B>Rights Plan</B>&rdquo; shall mean any plan or arrangement of the sort commonly referred to as a &ldquo;rights
plan&rdquo; or &ldquo;stockholder rights plan&rdquo; or &ldquo;shareholder rights plan&rdquo; or &ldquo;poison pill&rdquo; that is designed
to increase the cost to a potential acquirer of exceeding the applicable ownership thresholds through the issuance of new rights, common
stock or preferred shares (or any other security or device that may be issued to stockholders of the Company, other than ratably to all
stockholders of the Company) that carry severe redemption provisions, favorable purchase provisions or otherwise, and any related rights
agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><B>Additional Agreements.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Unless the Company or the Board has breached any material provision of this Agreement and failed to cure
such breach within five (5) business days following the receipt of written notice from the Icahn Group specifying any such breach, solely
in connection with the 2022 Annual Meeting, each member of the Icahn Group shall (1) cause, in the case of all Voting Securities owned
of record, and (2) instruct and cause the record owner, in the case of all shares of Voting Securities beneficially owned but not owned
of record, directly or indirectly, by it, or by any Icahn Affiliate, in each case as of the record date of the 2022 Annual Meeting or
as to which the member of the Icahn Group otherwise has the power to vote or direct the vote, in each case that are entitled to vote at
the 2022 Annual Meeting, to be present for quorum purposes and to be voted, at the 2022 Annual Meeting or at any adjournment or postponement
thereof, (A) for each nominee on the 2022 IFF Slate, (B) against any nominees that are not nominated by the Board for election at the
2022 Annual Meeting, (C) against any stockholder proposal to increase the size of the Board, and (D) in favor of the ratification of the
Company&rsquo;s auditors. Except as provided in the foregoing sentence and in <B>Section 2(b)</B>, the Icahn Group shall not be restricted
from voting &ldquo;For&rdquo;, &ldquo;Against&rdquo; or &ldquo;Abstaining&rdquo; from any other proposals at the 2022 Annual Meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Unless the Company or the Board has breached any material provision of this Agreement and failed to cure
such breach within five (5) business days following the receipt of written notice from the Icahn Group specifying any such breach, that
for any annual meeting of stockholders subsequent to the 2022 Annual Meeting, if the Board has agreed to nominate the Independent Director
then serving on the Board for election at such annual meeting and the Independent Director has consented to be nominated at such annual
meeting, each member of the Icahn Group shall (1) cause, in the case of all Voting Securities owned of record, and (2) instruct and cause
the record owner, in the case of all shares of Voting Securities beneficially owned but not owned of record, directly or indirectly, by
it, or by any Icahn Affiliate, in each case as of the record date of the applicable annual meeting or as to which the member of the Icahn
Group otherwise has the power to vote or direct the vote, in each case that are entitled to vote at such annual meeting, to be present
for quorum purposes and to be voted at such annual meeting or at any adjournment or postponement thereof, (A) for each director nominated
by the Board for election at such annual meeting, (B) against any (i) stockholder proposal to increase the size of the Board and (ii)
nominees that are not nominated by the Board for election at such annual meeting, and (C) in favor of the ratification of the Company&rsquo;s
auditors. Except as provided in the foregoing sentence, the Icahn Group shall not be restricted from voting &ldquo;For&rdquo;, &ldquo;Against&rdquo;
or &ldquo;Abstaining&rdquo; from any other proposals at any such annual meeting following the 2022 Annual Meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Unless the Company or the Board has breached any material provision of this Agreement and failed to cure
such breach within five (5) business days following the receipt of written notice from the Icahn Group specifying any such breach, that
for any special meeting of shareholders that includes a proposal to remove directors or to expand the Board and add directors, then so
long as (x) the Independent Director is a member of the Board at the time of such special meeting or (y) the Icahn Group has replacement
rights pursuant to clause 1(a)(v) at such time (including at such special meeting), each member of the Icahn Group shall (1) cause, in
the case of all Voting Securities owned of record, and (2) instruct and cause the record owner, in the case of all shares of Voting Securities
beneficially owned but not owned of record, directly or indirectly, by it, or by any Icahn Affiliate, in each case as of the record date
of the applicable special meeting or as to which the member of the Icahn Group otherwise has the power to vote or direct the vote, in
each case that are entitled to vote at such special meeting, to be present for quorum purposes and to be voted at such special meeting
or at any adjournment or postponement thereof, (A) for each director nominated or supported by the Board for election at such special
meeting, and (B) against any (i) proposal to remove directors or increase the size of the Board and (ii) nominees that are not nominated
by the Board for election at such special meeting. Except as provided in the foregoing sentence, the Icahn Group shall not be restricted
from voting &ldquo;For&rdquo;, &ldquo;Against&rdquo; or &ldquo;Abstaining&rdquo; from any other proposals at any such special meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">As used in this Agreement, the term &ldquo;<B>Voting Securities</B>&rdquo; shall mean the Common Shares
that such person has the right to vote or has the right to direct the vote. For purposes of this <B>Section 2</B>, no person shall be,
or be deemed to be, the &ldquo;beneficial owner&rdquo; of, or to &ldquo;beneficially own,&rdquo; any securities beneficially owned by
any director of the Company to the extent such securities were acquired directly from the Company by such director as or pursuant to director
compensation for serving as a director of the Company. For purposes of this Agreement, (x) the term &ldquo;<B>Affiliate</B>&rdquo; shall
have the meaning set forth in Rule 12b-2 promulgated by the SEC under the Exchange Act, and the term &ldquo;<B>Icahn Affiliate</B>&rdquo;
shall mean such Affiliates that are controlled by the members of the Icahn Group, and (y) t<FONT STYLE="font-family: Times New Roman, Times, Serif">he
term &ldquo;<B>Associate</B>&rdquo; shall mean (A) any trust or other estate in which such person has a substantial beneficial interest
or as to which such person serves as trustee or in a similar </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">fiduciary
capacity, and (B)&nbsp;any relative or spouse of such person, or any relative of such spouse, who has the same home as such person or
who is a director or officer of such person or of any of its parents or subsidiaries</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.</B></FONT></TD><TD STYLE="text-align: justify"><B>Icahn Group Restrictions.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">From and after the appointment of the Independent Director to the Board pursuant to <B>Section 1(a)(i)</B>
until the Termination Time (as such term is defined in <B>Section 9</B> below) (the &ldquo;<B>Standstill Period</B>&rdquo;), so long as
the Company has not breached any material provision of this Agreement and failed to cure such breach within five (5) business days following
the receipt of written notice from the Icahn Group specifying any such breach, no member of the Icahn Group shall, directly or indirectly,
and each member of the Icahn Group shall cause each of the Icahn Affiliates and Associates not to, directly or indirectly:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">acquire, offer or propose to acquire any Voting Securities (or beneficial ownership thereof), or rights
or options to acquire any Voting Securities (or beneficial ownership thereof) of the Company if after any such case, immediately after
the taking of such action the Icahn Group, together with its respective Icahn Affiliates and Associates, would in the aggregate, beneficially
own more than 9.9% of the then outstanding Common Shares; provided that, for purposes of this <B>Section 3(a)(i)</B>, no Person shall
be, or be deemed to be, the &ldquo;beneficial owner&rdquo; of, or to &ldquo;beneficially own,&rdquo; any securities beneficially owned
by any director of the Company to the extent such securities were acquired directly from the Company by such director as or pursuant to
director compensation for serving as a director of the Company;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">form or join in a partnership, limited partnership, syndicate or a &ldquo;group&rdquo; as defined under
Section 13(d) of the Exchange Act, with respect to the securities of the Company;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">present (or request to present) at any annual meeting or any special meeting of the Company&rsquo;s stockholders,
any proposal for consideration for action by stockholders or engage in any solicitation of proxies or consents or become a &ldquo;participant&rdquo;
in a &ldquo;solicitation&rdquo; (as such terms are defined in Regulation 14A under the Exchange Act) of proxies or consents (including,
without limitation, any solicitation of consents that seeks to call a special meeting of stockholders) or, except as provided in this
Agreement, otherwise publicly propose (or publicly request to propose) any nominee for election to the Board or seek representation on
the Board or the removal of any member of the Board;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">grant any proxy, consent or other authority to vote with respect to any matters (other than to the named
proxies included in the Company&rsquo;s proxy card for any annual meeting or special meeting of stockholders) or deposit any Voting Securities
in a voting trust or subject them to a voting agreement or other arrangement of similar effect (excluding customary brokerage accounts,
margin accounts, prime brokerage accounts and the like), in each case, except as provided in <B>Section 2(a)</B> or <B>Section 2(b)</B>;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">call or seek to call any special meeting of the Company or action by consent resolutions or make any request
under Section 624 of the New York Business Corporation Law or other applicable common law or legal provisions regarding</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">inspection of books
and records or other materials (including stocklist materials) of the Company or any of its subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">institute, solicit, assist or join, as a party, any litigation, arbitration or other proceeding against
or involving the Company;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vii)</TD><TD STYLE="text-align: justify">separately or in conjunction with any other person in which it is or proposes to be either a principal,
partner or financing source or is acting or proposes to act as broker or agent for compensation, submit a proposal for or offer of (with
or without conditions), any Extraordinary Transaction (as defined below); provided that the Icahn Group shall be permitted to sell or
tender their Common Shares, and otherwise receive consideration, pursuant to any Extraordinary Transaction; and provided further that
(A) if a third party (other than the Icahn Group or an Icahn Affiliate) commences a tender offer or exchange offer for all of the outstanding
Common Shares that is not rejected by the Board in its Recommendation Statement on Schedule 14D-9, then the Icahn Group shall similarly
be permitted to make an offer for the Company or commence a tender offer or exchange offer for all of the outstanding Common Shares at
the same or higher consideration per share, provided that the foregoing (y) will not relieve the Icahn Group of its obligations under
the Confidentiality Agreement and (z) will not be deemed to require the Company to make any public disclosures and (B) the Company may
waive the restrictions in this <B>Section 3(a)(vii)</B> with the approval of the Board. &ldquo;Extraordinary Transaction&rdquo; means,
collectively, any of the following involving the Company or any of its subsidiaries or its or their securities or all or substantially
all of the assets or businesses of the Company and its subsidiaries: any tender offer or exchange offer, merger, acquisition, business
combination, reorganization, restructuring, recapitalization, sale or acquisition of material assets, or liquidation or dissolution; provided
that Extraordinary Transaction shall not include, and neither this <B>Section 3(a)</B> nor any other term of this Agreement, shall restrict
the Icahn Group from, on any date following the date of this Agreement and prior to the first anniversary of this Agreement, commencing
and consummating one tender offer pursuant to applicable U.S. laws and regulations to acquire additional Common Shares, so long as (1)
such tender offer shall be consummated, terminated or withdrawn no later than 45 days following the date of the initial public announcement
of the tender offer and (2) upon consummation of such tender offer the Icahn Group would not beneficially own more than 9.9% of the outstanding
Common Shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(viii)</TD><TD STYLE="text-align: justify">seek, or encourage any person, to submit nominations in furtherance of a &ldquo;contested solicitation&rdquo;
for the election or removal of directors with respect to the Company or, except as expressly provided in this Agreement, seek, encourage
or take any other action with respect to the election or removal of any directors;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ix)</TD><TD STYLE="text-align: justify">make any public communication in opposition to (A) any merger, acquisition, amalgamation, recapitalization,
restructuring, disposition, distribution, spin-off, asset sale, joint venture or other business combination or (B) any financing transaction,
in each case involving the Company;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(x)</TD><TD STYLE="text-align: justify">seek to advise, encourage, support or influence any person with respect to the voting or disposition of
any securities of the Company at any annual meeting or special meeting of stockholders, except in accordance with <B>Section 2(a)</B>
or <B>Section 2(b)</B>;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(xi)</TD><TD STYLE="text-align: justify">publicly disclose any intention, plan or arrangement inconsistent with any provision of this <B>Section
3</B>; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(xii)</TD><TD STYLE="text-align: justify">encourage or support any other person to take any of the actions described in this <B>Section 3 </B>that
the Icahn Group is restricted from doing.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Subject to applicable law, from the date of this Agreement until the end of the Standstill Period, (i)
so long as the Company has not breached any material provision of this Agreement and failed to cure such breach within five (5) business
days following the receipt of written notice from the Icahn Group specifying any such breach, neither a member of the Icahn Group nor
any of the Icahn Affiliates or Associates (including such persons&rsquo; officers, directors and persons holding substantially similar
positions however titled) shall make, or cause to be made, by press release or similar public statement, including to the press or media
(including social media), or in an SEC or other public filing, any statement or announcement that disparages (as distinct from objective
statements reflecting business criticism) the Company or the Company&rsquo;s respective current or former officers or directors and (ii)
so long as the Icahn Group has not breached any material provision of this Agreement and failed to cure such breach within five (5) business
days following the receipt of written notice from the Company specifying any such breach, neither the Company nor any of its Affiliates
or Associates (including such persons&rsquo; officers, directors and persons holding substantially similar positions however titled) shall
make, or cause to be made, by press release or similar public statement, including to the press or media (including social media), or
in an SEC or other public filing, any statement or announcement that disparages (as distinct from objective statements reflecting business
criticism) any member of the Icahn Group or Icahn Affiliates or any of their respective current or former officers or directors.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>The Icahn Group shall not enter into any agreement with, or compensate, the Independent Director with respect to his or her role or
service (including voting) as a director of the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.</B></FONT></TD><TD STYLE="text-align: justify"><B>Public Announcements. </B>Unless otherwise agreed, no earlier than 6:30 a.m., New York City time, on
the first trading day after the date of this Agreement, the Company shall announce the execution of this Agreement by means of a press
release in the form attached to this Agreement as <B>Exhibit A</B>. The Icahn Group will not issue a separate press release. The Icahn
Group shall have an opportunity to review in advance the Form 8-K filing to be made by the Company with respect to this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.</B></FONT></TD><TD STYLE="text-align: justify"><B>Confidentiality Agreement. </B>The Company hereby agrees that: (i) the Independent Director is permitted
to and may provide confidential information subject to and in accordance with the terms of the confidentiality agreement in the form attached
to this Agreement as <B>Exhibit B</B> (the &ldquo;<B>Confidentiality Agreement</B>&rdquo;) (which the Icahn Group agrees to execute and
deliver to the Company) and (ii) the Company will execute and deliver the Confidentiality Agreement to the Icahn Group substantially contemporaneously
with execution and delivery thereof by the other signatories thereto. At any time the Independent Director is a member of the Board, the
Board shall not adopt a policy precluding members of the Board from speaking to Mr. Carl C. Icahn, and the Company confirms that it will
advise members of the Board including the Independent Director that they may, but are not obligated to, speak to Mr. Carl C. Icahn (but
subject to the Confidentiality Agreement, <I>mutatis mutandis</I>), if they are willing to do so and subject to their fiduciary duties
and Company Policies and subject to keeping the Company&rsquo;s General Counsel updated on the general</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">nature and contours
of all such discussions (but may caution them regarding specific matters, if any, that involve conflicts between the Company and the Icahn
Group).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6.</B></FONT></TD><TD STYLE="text-align: justify"><B>Representations and Warranties of All Parties. </B>Each of the parties represents and warrants to the
other party that: (a) such party has all requisite company power and authority to execute and deliver this Agreement and to perform its
obligations hereunder; (b) this Agreement has been duly and validly authorized, executed and delivered by it and is a valid and binding
obligation of such party, enforceable against such party in accordance with its terms; and (c) this Agreement will not result in a violation
of any terms or conditions of any agreements to which such person is a party or by which such party may otherwise be bound or of any law,
rule, license, regulation, judgment, order or decree governing or affecting such party.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>7.</B></FONT></TD><TD STYLE="text-align: justify"><B>Representations and Warranties of Icahn Group. </B>Each member of the Icahn Group jointly represents
and warrants that, as of the date of this Agreement, (a) the Icahn Group collectively beneficially own, an aggregate of 4,309,105 Common
Shares, (b) except as set forth in the preceding clause (a) or as otherwise disclosed to the Company, no member of the Icahn Group, individually
or in the aggregate with any Icahn Affiliate, has any other beneficial ownership of, or economic exposure to, any Common Shares, nor does
it currently have or have any right to acquire any interest in any other securities of the Company (or any rights, options or other securities
convertible into or exercisable or exchangeable (whether or not convertible, exercisable or exchangeable immediately or only after the
passage of time or the occurrence of a specified event) for such securities or any obligations measured by the price or value of any securities
of the Company or any of its controlled Affiliates, including any swaps or other derivative arrangements designed to produce economic
benefits and risks that correspond to the ownership of Common Shares, whether or not any of the foregoing would give rise to beneficial
ownership (as determined under Rule 13d-3 promulgated under the Exchange Act), and whether or not to be settled by delivery of Common
Shares, payment of cash or by other consideration, and without regard to any short position under any such contract or arrangement), and
(c) no member of the Icahn Group has any knowledge of any other stockholder of the Company that intends to submit a notice to the Company
to nominate directors at the 2022 Annual Meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>8.</B></FONT></TD><TD STYLE="text-align: justify"><B>Representations and Warranties and Covenants of the Company.</B> The Company represents and warrants,
that as of the date of this Agreement, (a) none of the Company, the Board nor their respective advisors are engaged in discussions to
grant board representation or board designation rights to any other stockholder of the Company, except for the Icahn Group, and (b) the
date for the 2022 Annual Meeting is scheduled for May 4, 2022 (and shall, in any event, be held no later than June 3, 2022). Further,
the Company agrees that if the Company enters into an agreement, arrangement or understanding, or otherwise grants any rights, to any
other stockholder of the Company to avoid a proxy or similar contest with such stockholder at the 2022 Annual Meeting, then to the extent
such agreement, arrangement or understanding grants any right or rights that are more favorable than those set forth in this Agreement,
the Company agrees it shall offer the same such rights to the Icahn Group.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>9.</B></FONT></TD><TD STYLE="text-align: justify"><B>Miscellaneous. </B>Following the appointment of the Independent Director to the Board pursuant to <B>Section
1(a)(i)</B>, this Agreement shall thereafter terminate and be of no further force or effect upon <U>the earlier of</U> (x) 35 calendar
days before the advance notice deadline set forth in the Company&rsquo;s Bylaws for the Company&rsquo;s 2023 annual meeting of stockholders
and (y) the day that is the seventh calendar day after the Icahn Group gives written notice to the Company (which notice shall not be
given before May 31, 2022) of the Icahn Group&rsquo;s election to terminate this Agreement (such earlier date, the <B>&ldquo;Termination
Time&rdquo;</B>). The parties hereto recognize and agree that if for any reason any of the provisions of this Agreement are not performed
in accordance with their specific terms or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">are otherwise breached,
immediate and irreparable harm or injury would be caused for which money damages would not be an adequate remedy. Accordingly, each party
agrees that in addition to other remedies the other party shall be entitled to at law or equity, the other party shall be entitled to
an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement
exclusively in the Delaware Court of Chancery or other federal or state courts of the State of Delaware. In the event that any action
shall be brought in equity to enforce the provisions of this Agreement, no party shall allege, and each party hereby waives the defense,
that there is an adequate remedy at law. Furthermore, each of the parties hereto (i) consents to submit itself to the personal jurisdiction
of the Delaware Court of Chancery or other federal or state courts of the State of Delaware in the event any dispute arises out of this
Agreement or the transactions contemplated by this Agreement, (ii) agrees that it shall not attempt to deny or defeat such personal jurisdiction
by motion or other request for leave from any such court, (iii) agrees that it shall not bring any action relating to this Agreement or
the transactions contemplated by this Agreement in any court other than the Delaware Court of Chancery or the other federal or state courts
of the State of Delaware, and each of the parties irrevocably waives the right to trial by jury, (iv) agrees to waive any bonding requirement
under any applicable law, in the case any other party seeks to enforce the terms by way of equitable relief, and (v) irrevocably consents
to service of process by a reputable overnight mail delivery service, signature requested, to the address of such party&rsquo;s principal
place of business or as otherwise provided by applicable law. THIS AGREEMENT SHALL BE GOVERNED IN ALL RESPECTS, INCLUDING VALIDITY, INTERPRETATION
AND EFFECT, BY THE LAWS OF THE STATE OF DELAWARE APPLICABLE TO CONTRACTS EXECUTED AND TO BE PERFORMED WHOLLY WITHIN SUCH STATE WITHOUT
GIVING EFFECT TO THE CHOICE OF LAW PRINCIPLES OF SUCH STATE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.</B></FONT></TD><TD STYLE="text-align: justify"><B>No Waiver. </B>Any waiver by any party of a breach of any provision of this Agreement shall not operate
as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Agreement. The
failure of a party to insist upon strict adherence to any term of this Agreement on one or more occasions shall not be considered a waiver
or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.</B></FONT></TD><TD STYLE="text-align: justify"><B>Entire Agreement. </B>This Agreement and the Confidentiality Agreement contain the entire understanding
of the parties with respect to the subject matter hereof and may be amended only by an agreement in writing executed by the parties hereto.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>12.</B></FONT></TD><TD STYLE="text-align: justify"><B>Notices. </B>All notices, consents, requests, instructions, approvals and other communications provided
for herein and all legal process in regard hereto shall be in writing and shall be deemed validly given, made or served, if (a) given
by email, when such email is transmitted to the email address set forth below (provided no &ldquo;bounce back&rdquo; or similar message
of non-delivery is received with respect thereto; provided further that notice given by email shall not be effective until either (i)
the receiving party&rsquo;s receipt of a duplicate copy of such email notice by one of the other methods described in this <B>Section
12</B> or (ii) the receiving party delivers a written confirmation of receipt of such notice by email or any other method described in
this <B>Section 12</B>), (b) delivered by hand to the address specified in this <B>Section 12</B>, when actually received by hand providing
proof of delivery, or (c) on the next Business Day if transmitted by national overnight courier (with confirmation of delivery) to the
address specified in this <B>Section 12</B>:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">if to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">International Flavors &amp; Fragrances Inc.<BR>
521 West 57<SUP>th</SUP> Street</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">New York, NY 10019</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.5in">&nbsp;</TD>
    <TD STYLE="width: 1in">Attention: &nbsp;</TD>
    <TD>Jennifer A. Johnson, EVP, General Counsel and Corporate Secretary</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>jennifer.a.johnson@iff.com</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">With copies to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Davis Polk &amp; Wardwell LLP<BR>
450 Lexington Avenue<BR>
New York, NY 10017<BR>
</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.5in">&nbsp;</TD>
    <TD STYLE="width: 1in"><FONT STYLE="font-size: 10pt">Attention:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Louis Goldberg </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Brian Wolfe&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Email:</FONT></TD>
    <TD>louis.goldberg@davispolk.com </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">brian.wolfe@davispolk.com </FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-indent: -40.5pt">if to the Icahn Group:<BR></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-indent: -40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Icahn Capital LP<BR>
16690 Collins Avenue, PH-1<BR>
Sunny Isles Beach, FL 33160&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.5in">&nbsp;</TD>
    <TD STYLE="width: 1in"><FONT STYLE="font-size: 10pt">Attention: &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn, Chief Operating Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-size: 10pt">jlynn@sfire.com</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>13.</B></FONT></TD><TD STYLE="text-align: justify"><B>Severability. </B>If at any time subsequent to the date of this Agreement, any provision of this Agreement
shall be held by any court of competent jurisdiction to be illegal, void or unenforceable, such provision shall be of no force and effect,
but the illegality or unenforceability of such provision shall have no effect upon the legality or enforceability of any other provision
of this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>14.</B></FONT></TD><TD STYLE="text-align: justify"><B>Counterparts. </B>This Agreement may be executed (including by PDF) in two or more counterparts which
together shall constitute a single agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>15.</B></FONT></TD><TD STYLE="text-align: justify"><B>Successors and Assigns. </B>This Agreement shall not be assignable by any of the parties to this Agreement.
This Agreement, however, shall be binding on successors of the parties hereto.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>16.</B></FONT></TD><TD STYLE="text-align: justify"><B>No Third Party Beneficiaries. </B>This Agreement is solely for the benefit of the parties hereto and
is not enforceable by any other persons.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>17.</B></FONT></TD><TD STYLE="text-align: justify"><B>Fees and Expenses. </B>Neither the Company, on the one hand, nor the Icahn Group, on the other hand,
will be responsible for any fees or expenses of the other in connection with this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>18.</B></FONT></TD><TD STYLE="text-align: justify"><B>Interpretation and Construction. </B>Each of the parties hereto acknowledges that it has been represented
by counsel of its choice throughout all negotiations that have preceded the execution of this Agreement, and that it has executed the
same with the advice of said independent counsel. Each party and its counsel cooperated and participated in the drafting and preparation
of this Agreement and the documents referred to herein, and any and all drafts relating thereto exchanged among the parties shall be deemed
the work product of all of the parties and may not be construed against any party by reason of its drafting or preparation. Accordingly,
any rule of law or any legal decision that would require interpretation of any ambiguities in this Agreement against any party that drafted
or prepared it is of no application and is hereby expressly waived by each of the parties</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">hereto, and any
controversy over interpretations of this Agreement shall be decided without regards to events of drafting or preparation. The section
headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of
this Agreement. Unless context otherwise requires, references herein to Exhibits, Sections or Schedules mean the Exhibits, Sections or
Schedules attached to this Agreement. The term &ldquo;including&rdquo; shall be deemed to mean &ldquo;including without limitation&rdquo;
in all instances. In all instances, the term &ldquo;or&rdquo; shall not be deemed to be exclusive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Pages Follow]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
each of the parties hereto has executed this Agreement, or caused the same to be executed by its duly authorized representative as of
the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>International Flavors &amp; Fragrances Inc. </B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;/s/ Jennifer Johnson</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jennifer Johnson</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Executive Vice President and General Counsel</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page to Cooperation Agreement between<BR> IFF and the Icahn Group]</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 34%"><FONT STYLE="font-size: 10pt"><B>ICAHN GROUP</B></FONT></TD>
    <TD STYLE="width: 6%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">CARL C. ICAHN</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Carl C. Icahn</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Carl C. Icahn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN PARTNERS LP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jesse Lynn</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Operating Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN PARTNERS MASTER FUND LP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jesse Lynn </FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Operating Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN ENTERPRISES G.P. INC.</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Ted Papapostolou </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Ted Papapostolou</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page to Cooperation Agreement between<BR> IFF and the Icahn Group]</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN ENTERPRISES HOLDINGS L.P.</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">By: Icahn Enterprises G.P. Inc., its general partner</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Ted Papapostolou </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Ted Papapostolou</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">IPH GP LLC</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jesse Lynn </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Operating Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN CAPITAL LP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jesse Lynn </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Operating Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN ONSHORE LP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jesse Lynn </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Operating Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN OFFSHORE LP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jesse Lynn </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Operating Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">BECKTON CORP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Jesse Lynn </FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Vice President</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page to Cooperation Agreement between<BR> IFF and the Icahn Group]</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CARL C. ICAHN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ICAHN PARTNERS LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ICAHN PARTNERS MASTER FUND LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ICAHN ENTERPRISES G.P. INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ICAHN ENTERPRISES HOLDINGS L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IPH GP LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ICAHN CAPITAL LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ICAHN ONSHORE LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ICAHN OFFSHORE LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BECKTON CORP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 70%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">FOR IMMEDIATE RELEASE</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Contact:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Michael DeVeau</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Investor Relations &amp; Communications Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">212.708.7164</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Michael.DeVeau@iff.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt"><IMG SRC="image_003.jpg" ALT=""></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 12pt; vertical-align: bottom"><IMG SRC="image_004.jpg" ALT="">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 12pt; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 12pt; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>IFF Appoints Barry A. Bruno to Board of Directors<BR>
    <BR>
    </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>New York, N.Y. (February 9, 2022) </B>&ndash; IFF (NYSE: IFF) today
    announced the appointment of Barry A. Bruno to the Company&rsquo;s Board of Directors as an independent director, effective February 8,
    2022.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;We are pleased to welcome Barry to the IFF Board,&rdquo; said
    Ed Breen, IFF Lead Director. &ldquo;Barry&rsquo;s leadership experience and track record with innovative, global consumer brands and deep
    international experience will benefit IFF&rsquo;s shareholders, employees and customers as IFF executes its strategic and operating priorities.&rdquo;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;I am honored to join IFF&rsquo;s Board at this moment of great
    opportunity for the Company,&rdquo; said Mr. Bruno. &ldquo;IFF is an innovative, customer-centric leader in solutions with global reach
    and an impressive portfolio, and I look forward to contributing to IFF&rsquo;s ongoing success.&rdquo;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With the addition of Mr. Bruno as an independent director, the IFF
    Board will comprise 14 members. In connection with this appointment, IFF has entered into a cooperation agreement with Icahn Capital LP
    and its affiliates, pursuant to which Icahn Capital recommended Mr. Bruno as an independent director.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Barry will make a strong addition to the IFF Board,&rdquo; said
    Carl Icahn, CEO of Icahn Capital. &ldquo;IFF is well-positioned, with the right strategic and operating plan to capitalize on global market
    trends and opportunities.&rdquo;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Barry A. Bruno</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Bruno is Executive Vice President and Chief Marketing Officer of
    Church &amp; Dwight Co., Inc., a role he has held since October 2021. During his tenure with Church &amp; Dwight, he has held the roles
    of Executive Vice President, International; Vice President, International Marketing and Global Markets Group; and Director &ndash; Export.
    He helped lead Church &amp; Dwight&rsquo;s growth in China and other international markets and has played a key role overseeing post-merger
    integration initiatives. Prior to joining Church &amp; Dwight, Mr. Bruno held various senior leadership positions with Johnson &amp; Johnson
    in its consumer, pharmaceutical and diagnostics business units.<BR>
    </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Welcome to IFF</U></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At IFF (NYSE: IFF), an industry leader in food, beverage, scent, health
    and biosciences, science and creativity meet to create essential solutions for a better world &ndash; from global icons to unexpected
    innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners
    with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more
    good for people and planet. Learn more at iff.com, Twitter, Facebook, Instagram, and LinkedIn.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT B</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">[CONFIDENTIALITY
AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CONFIDENTIALITY AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">From: International Flavors &amp; Fragrances Inc.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February 8, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To: Each of the persons or entities listed on Schedule A (the &ldquo;<U>Icahn
Group</U>&rdquo; or &ldquo;<U>you</U>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">This letter agreement shall
become effective upon the execution of the Cooperation Agreement (the &ldquo;<U>Cooperation Agreement</U>&rdquo;), dated as of February
8, 2022, among International Flavors &amp; Fragrances Inc. (the &ldquo;<U>Company</U>&rdquo;) and the Icahn Group. Capitalized terms used
but not otherwise defined herein shall have the meanings given to such terms in the Cooperation Agreement. The Company understands and
agrees that, subject to the terms of, and in accordance with, this letter agreement and during the term of the Cooperation Agreement,
the Independent Director may, if and to the extent he or she desires to do so, disclose non-privileged information (but not including
providing copies of Board materials) he or she obtains while serving as a member of the Board of Directors (&ldquo;Board&rdquo;) of the
Company to you and your Representatives (as hereinafter defined), and may discuss such information with any and all such persons, subject
to the terms and conditions of this letter agreement, and that other members of the Board may similarly disclose information to you if
they wish to do so, subject to the Company Policies (subject to the Confidentiality Agreement), if they are willing to do so and subject
to their fiduciary duties and Company Policies and subject to keeping the Company&rsquo;s General Counsel updated on the general nature
and contours of all such discussions. The Company may also furnish non-privileged information to you and your Representatives. As a result,
you may receive certain non-public information regarding the Company. You acknowledge that this information is proprietary to the Company
and may include trade secrets or other business information the disclosure of which could harm the Company. In consideration for, and
as a condition of, the information being furnished to you and your agents, affiliates, representatives, attorneys, advisors, directors,
officers or employees, subject to the restrictions in paragraph 2 (collectively, the &ldquo;<U>Representatives</U>&rdquo;), you agree
to treat any and all information concerning or relating to the Company or any of its subsidiaries or current or former affiliates that
is furnished to you or your Representatives (regardless of the manner in which it is furnished, including in written or electronic format
or orally, gathered by visual inspection or otherwise) by the Independent Director, or by or on behalf of the Company or any Company Representative
(as defined below), including discussions or matters considered in meetings of the Board or Board committees, together with any notes,
analyses, reports, models, compilations, studies, interpretations, documents, records or extracts thereof containing, referring, relating
to, based upon or derived from such information, in whole or in part (collectively, &ldquo;<U>Evaluation Material</U>&rdquo;), in accordance
with the provisions of this letter agreement, and to take or abstain from taking the other actions hereinafter set forth..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">The term &ldquo;Evaluation Material&rdquo; does not include information that (i) is or has become generally
available to the public other than as a result of a direct or indirect disclosure by you or your Representatives in violation of this
letter agreement or any other obligation of confidentiality, (ii) was within your or any of your Representatives&rsquo; possession on
a non-confidential basis prior to its being furnished to you by the Independent Director, or by or on behalf of the Company or its agents,
representatives, attorneys, advisors, directors, officers or employees (collectively, the &ldquo;<U>Company Representatives</U>&rdquo;),
or (iii) is received from a source other than the Independent Director, the Company or any of the Company Representatives; <I>provided,
</I>that in the case of (ii) or (iii) above, the source of such information was not believed by you, after reasonable inquiry, to be bound
by a confidentiality agreement with or other contractual, legal or fiduciary obligation of confidentiality to the Company or any other
person with respect to such information at the time the information was disclosed to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">You and your Representatives will, and you will cause your Representatives to, (a) keep the Evaluation
Material strictly confidential and (b) not disclose any of the Evaluation Material in any manner whatsoever without the prior written
consent of the Company; <I>provided, however, </I>that you may privately disclose any of such information: (A) to your Representatives
(i) who need to know such information for the purpose of advising you on your investment in the Company and (ii) who are informed by you
of the confidential nature of such information and agree to be bound by the terms of this letter agreement as if they were a party hereto;
<I>provided, further, </I>that you will be responsible for any violation of this letter agreement by your Representatives as if they were
parties to this letter agreement; and (B) to the Company and the Company Representatives. It is understood and agreed that the Independent
Director shall not disclose to you or your Representatives any Legal Advice (as defined below) that may be included in the Evaluation
Material with respect to which such disclosure would constitute waiver of the Company&rsquo;s attorney client privilege or attorney work
product privilege. &ldquo;<U>Legal Advice</U>&rdquo; as used in this letter agreement shall be solely and exclusively limited to the advice
provided by legal counsel and any discussions, deliberations or materials concerning such advice or which would otherwise be subject to
legal privileges and protections and shall not include factual information or the formulation or analysis of business strategy solely
to the extent that it is not protected by the attorney-client, attorney work product or other legal privilege.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">In the event that you or any of your Representatives are required by applicable subpoena, legal process
or other legal requirement to disclose any of the Evaluation Material, you will (a) promptly notify (except where such notice would be
legally prohibited) the Company in writing by email, facsimile and certified mail so that the Company may seek a protective order or other
appropriate remedy (and if the Company seeks such an order, you will provide such cooperation as the Company shall reasonably request),
at its cost and expense and (b) produce or disclose only that portion of the Evaluation Material which your outside legal counsel of national
standing advises you in writing is legally required to be so produced or disclosed and you will inform the recipient of such Evaluation
Material of the existence of this letter agreement and the confidential nature of such Evaluation Material. In no event will you or any
of your Representatives oppose action by the Company to obtain a protective order or other relief to prevent the disclosure of the Evaluation
Material or to obtain reliable assurance that confidential treatment will be afforded the Evaluation Material. For the avoidance of doubt,
it is understood that there shall be no &ldquo;legal requirement&rdquo; requiring you to disclose any Evaluation Material solely by virtue
of the fact that, absent such disclosure, you would be prohibited from purchasing, selling, or engaging in derivative or other voluntary
transactions with respect to the Common Shares of the Company or otherwise proposing or making an offer to do any of the foregoing, or
you would be unable to file any proxy or other solicitation materials in compliance with Section 14(a) of the Exchange Act or the rules
promulgated thereunder.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">You acknowledge that (a) none of the Company or any of the Company Representatives makes any representation
or warranty, express or implied, as to the accuracy or completeness of any Evaluation Material, and (b) none of the Company or any of
the Company Representatives shall have any liability to you or to any of your Representatives relating to or resulting from the use of
the Evaluation Material or any errors therein or omissions therefrom. You and your Representatives (or anyone acting on your or their
behalf) shall not directly or indirectly initiate contact or communication with any executive or employee of the Company (other than the
Chairman of the Board, Chief Executive Officer, Chief Financial Officer, General Counsel, or such other persons approved in writing by
the foregoing or the Board) concerning Evaluation Material, or to seek any information in connection therewith from any such person other
than the foregoing, without the prior consent of the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify">All Evaluation Material shall remain the property of the Company. Neither you nor any of your Representatives
shall by virtue of any disclosure of or your use of any Evaluation Material acquire any rights with respect thereto, all of which rights
(including all intellectual property rights) shall remain exclusively with the Company. At any time after the date on which no Independent
Director is a director of the Company, upon the request of the Company for any reason, you will promptly return to the Company or destroy
all hard copies of the Evaluation Material and use reasonable best efforts to permanently erase or delete all electronic copies of the
Evaluation Material in your or any of your Representatives&rsquo; possession or control (and, upon the request of the Company, shall promptly
certify to the Company that such Evaluation Material has been erased or deleted, as the case may be). Notwithstanding the foregoing, the
obligation to return or destroy Evaluation Material shall not cover information (i) that is maintained on routine computer system backup
tapes, disks or other backup storage devices as long as such backed-up information is not used, disclosed, or otherwise recovered from
such backup devices or (ii) retained on a confidential basis solely to the extent required to comply with applicable law and/or any internal
record retention requirements; provided that such materials referenced in this sentence shall remain subject to the terms of this letter
agreement applicable to Evaluation Material, and you and your Representatives will continue to be bound by the obligations contained herein
for as long as any such materials are retained by you or your Representatives.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify">You acknowledge, and will advise your Representatives, that the Evaluation Material may constitute material
non-public information under applicable federal or state securities laws, and you agree that you shall not, and you shall use reasonable
best efforts to ensure that your Representatives do not, trade or engage in any derivative or other transaction in the Company Shares
or any of the Company&rsquo;s other securities on the basis of such information in violation of such laws.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify">You hereby represent and warrant to the Company that (i) you have all requisite company power and authority
to execute and deliver this letter agreement and to perform your obligations hereunder, (ii) this letter agreement has been duly authorized,
executed and delivered by you, and is a valid and binding obligation, enforceable against you in accordance with its terms, (iii) this
letter agreement will not result in a violation of any terms or conditions of any agreements to which you are a party or by which you
may otherwise be bound or of any law, rule, license, regulation, judgment, order or decree governing or affecting you, and (iv) your entry
into this letter agreement does not require approval by any owners or holders of any equity or other interest in you (except as has already
been obtained).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify">Any waiver by the Company of a breach of any provision of this letter agreement shall not operate as or
be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this letter agreement. The
failure of the Company to insist upon strict adherence to any term of this letter agreement on one or more occasions shall not be considered
a waiver or deprive the Company of the right thereafter to insist upon strict adherence to that term or any other term of this letter
agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify">You acknowledge and agree that the value of the Evaluation Material to the Company is unique and substantial,
but may be impractical or difficult to assess in monetary terms. You further acknowledge and agree that in the event of an actual or threatened
violation of this letter agreement, immediate and irreparable harm or injury would be caused for which money damages would not be an adequate
remedy. Accordingly, you acknowledge and agree that, in addition to any and all other remedies which may be available to the Company at
law or equity, the Company shall be entitled to an injunction or injunctions to prevent breaches of this letter agreement and to enforce
specifically the terms and provisions of this letter agreement exclusively in the Delaware Court of</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">Chancery or other
federal or state courts of the State of Delaware. In the event that any action shall be brought in equity to enforce the provisions of
this letter agreement, you shall not allege, and you hereby waive the defense, that there is an adequate remedy at law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify">Each of the parties (a) consents to submit itself to the personal jurisdiction of the Delaware Court of
Chancery or other federal or state courts of the State of Delaware in the event any dispute arises out of this letter agreement or the
transactions contemplated by this letter agreement, (b) agrees that it shall not attempt to deny or defeat such personal jurisdiction
by motion or other request for leave from any such court, (c) agrees that it shall not bring any action relating to this letter agreement
or the transactions contemplated by this letter agreement in any court other than the Delaware Court of Chancery or other federal or state
courts of the State of Delaware, and each of the parties irrevocably waives the right to trial by jury, (d) agrees to waive any bonding
requirement under any applicable law, in the case any other party seeks to enforce the terms by way of equitable relief, and (e) irrevocably
consents to service of process by a reputable overnight delivery service, signature requested, to the address of such party&rsquo;s principal
place of business or as otherwise provided by applicable law. THIS LETTER AGREEMENT SHALL BE GOVERNED IN ALL RESPECTS, INCLUDING VALIDITY,
INTERPRETATION AND EFFECT, BY THE LAWS OF THE STATE OF DELAWARE APPLICABLE TO CONTRACTS EXECUTED AND TO BE PERFORMED WHOLLY WITHIN SUCH
STATE WITHOUT GIVING EFFECT TO THE CHOICE OF LAW PRINCIPLES OF SUCH STATE.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify">This letter agreement and the Cooperation Agreement contain the entire understanding of the parties with
respect to the subject matter hereof and thereof and supersedes all prior or contemporaneous agreements or understandings, whether written
or oral. This letter agreement may be amended only by an agreement in writing executed by the parties hereto.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify">All notices, consents, requests, instructions, approvals and other communications provided for in this
letter agreement and all legal process in regard to this letter agreement shall be in writing and shall be deemed validly given, made
or served, if (a) given by email, when such email is transmitted to the email address set forth below (provided no &ldquo;bounce back&rdquo;
or similar message of non-delivery is received with respect thereto; provided further that notice given by email shall not be effective
until either (i) the receiving party&rsquo;s receipt of a duplicate copy of such email notice by one of the other methods described in
this <B>Section 12</B> or (ii) the receiving party delivers a written confirmation of receipt of such notice by email or any other method
described in this <B>Section 12</B>), (b) delivered by hand to the address specified in this <B>Section 12</B>, when actually received
by hand providing proof of delivery, or (c) on the next Business Day if transmitted by national overnight courier (with confirmation of
delivery) to the address specified in this <B>Section 12</B>:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">if to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">International Flavors &amp; Fragrances Inc.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">521 West 57<SUP>th</SUP> Street</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">New York, NY 10019</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.5in; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1in; font-size: 10pt">Attention: &nbsp;</TD>
    <TD STYLE="font-size: 10pt">Jennifer A. Johnson, </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">EVP, General Counsel and Corporate Secretary</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;jennifer.a.johnson@iff.com</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">With copies to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Davis Polk &amp; Wardwell LLP</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">450 Lexington Avenue</P>




<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">New York, NY 10017</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.5in">&nbsp;</TD>
    <TD STYLE="width: 1in"><FONT STYLE="font-size: 10pt">Attention:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Louis Goldberg </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Brian Wolfe&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Email:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">louis.goldberg@davispolk.com </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">brian.wolfe@davispolk.com </FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-indent: -40.5pt">if to the Icahn Group:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-indent: -40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Icahn Capital LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-indent: -40.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">16690 Collins Avenue, PH-1&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Sunny Isles Beach, FL 33160</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-indent: -40.5pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.5in">&nbsp;</TD>
    <TD STYLE="width: 1in"><FONT STYLE="font-size: 10pt">Attention:&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn, Chief Operating Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">jlynn@sfire.com</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify">If at any time subsequent to the date hereof, any provision of this letter agreement shall be held by
any court of competent jurisdiction to be illegal, void or unenforceable, such provision shall be of no force and effect, but the illegality
or unenforceability of such provision shall have no effect upon the legality or enforceability of any other provision of this letter agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify">This letter agreement may be executed (including by PDF) in two or more counterparts which together shall
constitute a single agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify">This letter agreement and the rights and obligations herein may not be assigned or otherwise transferred,
in whole or in part, by you without the express written consent of the Company. This letter agreement, however, shall be binding on successors
of the parties to this letter agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.</TD><TD STYLE="text-align: justify">This letter agreement shall expire two (2) years from the date on which the Cooperation Agreement terminates;
except that the obligations hereunder will remain in effect for information that is retained as provided in <B>Section 5</B> and except
that you shall maintain in accordance with the confidentiality obligations set forth herein any Evaluation Material constituting trade
secrets for such longer time as such information constitutes a trade secret of the Company as defined under 18 U.S.C. &sect; 1839(3) and
(ii) retained pursuant to <B>Section 5</B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.</TD><TD STYLE="text-align: justify">No licenses or rights under any patent, copyright, trademark, or trade secret are granted or are to be
implied by this letter agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.</TD><TD STYLE="text-align: justify">Each of the parties acknowledges that it has been represented by counsel of its choice throughout all
negotiations that have preceded the execution of this letter agreement, and that it has executed the same with the advice of said counsel.
Each party and its counsel cooperated and participated in the drafting and preparation of this letter agreement and the documents referred
to herein, and any and all drafts relating thereto exchanged among the parties shall be deemed the work product of all of the parties
and may not be construed against any party by reason of its drafting or preparation. Accordingly, any rule of law or any legal decision
that would require interpretation of any ambiguities in this letter agreement against any party that drafted or prepared it is of no application
and is hereby expressly waived by each of the parties, and any controversy over interpretations of this letter agreement shall be decided
without regards to events of drafting or preparation. The term &ldquo;including&rdquo; shall in all instances be deemed to mean &ldquo;including
without limitation.&rdquo; In all instances, the term &ldquo;or&rdquo; shall not be deemed to be exclusive.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Pages Follow]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please confirm your agreement with the foregoing
by signing and returning one copy of this letter agreement to the undersigned, whereupon this letter agreement shall become a binding
agreement between you and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">International Flavors &amp; Fragrances Inc. </FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><U></U></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD>Jennifer Johnson</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>Executive Vice President and General Counsel</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted and agreed as of the date first written above:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%">&nbsp;</TD>
    <TD STYLE="width: 14%">&nbsp;</TD>
    <TD STYLE="width: 32%">&nbsp;</TD>
    <TD STYLE="width: 35%"><FONT STYLE="font-size: 10pt">CARL C. ICAHN</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Carl C. Icahn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page to Confidentiality Agreement between IFF and the Icahn Group]</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN PARTNERS LP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Operating Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN PARTNERS MASTER FUND LP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Operating Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN ENTERPRISES G.P. INC.</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Ted Papapostolou</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>Chief Financial Officer<FONT STYLE="font-size: 10pt"> </FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN ENTERPRISES HOLDINGS L.P.</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">By: Icahn Enterprises G.P. Inc., its general partner</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Ted Papapostolou</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">IPH GP LLC</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Operating Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN CAPITAL LP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Operating Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page to Confidentiality Agreement between IFF and the Icahn Group]</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN ONSHORE LP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Operating Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">ICAHN OFFSHORE LP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Operating Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">BECKTON CORP</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Jesse Lynn</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Vice President</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page to Confidentiality Agreement between IFF and the Icahn Group]</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"><U>SCHEDULE A</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Beckton Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Icahn Capital LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Icahn Enterprises Holdings L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Icahn Enterprises G.P. Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Icahn Offshore LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Icahn Onshore LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Icahn Partners LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Icahn Partners Master Fund LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IPH GP LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Icahn Capital LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Carl C. Icahn</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>dp166855_ex9901.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 70%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">FOR IMMEDIATE RELEASE</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Contact:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Michael DeVeau</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Chief Investor Relations &amp; Communications Officer</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">212.708.7164</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Michael.DeVeau@iff.com</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt"><IMG SRC="ex9901_001.jpg" ALT=""></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 12pt; vertical-align: bottom"><IMG SRC="ex9901_002.jpg" ALT="">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 12pt; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 12pt; vertical-align: bottom"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>IFF Appoints Barry A. Bruno to Board of Directors<BR>
<BR>
</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>New York, N.Y. (February 9, 2022) </B>&ndash; IFF (NYSE: IFF) today
announced the appointment of Barry A. Bruno to the Company&rsquo;s Board of Directors as an independent director, effective February 8,
2022.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&ldquo;We are pleased to welcome Barry to the IFF Board,&rdquo; said
Ed Breen, IFF Lead Director. &ldquo;Barry&rsquo;s leadership experience and track record with innovative, global consumer brands and deep
international experience will benefit IFF&rsquo;s shareholders, employees and customers as IFF executes its strategic and operating priorities.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&ldquo;I am honored to join IFF&rsquo;s Board at this moment of great
opportunity for the Company,&rdquo; said Mr. Bruno. &ldquo;IFF is an innovative, customer-centric leader in solutions with global reach
and an impressive portfolio, and I look forward to contributing to IFF&rsquo;s ongoing success.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">With the addition of Mr. Bruno as an independent director, the IFF Board
will comprise 14 members. In connection with this appointment, IFF has entered into a cooperation agreement with Icahn Capital LP and
its affiliates, pursuant to which Icahn Capital recommended Mr. Bruno as an independent director.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&ldquo;Barry will make a strong addition to the IFF Board,&rdquo; said
Carl Icahn, CEO of Icahn Capital. &ldquo;IFF is well-positioned, with the right strategic and operating plan to capitalize on global market
trends and opportunities.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Barry A. Bruno</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Mr. Bruno is Executive Vice President and Chief Marketing Officer of
Church &amp; Dwight Co., Inc., a role he has held since October 2021. During his tenure with Church &amp; Dwight, he has held the roles
of Executive Vice President, International; Vice President, International Marketing and Global Markets Group; and Director &ndash; Export.
He helped lead Church &amp; Dwight&rsquo;s growth in China and other international markets and has played a key role overseeing post-merger
integration initiatives. Prior to joining Church &amp; Dwight, Mr. Bruno held various senior leadership positions with Johnson &amp; Johnson
in its consumer, pharmaceutical and diagnostics business units.<BR>
<BR>
</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><U>Welcome to IFF</U></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">At IFF (NYSE: IFF), an industry leader in food, beverage, scent, health
and biosciences, science and creativity meet to create essential solutions for a better world &ndash; from global icons to unexpected
innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners
with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more
good for people and planet. Learn more at iff.com, Twitter, Facebook, Instagram, and LinkedIn.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex9901_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex9901_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !0 ' # 2(  A$! Q$!_\0
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M5W5?)XQ)8B:7<^LP3;P\&^Q\UZWSK^I9_P"?J7_T,U0J]K?_ "']2_Z^I?\
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M_H9JC7UE'^''T7Y'R57XY>K_ #/8/A%_R+]__P!??_LBUZ'7GGPB_P"1?O\
M_K[_ /9%KT.OE,?_ +S/U/J\!_NT/0*H:Y_R -1_Z]I/_035^J&N?\@#4?\
MKVD_]!-<T/B1U3^%GS4/NCZ4M(/NCZ4M?;GPY] > O\ D1]*_P"N1_\ 0C71
AUSG@+_D1]*_ZY'_T(UT=?%XC^-/U?YGVF'_A1]%^1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex9901_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex9901_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  1 .0# 2(  A$! Q$!_\0
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2%5A?A?J88[XX^@4445TG(?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !0 ' # 2(  A$! Q$!_\0
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M5W5?)XQ)8B:7<^LP3;P\&^Q\UZWSK^I9_P"?J7_T,U0J]K?_ "']2_Z^I?\
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M_H9JC7UE'^''T7Y'R57XY>K_ #/8/A%_R+]__P!??_LBUZ'7GGPB_P"1?O\
M_K[_ /9%KT.OE,?_ +S/U/J\!_NT/0*H:Y_R -1_Z]I/_035^J&N?\@#4?\
MKVD_]!-<T/B1U3^%GS4/NCZ4M(/NCZ4M?;GPY] > O\ D1]*_P"N1_\ 0C71
AUSG@+_D1]*_ZY'_T(UT=?%XC^-/U?YGVF'_A1]%^1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  1 .0# 2(  A$! Q$!_\0
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2%5A?A?J88[XX^@4445TG(?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>iff-20220208.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a85s7xRiXgen8uCZHRMWa2O2aP9x5V62Zkxtmt+fUk6jyIu/8VkiSejxvamUSEK -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:IFF="http://iff.com/20220208" elementFormDefault="qualified" targetNamespace="http://iff.com/20220208">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://iff.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="iff-20220208_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="iff-20220208_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="iff-20220208_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="IFF_Sec1.75PercentSeniorNotesDue2024Member" name="Sec1.75PercentSeniorNotesDue2024Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="IFF_Sec1.800PercentSeniorNotesDue2026Member" name="Sec1.800PercentSeniorNotesDue2026Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>iff-20220208_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://iff.com/role/Cover" xlink:href="iff-20220208.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://iff.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="iff-20220208.xsd#IFF_Sec1.75PercentSeniorNotesDue2024Member" xlink:label="loc_IFFSec1.75PercentSeniorNotesDue2024Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_IFFSec1.75PercentSeniorNotesDue2024Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="iff-20220208.xsd#IFF_Sec1.800PercentSeniorNotesDue2026Member" xlink:label="loc_IFFSec1.800PercentSeniorNotesDue2026Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_IFFSec1.800PercentSeniorNotesDue2026Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_50" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_50" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_50" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_50" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_50" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_50" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_50" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_50" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_50" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_50" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_50" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_50" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_50" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_50" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_50" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_50" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_50" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_50" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>iff-20220208_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="iff-20220208.xsd#IFF_Sec1.75PercentSeniorNotesDue2024Member" xlink:label="IFF_Sec1.75PercentSeniorNotesDue2024Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IFF_Sec1.75PercentSeniorNotesDue2024Member" xlink:to="IFF_Sec1.75PercentSeniorNotesDue2024Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IFF_Sec1.75PercentSeniorNotesDue2024Member_lbl" xml:lang="en-US">Sec 1. 75 Percent Senior Notes Due 2024 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="iff-20220208.xsd#IFF_Sec1.800PercentSeniorNotesDue2026Member" xlink:label="IFF_Sec1.800PercentSeniorNotesDue2026Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IFF_Sec1.800PercentSeniorNotesDue2026Member" xlink:to="IFF_Sec1.800PercentSeniorNotesDue2026Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="IFF_Sec1.800PercentSeniorNotesDue2026Member_lbl" xml:lang="en-US">Sec 1. 800 Percent Senior Notes Due 2026 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>iff-20220208_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://iff.com/role/Cover" xlink:href="iff-20220208.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://iff.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="iff-20220208.xsd#IFF_Sec1.75PercentSeniorNotesDue2024Member" xlink:label="loc_IFFSec1.75PercentSeniorNotesDue2024Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_IFFSec1.75PercentSeniorNotesDue2024Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="iff-20220208.xsd#IFF_Sec1.800PercentSeniorNotesDue2026Member" xlink:label="loc_IFFSec1.800PercentSeniorNotesDue2026Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_IFFSec1.800PercentSeniorNotesDue2026Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139758082021672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 08, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb.  08,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-4858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTERNATIONAL FLAVORS & FRAGRANCES INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000051253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-1432060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">521 West 57th Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-5500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value 12 1/2&#162; per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IFF<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=IFF_Sec1.75PercentSeniorNotesDue2024Member', window );">Sec 1. 75 Percent Senior Notes Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.75% Senior Notes due 2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IFF 24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=IFF_Sec1.800PercentSeniorNotesDue2026Member', window );">Sec 1. 800 Percent Senior Notes Due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.800% Senior Notes due 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IFF 26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=IFF_Sec1.75PercentSeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=IFF_Sec1.75PercentSeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=IFF_Sec1.800PercentSeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=IFF_Sec1.800PercentSeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>dp166855_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:IFF="http://iff.com/20220208"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="iff-20220208.xsd" xlink:type="simple"/>
    <context id="From2022-02-08to2022-02-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <startDate>2022-02-08</startDate>
            <endDate>2022-02-08</endDate>
        </period>
    </context>
    <context id="From2022-02-082022-02-08_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-08</startDate>
            <endDate>2022-02-08</endDate>
        </period>
    </context>
    <context id="From2022-02-082022-02-08_custom_Sec1.75PercentSeniorNotesDue2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">IFF:Sec1.75PercentSeniorNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-08</startDate>
            <endDate>2022-02-08</endDate>
        </period>
    </context>
    <context id="From2022-02-082022-02-08_custom_Sec1.800PercentSeniorNotesDue2026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">IFF:Sec1.800PercentSeniorNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-08</startDate>
            <endDate>2022-02-08</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-02-08to2022-02-08">0000051253</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-02-08to2022-02-08">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-02-08to2022-02-08">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2022-02-08to2022-02-08">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-02-08to2022-02-08">2022-02-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-02-08to2022-02-08">INTERNATIONAL FLAVORS &amp; FRAGRANCES INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-02-08to2022-02-08">NY</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-02-08to2022-02-08">1-4858</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-02-08to2022-02-08">13-1432060</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-02-08to2022-02-08">521 West 57th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-02-08to2022-02-08">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-02-08to2022-02-08">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-02-08to2022-02-08">10019</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-02-08to2022-02-08">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-02-08to2022-02-08">765-5500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-02-08to2022-02-08">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-02-08to2022-02-08">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-02-08to2022-02-08">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-02-08to2022-02-08">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-02-082022-02-08_us-gaap_CommonStockMember">Common Stock, par value 12 1/2&#xa2; per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-082022-02-08_us-gaap_CommonStockMember">IFF</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-082022-02-08_us-gaap_CommonStockMember">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-082022-02-08_custom_Sec1.75PercentSeniorNotesDue2024Member">1.75% Senior Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-082022-02-08_custom_Sec1.75PercentSeniorNotesDue2024Member">IFF 24</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-082022-02-08_custom_Sec1.75PercentSeniorNotesDue2024Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-02-082022-02-08_custom_Sec1.800PercentSeniorNotesDue2026Member">1.800% Senior Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-02-082022-02-08_custom_Sec1.800PercentSeniorNotesDue2026Member">IFF 26</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-02-082022-02-08_custom_Sec1.800PercentSeniorNotesDue2026Member">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-02-08to2022-02-08">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MT_X]>/<^2L;W5'+YC[#Y"5!+ P04    " #XA$E4EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( /B$252JQ"(6,P$
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M'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " #XA$E4)!Z;HJT   #X 0  &@
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,
M75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO
M *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR
M./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/
M3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ ^(1)5&60>9(9 0  SP,
M !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +
M77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5
M!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP
M39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM
M2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>
M,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]
M#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4
M" #XA$E4!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( /B$25307\[X[P   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( /B$25297)PC
M$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ ^(1)5%\>N<[V!   8A4  !@              ("!#@@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( /B$253@]#J)
MJ@(  # ,   -              "  3H-  !X;"]S='EL97,N>&UL4$L! A0#
M%     @ ^(1)5)>*NQS     $P(   L              ( !#Q   %]R96QS
M+RYR96QS4$L! A0#%     @ ^(1)5*K$(A8S 0  (@(   \
M ( !^!   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( /B$250D'INBK0
M /@!   :              "  5@2  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( /B$251ED'F2&0$  ,\#   3              "
M 3T3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  (<4
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>122</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp166855_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://iff.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="dp166855_8k.htm">dp166855_8k.htm</File>
    <File>dp166855_ex0301.htm</File>
    <File>dp166855_ex1001.htm</File>
    <File>dp166855_ex9901.htm</File>
    <File>iff-20220208.xsd</File>
    <File>iff-20220208_def.xml</File>
    <File>iff-20220208_lab.xml</File>
    <File>iff-20220208_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dp166855_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 4,
   "dts": {
    "definitionLink": {
     "local": [
      "iff-20220208_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dp166855_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "iff-20220208_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iff-20220208_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "iff-20220208.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 66,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 122,
   "memberCustom": 2,
   "memberStandard": 1,
   "nsprefix": "IFF",
   "nsuri": "http://iff.com/20220208",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "dp166855_8k.htm",
      "contextRef": "From2022-02-08to2022-02-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://iff.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "dp166855_8k.htm",
      "contextRef": "From2022-02-08to2022-02-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 3,
   "tag": {
    "IFF_Sec1.75PercentSeniorNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sec 1. 75 Percent Senior Notes Due 2024 [Member]"
       }
      }
     },
     "localname": "Sec1.75PercentSeniorNotesDue2024Member",
     "nsuri": "http://iff.com/20220208",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "IFF_Sec1.800PercentSeniorNotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sec 1. 800 Percent Senior Notes Due 2026 [Member]"
       }
      }
     },
     "localname": "Sec1.800PercentSeniorNotesDue2026Member",
     "nsuri": "http://iff.com/20220208",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://iff.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0000950103-22-002304-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-22-002304-xbrl.zip
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M9,8%<# .8]2H@4G+3-/[BC9KVMEX&9\W:F#O>0@+$PAUG=& ZRD<82]:.4Q
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MS9UH9C:NBR>YRV&%W4LKL,M1\\:.JK56I5$KML#M+9Z3D_/B3;W1)/^A?>.
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M/P\':-^=LWJ]Y0R2F8_A@,^@^S]%4KZJR;@#P4A[2"1>U 4-GLAKC_&#BYB
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M,MFOY&7:=% +1=/$9!^VMJ*:[WSR72DT*4%#XAH#<'QM-/>^YA&)+F]++TW
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M?^7;HHA)M'5YB"GH! 35ZE%XW4T&$0-7A60@#PY(M<Q_>4CFCQ_XK1^\*%H
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M_O?/_Z)A^KZ/G)2)H$%R]PA9(\,8IYB#Y=V!F":URXY%; B79&6$NK$:19N
M,V1\D;1\"SSS1_;UI_W^3\MC#"27C@/$:$=3,=$YF)$%EZQ6:<+A&[U(DVL!
MRSPV'3O;@? 664Q<.G*I_"=Y*2=_]4/VV"G'W=9O]::<#6,%^OCZ1,(<[4:=
M+ T%!\&"HY@:I6.>4[&74D=R$3QI)QFI/&:P.!HHIX#51"PD4"5%F2R6PP1S
MD#$V+FN*/)))=]2^6->ZFHE5M 6>#@<$@IJ#:S#SG8E-W"% JL%/,:;EY)C2
MGJ+PF!;:1A3T"5QMM?3]GNG-SWOJ8^0J[\$V1VR,O"&@-VZW+P#0*>"X#8(>
MW36 /APX"0.= 'H4QL][RVV\[UVTM]OQ2*?&U-Y+\%R5\1AM2G@TZ8ZG4@J*
M:QJ2"K_3!M& W#;9D U"AO9TR&B[;,B,0PBJ>%6>I/G6\."TID;J#/U&Z91[
MXII5V('2)(8NJ=SUFJPL/BM.W13RAG44NCI!$FM9>.54R*2WO;O57OHJV_=R
M%+5OV.& *PCMO:*J"2M=+$18HV$MW)0=RPDS;"))99?-R.9A+7A.D'"%#TJ\
M8?<%BY7ZP@*>ZLJ#/==>I929FX5D#K^SD,SA#QN2.7#H33OKXDQ*.)NR3&M*
M)V X:%@8=BKTI&3.S38R/P<+[HV@Q7FSOA,9#MO5>2A_'-49LA-[/C;98"KS
M&:FTC8W409%F#!F*KK!R%D8V,KP=KB*/L^/^YJ!?S/<@Y'&[<_[J:P#K*U$H
M?</J6[QPSVX'F*$;)OCXV\=M-RUR/\ N.-Q_[6S&+5;[WG?7:PO5->KDQX1U
MGW4FA=)TG=PQ?KL=2ALY(&TH*\X1DFHI#!-H$Z/53U_BZ<(3JK/TU<_MJQ6\
MJ&YY?TO0]PEYNF'%WVQ &(.@;G1[3)?--F^]FN;(<PIHWMLT]&M6/.[R,WG:
M?W&GW8?2I3;PJP"[(?#M*P"[5,127'+U";:?8JH'?>K[ WG5+7ND9K:2%WJG
M^W++F7VZ+W9[+%[3%JZ:X># PP; VDH_R2F]2##[R;)#+3"N;37]8$"SJP ;
M'@XB-1QLRE#66@'K.6NVD+)EQO5%L4UT$P9;Z0C45!0V!6%3E&92F,_'J3[R
MT]3L^;GK!+7,]=VL7@K;4\7;U3>J/\ =[;R^L3GGS.RD?LF\ H:%-39-W13-
MYUXZIIN-:<-X-J./YJMC_SC1(20W.(! :KC:.DANU4:TU81MXY:(-F$C2AXW
MD)/F(^]H%?K-*MBGM+^-\"M&EA6$^6\G"Q>%"!HHNL" CDLR_81:+6=KW:E-
M]HN-17J1&E,40U85@4SO>E68EBEX>M%*W$D4-.YL.P6+_]5M_VTG/_/-P<K.
M>"X#&<^)R7@V<W2#/&E=B\%45VEKO:UTW+E(N5HQ[0O3VVYJ^K;+#S=9B"[8
MEPD3)<[=5:9YPJD37T+VW;4JM]4+$MNN6L-34_6_UY;=3MR\UVSS7PB;.9'+
MF^ L1MP;%9WCD1,9OBBNV@I0<.C)M+Z_>;Q)!.+1=Q:!>/3#1B#VQZXB@[U-
M7-,%ES=G5;6FB!DJ8RKX!PV/M>4^4VUCK\?1SOZ(#\B4$AG(%N4*:[#CYFGI
M]55P]O__A=M+]4%=.*:Q-9!Y-EN#3X=4<VLN:D/HKY,_%_V@@RZN9:<$')^;
MYI6\3YEFRPD8+%I*X/%9YD:'.CD5PP&_75I>9E-OOGKSG\=W:85T<*6%$/\+
MG'TX"S.C["KRL\D>1(9"G.@9NAO*(@DY1^JSU*[]^V6=H8V7"\2M"_[D5_"C
M&?G/QQR&X1QO Z$Y)B<YOG*C<^N^AL66<&%-D;?!K:HI)&$+=45_ GKX7+\"
MT5#,X0FDZ!6DQI\BRTX-RV+Q4EA(- *K9<*D,3+V>UOB>]Y0QR/9-X3I@)O!
M*8QT=NP45KOLR#KO9J^UY*#]A6M7GFR,:;YV3AO:!_%P8!\O].I7R(5A"GNX
ME<RD(H56PRY]J)VSS.; ;-H?LR)EJT8X.&U(8D8J(L:@"P/&,(ZR3"\+10+-
M38GE*3X5>(@C7?5.-)SK_?GB7Q0G_9K=80]5=UB[AZ'=%\;)_&J3IXWLKV^T
M$>R!K>B\1K O_O&2IJ)B7IQYI( /F)=@]ML_+]*<B!1;ZL@%':TT/.H;#%PB
M:5(BS4]MOG)30](@++>H<<2%:Z/*%A)\6X<QW"50([ZD&JJ)VG!:@N+DM<?2
MES?HKTG?_3\[_)462FJ=<Z (R4PJO.J7X,)5U*,#P5WEC%L8YCM%5B!.=T<K
M$*+2TNQ96+(\HBQ<#B' 4.!_<9V%&'I_;Q2\367<R1TT02_!O)7X>]SD ::;
MQZJ[L0KY>Y F6"!XV4CW]\!VNY5!4C6$T#P#,5&O<3>,\Z* F4O@#,0<V#2V
M$B:^9 :M$%;ZF?C,SK5$DK&Y \1AM$/;-CC3+3U7,#)&^L[/RH3//MI)??UB
M4-OMTKZK+]LC=&WHE"&<!<MX4H 52]LFL-V9YR,X>4;[^]0CBC?_Y-BPMUA;
M9)%<>4UK*%(M8L^.A-SK)/6-R@<J%3I+DEJSP)/AP*""#='B=.'924<C+U!'
M*ZM6)"3/Q"[8W#8."Y)DO41*M&P,D4V-3&@2MIE2S.HR/_JUXZG"@!$#?B7:
M2&V]B' 6>J5+N?UB]KNIVJO+[!SL+:I1=&JUAX6TF#^FUX]2/%E)R&:9,A12
M%[;U$5I5Y1"3)]=,RV[9G3M(7FHYW*A%4%R1PRTP#/DT^CG([ -[O\KLO6P]
M2X  '7VR9T4'-NPPE*N+>HMT;U[*NS68)Y2J_UOR.5NNE\/!.YTD&%@%SL[_
MIMSGI[?HV(@A[25/B"1-TBX)38CD[ICF8!UQ?6.!-U%&/PAM.IEB0[%4-0\!
M2XG30M!8_"_-OVHR.TT%%NY_:G=BI2PN,+G$8:Q/ L)9FH*:9BO^*3 9!X><
M'J,2^9;%.M?M01(A&^7!2<,NC(# &.QO1'N)$>R^GUU/(ULTXAVJ+38R'H.=
M3NC RC-T'D")#,BLN##F@C(C9.UP/C&E*5\1'>Z$2+UF;.W?=:2R.\;R^#N+
ML3S^86,LCUWVM:!C$S25@J:0+V7:E1?AU6G&UD!E 8$22YF5R968 6(>!&V!
M*3<_M:K,.<X2N-@&:3G\8TLM>#_\-PS5R"]L/GF1S#AX&A:]W"%.4ZVKSDCU
M5>%#&^R#\J$V62C\:NO5%._8Z*B4*=\1$[V7TM6KU2NF-G@$_NC&2M@ *I*.
M4,/!93)%-D"IFL6!<XZ3-.M0'.J!N3,YZ[,TF6%0(FSN$B,W=9>C];4Z9EM=
M1# "XKRFRL\./!@T5 %[F):8Y2;#"-E_=$XB4[Z[-<.4.'9%F !>XLIM+8F'
M@VFRF*Z9YGJ2(,0L4[!1FU5J.+TU8GS<18/XY?>^>=K($5JF07D@J@B7SFDU
M%E1CVPJ/AH5BR0YTR!WAP2M8)ODG5OO!P^FL*%-LZL "92B&WHU+K:KVVR)_
M-VQ^#FS<^NUT/].\T]AUM7X077*)@[UY8LNM"AP"/A@7X+JB,80SZ7O.EAU"
M)S70?K>1C7JHO?S@Y%+B2!_3%X&1ERTX*]VQDE%DEC@ L,4PQ"E6,:^^2$ZY
M<F<!)P1?'B-V2^Q,5M4CKS0)A"Y"VFV52>UO:E)M4!^]OY(FRXB%B]&-<:N&
MX:NWA2>Q,A7OHC>SQ/&-%I!QK:X5C#8L(.*_I TK$SC'GQ-XBL2U&24+P^+D
M:ZN[;@[RQAFJQ=-8<;XM*"/LL4=_@12'FV$S8Z\_7H7&,*\EC1%_$5M[H3EK
M,F,]"ND;8ZK?,LGCHVZ.Q_WQ+EFR.U/#\@B>_(G+SQE&YM"/_X;Y'!]WU0"U
M./5'("%5.]; Z5+DS!DF#IA>4G3HQ%+&YKIT_A)5^Z=B#WZ_!D=TK3GG3U-+
MD!%FLZ@Z,J$1],"D9SG4Q;JB(#Y+G_JB3-.'V!8'QYL5,VX0A[$<Z>Z14&LB
M;A?)3C9F.;T:*7RKTAA<5V)T;/?DH5;"\K@RG:>E5)IX9N@.]C-++Z5+%,V(
M>H/HO<Y@<<K&*NY S8UG&J]&52B6/:WZM: ]33DSU"*UY#]A@2@_N<M[D9*&
M&:4DI*D5U$+-9:):5G=S3;LSP^30&>8OI*LZ4;W:I:$FAQ@#-?=@<_N-A7<F
M(W2&3-C$KML8#G;$43!U%QA6Z8T_9*M3U/.Y[:@V;3>%@^KP=H'4'4/7'M2Q
MO^ -=6@7D3#I(^UTM7>25R2?S]?D.1Q5*4<QV<$\WATY3,GY.1+BU^F(Q(QS
MRMEJ<2K"=,?VCRQHX)1@*0O"X"13FJ?&[A8\BYSB4.T35DYO]V"X)E9VO%TS
MS4%=-C;(0X011]A->.. ?9?4<[R9@H@^ORPRS@]"7[!83VH=[F8OFTZ:M2X$
MSNF5'PX:*\M! H+^T86Q!2]^6$S@IY)"PUYZ9.+M8:.,9$Q2INUQZ^'@4>S-
M/0R83"6\!Z7OT7+%XEEAA/3:,'GH$#Z)1MI![=V=0]-.=P6_7]T6KW&$<*L_
M1G,6^;MU%ZXA4>A7=TVIE9&KZJ(V34==GOU\EBU3$#JDMY.2((VP$,Y2#9A:
M9 F_J2!*K.2\UMP=S;;C33/(ZTHBP:@/.3+&<A@.J&N::@F1+A/8)NCF<Z,]
MM5*T ]0AR2JE=V+"O91ZG*^QMA@O*==579EMBD8,ZQLQ4L#Z3\XU]Z!5ID\E
MXW59@&A'FZ'K1_@TC!.4&4C[#-_RVK@,W+@0=RA:'YC)J22PEMX6-P#FB20Y
MZ/%8I#!LW)9V=);-,=Y'HV,\VOE%&JS25'U=F/[)=P;3/_EA87HWAOC@Y:G9
MKC8@<<0IW.-GAWLDR1+!C%4RF?8__H>[Q^#9?@,G1YD;L8E2U3!?-2<XH]'K
M%:[[1>M]&83^>_:<LQ!(N+U='LP96CLREYZR4V[<,H5A1 ?_U8R0.A7S6X--
M)H:Z+"K.?<9H!>7RHZ5@94R;*.AY!E:*Z@?(G)NA"F:-U&">E*-VMK#-^LM#
MN.WR].PA-/MX;$IM>>,Y7XT0=8O65VH(M+#>-Z2CN7(CO%$"&\-AO@Z;%S V
M["V%N'B!V UJ82JC7<-YORQJ8Z)KR2*)3=@X2NP NW\'VZNHE_5M= ]4NWFJ
MRP@#/I/5NW+.A?S8I9)(5[.*MOZB0.:H?&3[YK;!J>W,!I^4%= )I/=/%\D:
M9P#>G<MP</0FST&E#1GB^)\I0E\5"].NH2WU4^* :!,F<SQIQ 4I)Z\N8;,E
M*C9EZC(QF$!H*C8@I0[$C!IS@1JHX!),Z]L^6P7Y9&-&O$?!NZ\"MW0]E=9[
MVK$&3!G1I?D4GZO2Q2)6=6Q6ZERP]2T,[PJM:C+Q$B2)J*Z252PV7\*:K$H6
MZ/L1^#4SK4:M-KAF""EM.EQXS.B\S929/K*4EN5UD:6?Z:?I;HQJ\;BD3A-3
M\89+J@LOLEC@-"#S"<MHK&E4'5>#QSU0O"B;BH9'2=>*"28\4EAP12'#9#%L
M^2,["+L-U@9)YW,J-)S#SO\\XABGPJ28>"DGBAI95&%'Q<=9?HLJT%_7ZS*-
MV]?!4,BTK(<JH2/A0M*(X$(N M6-<?%9(L DM=X2&[&FF+D>11?I[)QR]XKY
M')>-_PT/7V!<B>4;E5NF.'EQ=)Y0[(CE$;@5%5Z#7APOBBOSBA90\79;<3=J
M 9V4RBB,RB".$7P2.6\R^Y0X9-")-#7YSQ9:>8V1[$6!LK]J=R$1F,UR"0!2
M&V7"6W&[P?QCH3A)=J462EH/=20Z*E-,<!V%L=%0W0K%:*#623(9*>ZJ6&B$
MZP;KF-5L7:KB-$&P-L>,+P@S6*1,6H,_E>VX NF-84=, DER@64IE!G+=T2Y
M!#.0I]>Q62 EV[P3;?$ D!*A^):J;+,/H%AXH<'N#@<;YBRZIRD;#A9%@DZT
M?59TVJM6\:TS3I*+)I%TSQ0'2+=2MQ4)FC.6;[&I)M=:LC"M+1L#>%.^CS<H
MHA+!*W4U-4]_;3% 2RQ3 _0^UY*7@\RD17@,*\L&!,6OC[3Y%"97]^U$A)"V
MR"6((\.&CT^X0ES4_$K]A%>.J*# &.+4Y\N4O!/,2J)Z,[KC=MJ'3K<]8O4<
MB0E5J3&$K4US<T"M-Z]B_PX3:_;W.]HV:F?!]17>%91"6]GTH2N<GKI.+1)Z
M-[.F'=GC[K^975,F&<$5ER ;]#9\RR!&G=6A(S])G?MM@!RUH<MYOYQL882+
M3HRG8S?G? *!9._0R]QJR7K._W[LI+O/FO6A5G]BGN;?+5ZC]O@Y'-YP7-0)
MPS:CH@CJM]3+V&T,Q,H)M6(D$8_!3^,4=@5P^ZKK]*:R7W3H<0<'0$M$W^M!
M^Q%S33BT^LYL?W+QP*[;Y,@9$&9S*^S$ZIP"-\5X[G"  =WQ4RN6.WYV<"@=
MP@7 QNBMRJX7</!>YZ_G@[7-@KDK!I*/PK8D"Q4]F%;+PC5I!1I;\RLVL5;O
M4%0"[T;'S;&Y)0HY'!@KR;*=D4$&U37M&S+IQ<+2V5L@."7YXAYG\MZ7[JN]
M6W=0Y>EW%E1Y^L,&5<:'#L4O"(N#$2<ON%'QD>C3:]VHV(,=J39KHT30+DV+
MZD40F*VYEE0,-K'1ET%\[9I,/*OF %UP.Z<AD$2A,NW;2M#%G7%@/3$&= [6
M'-V'G4<CUZ%J-"R5L:A4,;^QQ_:BET%I)[_J$M=2KT:G,VNFD=-PG8R#KNP0
M*]&DQY+\\=U%M_:?=71\["KH5DLA+5[ G.@R$"TXWTL.:8MQD#<P\A-00NVQ
M)(_)0XS<ZMSN!F]LXV8!DM9[G>:^PY8WCTC=Z[JJ;$?Q%#GW)L%5PFYM7YI"
MH]$DSOEN%Z":V%1JK3C2H+K.#P>N,+Z#QD);K53?>Z.K"V6 @Q2U$#MV+;.H
MVV:066I<D8!&RW1M#=P([-II@12$>*7I,00+,<NX)XK<61 +"8")JHTW/$KI
M$2M6H?TE';1 H;) \X5B 65$?A/^6]*( C>^QX7HF]3CQEV/U,)W46],$0&<
M)5-A]K$HW/@ 2R88*E'&.G%A+[-B00F9AEB%]#JNP3R%QX#F1Z:5PF)F(9L)
M,2L6[6@XF0V0*I>WL)'D4&&0]2/TG9"-L$>7=O,D][VHSV[:::EC43G(K]GR
MN!U F$V4<>$BYX55!ZMAO7)]#P;1HY9G*@!+5 &'U6?I*J67\ J";\FR6=D9
M, L,<$\6677!0=:,VO],T$7&>N2;I;(8@)T:40@-.3_3?HT R]"FK0S[?>->
M#N<"6?N:$A:H/D0@^+S('TIV8ZI-(P^2=S)3!"EZ/'EXT)+T'[7D_#^GS$E\
MN,Y?QY !MCO=YL$Z3_+Q_LY2I4=*SR:<L@^83[U.F2ZU.01-0L=L.A'VA%(L
M#^(Q:9YK+_. $[4=2)3J'Q[M/>:438IS?- -?Z/7;5-@S9B%T>FDNX,#/%.G
MX,]$AWOCG?F(>=/U?3\^_._-=W8[$QN:&2IU(<_<:RG#KT<]YJ0I$N=FI)A7
MX)#:*-9BX3D^+Z5 J^4HWZ-4Z]<1&G<1KH0(2S?:1(JBKNK,)V^C@)J.]![5
M\4V[,LG$1!0ON^15!-L&4\_BT?W-5=\!LW8+.=2];+.Y2J2\=BK[[6H^(KOW
M<G?5 +=3F[C1%5KF[1YU?Y/9<V+DS=J0;5PZ);33_#PYESY]NBT"?P@S'#L"
MWFN=8#0A=D_(IMD*C M=2(EY4J3-5<15J=I8_<KN*Z]^9M4:2I1<*4XJF1OO
M+$:!&(M'=>>GNA!AO2[DH8H"BQU:@$&_QJ/6S:/1J@G5=N-O38+/O,73OK<=
M<!,<_=EWAJ,_^W%Q]*Z0NNJ4MPG^1NQ/CC6Z%Y3-0#DS4]K-M=-'O9TB8BID
M,'*P=3*+U3DNU(92'57V2L/LHZ$S^E?O&+3%TOS:(K01P$,R: /0F^PC+Q-
M6L0MU[DD2%5A'Y)PG[IR5R0I4R/5J?!DK4H[2Y1?E!*"3]#VK>## BX53;U0
M8+DL%@$2")&87^([&7H)PPP"URZ33\(M9%X8NS83_KC@W%,1L-.LG*Z7F"PU
MQ>PP4@7:L[OFYK/\4QP,^)R+-&&,2X_2^)AV_Q"/OWB17,$"L(=)Z?':E>#2
M17\C4V'IE.>_AM?)._BW>N4DW;C)^K4A'VWNS'GJ]ET22E_#4-U:L1M*L")K
MSFH<@+^ E>+:0:LT$K.J[ ]UEF:R!A^NS/Z#$0YTSM!AS%6K\&(>N)L?!X$=
M7*?$AV5Z>;BQ$3N^HBI.$XUXFNON<17Z;IFY.0CB$\X.![H?F=50JS-@\>4E
MO_:ATV)!&AYNCKO8^T"U'.DK/K'-'/9[5)_>M$4:>L"W$XEMJMT^(K:Y3[]7
M>O\>7[CGOC5/;A8$@.G%5#32%2I Z*CNH.9V(4JEN6UA9!.C-*,L^O<Z>DM)
M6-K_T?G3@HX%::RL&D5L>'4.YW.!(29XG%6VPWEN4NJ866ER:VD(<\U)<-0.
M5&T>&HU]$Q ;2^Z73ED)YG;)99(M-.$*-[NV6,G:'W%O*]ZO_?BL0V0$ Q(%
M^K;5&CL:PM%=9 ITK,"H6JKZ&:H=F\J97'/K->(0XU06.,;3M,Q550%<B28W
M%>HL4D0*L-9B8<TORFT.0G&*.E7JP**N:^5[NWN\FS/>K<D)\O*%#DG<M&T+
MJ21CJ]GT+^V64Y'3MG;>TO KQ#\>#&K<WUZX9]'VNK'S5-<[)EC!58A@.98D
M)G;^+#)-+TN;DU?%,;S:FIEHA1QR:51; S(.]%JANX!TH5+=I*(TE04#+;#/
M)U96<>V./BPQ59S%T2Q9@I<._T@_8Z\_EH\\ZFF!G!J6\:#*B$S1'#QK1+RV
M92F)]2&' 1/*0(#E7'Z* 2ZZ6^OA-#62= C!")HAETQ5E[HTDTN(B<8&2PS5
M*WI31S+7.F?6+M<3AP=!SYLJP)-33:??** $S:_%FO-GE9S0'\T[D8<M#KS;
MZ3%6,F)2\N*;1ZI/YK'/]FA1^\1VP]W"REQ1WIW"%^_*9;MG+7+0U9PW!/L[
M'$O,'(-RU,4=W JK9C"7R(!4F:Z&%1(D.T9<H!56P!@=0@A5.W1 ?EP;9."Y
M_:/8X;'>[ ?@QG*E#J+?N)>]RCL4>=N$+*+6B$4L&9[<G(]JW)KL$(IV(JNL
M/M(T197PMDJM-&QBT,*4L:H#7?:2$8#4['5ABAE5YE&AP)_N!^]DM1!D2U-D
M\,*DP30_W_09A-$Y%7RFZM\M:ER7J?G%+)U+H@0WB&VS:G5-;,$\;8YPT43(
M:/>$FJ&U@S2]=HZY)8?0>.\[P^G'>S\L4'_PR*V%W$G]4K0/OB)RVKQW) M\
M:3E:R..C6C3I ;(53^C=9'7ZL]9SS[3-J%:@Y@PLD111K?]9HZ4%9EV2"8QN
MVG-1\HFSG)&SFI35U$+CGU+NBDF>[E$.;?'&/9<:M7=9;:L22Y!#$A%7G 6[
M9RPA?[J*.;!I8X'\Y.>L9J1\A!5=&[.\T2;F>6#Q@+]@]:_E @XJ/M<%NK ;
M5 XLFIE4K9[HFFO'X0V#FLH_1C2(#)HRA4MVTL_*UV2"*3N;2]2C]8BX]<4D
M](=\(E:SC&"SJV96H,]ET."I:5D'W,X*/V]@X/H-0C_LH-/G]N[8C6>=HSW)
MH:G\NF%#BI6B*KJ_+ [EA:&B4!1*>0S"!%/3($,QJ$BH4-H*9VR^@(GFFS?.
MD<U/VG12AH/>NI)M<VS[YOURB\'FOG+T&O6>PMK/9DYSMPR^IT[S8LB&2E0.
ML4=*HSRE@\ 3RW7EA&Q3:QU+I!HT)JK@MEH;/EC^]C8<6TFS1.NF[1KT#UE^
MA,K <',BS2QW&*/2L@O85CB^G4=[>R-BM6!4QDNNV2Z)W>[>I9=/L1WNHG%>
MHS^OB2]@IZ,%H^-KS$5%I0TY<N H=[.[!S*N&+D"K38_IP-99?\P/U9C392V
M\*Z9:F53S$=*[,=^N&D"!E)ZJ;E'="X^ J=.X(3C)K&%2;-G4W&6!$X!: >>
ME O=3B[0=Z7;&5* +\H]#K=8()>B@&[M#$TRYLJN"\3C9,$\;7V.<0(#P$U?
MXNBN$C2>>!;YN2]TWFIXES+(0^_(XNBHO8\<4W]M[L<>:M.=1)Q9MR:R-:]U
MN-7$"ZQ4'7>66D[B"47K!)^>JD6#3]>Y&T:Q^V%9;<&-F$"EA55]NI8!<_]!
M6(!_HNG)F7B=1(CIX/?(="A$2BH4#7"M"(2YR5C?)%'4"&.=IF*]$<(PE(IX
M0W-""45JCX+4R4CZY[YZ==-U=:K<;KJP9L)Q89V>;)E#BRUB>[MT6:7K+&9Z
MP5LY*J(R^[OBAJ^N'W+H]QA;EQ"*0ZCN:3ZU-=^&TA$2LXT>T)8\=$BT3/,R
MZ^)&';.5BZHWQ!9[FCUK5!3RXS)=+9*I\2W:J=Y-P_@V&Q;;",6AIFT<L]3=
MN^S6FR3VN4B\#:(T>*HL?.]LZ?7-&I/8[.JL.MP@6OA$-EYCP_Z]%Y)X)2C7
M.>XH47956EZFPAPY'#3O;V(QLEGQG?6J+Q..6LNQ(L[RC%Q$SSRC>5?TE'K^
M#/]35G&TG<S"?-;D!".25!M0M9'<H,)W\5QVHB9P@X(^H-P<&#9?2X,W8PBC
MJXVR&HZJX)&BQZ@<:6Z$8A;-.MKMT6!*$5/RJBV(I/I*DO%GI_=)W)F,=S]"
M[&=MN0%=>O!20G)T=&&T]#ZTB8*S":HH/(\6;6XXO<(LG]8IE*7>XEWCC38M
M)@E<=S7]!'YFBBSR<'YM7^;;DSN$\+Q[W\>(-T#VX^\-LA__L)#]>-]I6 0>
MPH7O(9Q\QB90B,B0(W #I_8+7%ESYEORM5@@>GZNG=G3"L#9D=!-3#7:9^82
MNUR1 ^>-VQM5P0G8& 6.=G)OJE3L\+.T\;(@1+HAW1WGQ#!TB2LR"_#JCT*,
M.RZ"*1:@;:UMUR)=,XVBL;H Z4ZA2\$CKY)K(3*F ";&945IN$I>I[0'D>QL
MWALQAK^+^RYRV+]I%"43:M,P$Y]TW=ML:7-S/JE?8[)H.$^4<D-ND_DJ9EXW
MH0/DZSJ*UP1:MA/'OD[QFN9IL-I0!8O7MJ]:VZE&]URXMM4.Z7=/'MZ"G%!M
MRJ#%537(%,PZ'ADK]E1? $+BHX!ZU=8NR[V^_SWFFK<28'7,N4OOW$S-].AU
M6WQ %M2&-,.)5RNV7YV\JB0R7/SJ^N%;PCSH5YVX!ZD-#\C5-#JK$A0JR):%
MH56A&&$G&85F<V]GH]!)<"&8^6Z2G[=;XY[#QULU>KV\R4&V-('3VG3%;0N1
MX8_8_:AOC*;WL!/F*3,5TP!@]#4R]23!IF1/M8(_7B37-7:( C. &K(9VHKQ
MX;W.5;]B]E$7?T%+75#WZCAP3$<+/@3*L,G"3/.-,+V_N.O3,D.AL;#SVDU(
M'8\0)KD.!_KDV_65\$M:Y#EE_8X<TP%,Z,ML*AUN&%D,/JRQKU($:O:$./)^
M%Z#7-3_8VXIT_4:JU5IROV]-:?'_UN"FMC+)>&POKRFO<KW@KA 6OTN8.L;N
MUW:O,]4S%K(%!^5E0 7[CN+*(D!O6S=1/RVX72"7Q&1N1"V)&QPAN,_,C:@M
M<6,X:%0/WZ\)M\U:]ESQL87)?-EFP+6VUS'627 365 MPB+@**>5G:C4F:G/
M^=Y"ZSX<W" R3?ALDBW\TH)&EDU7#7=1WN/4?PV?_?/V2^UD^[=5=*N>:"5<
M[-9,8\03#QRA[WSX\4_NOT(;P>,5HF[78;:?MG!ACSU-[MN==:A?&F@*HY"<
M%W13$-)DH&*F"P(E68!-_VBD@+9*$=J&^7^GS/]K:D:L<(OT/ZMX<1G;8>(^
ME:,?"MQ:60AW-)O]+M43AXF42H %IC+]\:0Q-;;8PD_E,[NCGQTKMQI/D8BR
MBWVMZ45<!ZTF[)D>6>UHN$2#=/N"2T,X!.?"2)*T5;L+*PERP\%IW%QDVU6^
MJ]F[4>!E_WL+O.S_L(&7QP[2\. E0S%YT58/K+*"-F99(2NIFXWCDWW84J=#
M_?>E3?PW[3FKUKWYSI^^XGB=5<*S*MQ!7ZY VK,QR!MFJ81VG%2(N0 V9S+,
MTND"%AH\DRW)8A26=PGOPHD2JNRL,Z4BVC($14C.+6)0I$YWLE&;%X5"6UID
M>K9+>WKX<.#FAV>UFMRLO$&9:R"!_&;)-6P-MJUG6Q)AJP5)W*R:]'?F#/=2
M%T9868C<9RU2C%D>?1]55M+OC8TASNVW?:;WG^RZ9_J3?Z;?4.;1</!>[P7.
M43UKG7JW^E66%.-PV!7E!EW2Z?2 :*CJK%ZC+9&4AKBKLU.(Z0[2*';A-#$"
M&'02?SJ*U'[@8TVT*IMZ>&%ZIFGBA0E+-B.-5=T?8F2YH^7K&0 :V_>^$8>,
M)80IL=<$*%H3EB:I"=+>GA3&0NW&AT=J6V%P=#@XXFJ>VY+#;+.^FP:!,&%_
MB5#C.UO[\7CWH(DW@C0]APO^7%=87/[@Y<>3X[/3]^^B1]&+5R__9UV4Z^6+
MGUYA GO-]?B2^:Q/K<NH$JAWP0^L[Q&M^[.PR:UOT+8-TR1JJ;,G18O"W74#
ME5 'W2QRBE,$)<N.I8$E@E"EX%OJ?&^[&[P$UW6_C)22>5 '&F!*8:'42V61
M7/4&(VRU7GUOD<>.\%&[X3'NAO?E>9)G_^&0870T^[-8ESD77+T2[4%V &T-
M8PAP@910'*!]IC%[/:TX]6ICZ;Y=LF?XQL<72>:&<;EI>AY=2,0.3_^D0O]'
M0K(763I'NG9DF$,#X3W3EJ@MP 8)$8?:C_:W]'.KZ.JBN$HOJ;^Z2M4,V#WX
MN@K'TN+2>R?-5YCJ)!(A58D*_<]*F2CP<$P9USLUM@TP1,JGV N+DNE)%UE5
M:THA/HJD6; =N'9R@M6QL>U ! %J^T5"$\2S/;77Q[;IP+RM"I+H:563P2AD
MC_B#N"E!@L?7'I%_E,G6)4-3=9M.>&<Z7@-W+Z.*NX+^&W,WJX)Q102LK,P8
M,!6+=2ZYR:[_$6.((EL8L:&]AO ,.H6(WEP1 &9-K3,1-WD[&:+,<D>V0];V
M#=*FRYZJ!)TSYYNR6W10A4'[LEAABVN:SS3GIC+V\)D(!?=N2<WBV4^P8TC&
M?M@P'*=[!"'ZU1J/2,9)7"BV*<G.4O#HIMLRI+<(^OZ=J6??)U"B]PF*WC^H
M8[U6Q-("K/5,#@<HIZ[MS[A4GIKF;:=779Q#[W+[2@0:Z6H"9A/5DAT?<$R.
MP'#PD32Y]IY=>8WQ>:F?B"9%\2ED/]Q._F:?F4=T=HEB,4:8@+!+BMGI/MM5
M]AFLD)W'>Z,( _IDF3*)M0K&4^]$)\M 11*<V9$NVO1=(M9MIJ9#G0@U<\25
MH63.7')0];3'+?-N1+XTZ,J9!*UE%I33\SGB-P=9G"^NO4UB;0G)5: W"*[U
ME@-F.]'5&.XL).Z\H(0C%4D"3#'UT+V#XZ!O@K;=-^&</PHU6_%M.DX9;P"/
MC;S/F5UI)/N-9^R<ZNM86VISP,;H'7">S0&BP>NP;R,V;S4'GY7S1J-QDMX$
M<'+NSVQ>-1,HTSCO<U)O%"DX^-XB!0?_&RF0X]P$+[DF8=[IJ+)\LHJ4L=5N
M<LF5;#:%(N]P$(.3"IL$Z<RQ25E\0I57Y _Y+KK*:@JF9LW1-AH)WOZ;D&5/
MG=PR8[$\18OE-">Y5?!<GHC8,E""YQTUO0I,4%?W8%?/OJ$. Z.ZGQ PCORA
M'+:TV.U8/RH_TS9Y0"AQ%$#;V6!TKFMI)[?M+;  W!ZG-;(\E5)L*C[W3+$&
M2J+*<<3Y,YFA7K4/N]#A)PIH^6]AG7(\&F.H61O6LL7T322Q;E54&2N:8*\(
MIT9</U#W@KV@"'1UD:HQLZK"2G4*<Z,KV)]1_N0&>WR"K+-;/X$%W%Y P.WY
MBF9*H?H'+X\^G)T>OST!=?O5AO#J_=&'U\/!^S?1Z],/<"C??_C8SUA45[)#
M3)!PG[U(YWZJBZ2#]\]6^B@H=L8H=GY)<^IG^CNZRQ6+FY-.T(X/N#%4!%;:
M+JL?W6"XZ#IV6^HF\SFX^,%.N=I$6R8YU1ZQ$@K5C_<&)/HSUG>JV./0<NSC
M<KQ;4_D%SLD9:%U>CX\FA=>R32GS5O!UGMQ\K6HW9IY?,T%)MB[KE/RTPQ&E
MAUD_D5@@"I\X /VP0")>Y N32Z;=O^$ '$-P"T>ZP-MB5S0;!41_A<V0E([P
M:T+0S%"U8&@)E"%'316&\7MA31C_MJB1R"4T \&Z$"ECX1ZR/!7TQHSWP).I
MZPW67R93\(A!R>TVG,5)JKH)&W(#PKK8]B$:%+\%6BEHF*5(3(V_\5W76&LG
M]\:]H(.X/:;</;ZS';[7W-P'N+E/+!)X^]"^ZJO(_.Y8C5PNM2T0)1T=L9CO
MP5[26TC' S4NFFDL-S96MH[L.:E\9&SK3#.QRIM@:*S<4^H0<PQO3G8$YO4J
M^I^),,* $44PXZ6Q[IMQIXV40^X <\7>\L8+0+L4>P?Q[8;@2("D]B1@YUCU
MV!J$2-AA!RM.JHVW$Y/0O'Y2M]ZUQVCGW>DEZ_"<.OLE,MO%Y*=4DJ3#9>VK
MQ1J,"%@G;89;$R;[T_(4VP*8VZ.JA!YJ$1(=J54);'*U0KA3J-NSWJ57*.EC
M 2 Y'D#@'H%ZIA^*/#NS$7AS#PG;7X ?'HON0$B70%/5!X8) XW'@ Z&\A<J
M!>@&0$G.P9K#(]CNL7-YK7"&@7PC:6ONXF!62C!EZW&Z:E%:!>&HN&T)$JNL
MCW9R8BO>HO.UV+Q3V"<G @2B:P?-LM!N*1$=4-Z7WF:X.U22@LGP\B _UPQP
M W/"S:0;]6!JCKP%;];L_ (C0QL$2FS7J7-;:TS94/NW4V+ Z\H7^&.<]E@7
MRS<,C,1J*!&M5^I5R>P)VGV\=?3/I>N  9VW05NX9"<$MP2W6'#>>^1/O5-@
M)F21'_I!?"]NWXBC# ?3BZ+ 3BNY LBR4BT/S& S*-\:G0JQ8]6M<?W8&*Z2
MT4B91(&K)<1L\ :]U2@9H+9R :)&*D 0B&'W3S68"6078#")0[AXRLSSD-!#
M9\M?P+1Q/FI#YYM-K2+&]*842:&;80T;S*X.$[NAIGRFD@+(+L<?\AIVL\X:
MK[;CU;SLOJ45KI:A,<P&WH%YEI^ X[R$?6'S13ZEZ8HE?Y:O:^[?CHY;C]!0
M^R';$ (X_-Y" (<_; @@X,!1>ML'0^7^3?AM3YV$L <O=Q(GL_?(DD"M^#'3
MU[M4FM?1.5N^BE-:!WMM(6$3[8N^;I?JCKP=#MZ;[*9-AIB##^G\I9W)*#:I
MH@[G/XD;;*@K+/L. &*JP6LN/\#"*5W#1I=<*7;%YET;[/U"\]*XJW T:MI_
M>SC9<IG.,%5F<<W,'MQX"HRS54TY@_1*H:EL55NEF4'J_8!)29Q7JP'.QA )
MLK>OL*C&&YR1AJM;4[:>&\K6%67-IK+8R12=<OI"R?CF3$H<Q&01J8ILF#(]
MO?V)_8.[,ZZ>>*66$^<,HJN9MT3I(]5)B<U0\>QBH6^:HED%JM7ONJF8A)E7
M^:$R@5M1$F>_83TE!I.ZC[%C5EGU^JBB+:;>8]6$(G98&*SEQ[O_*4>VM3($
M.U!Z\37+,\*3SO;,%@.QLGDS1;9DOQ]2=##Z3'LM(8]XB8BNL/FTRK%6L]@F
M"<'YEXE0JS:*0QF9$BJ8IK,U @6P[N#@,?C<#O\K2VH&!WF6ZA1WTZ%ZR]6R
M.I?8+Z\82'+89)@%]4S2G6!Y##,Q)?CQI*X7M086C.->(F$O14D$V@V[U;J'
MV2RKI@MT*3C;9+5(%$T*OJ9J7)!$LP+. _<F6)>"TV-)/C59LWO-2@"V<7KP
MU/#NK]J46'"AO*VHP_3#@6:!JS7!*A)7@R\D]5+-MJ6M^Q9&$^*B"E4:6B/&
M+& 6U8$?F[(G.I"2;NG/2ZB-3=QPGZP6=G8@(/+B .W)J_CB'9&!K&H)!V":
M<\O[\6M5_AF/J= LLWK(B,@T#?EL($0K/<XCDQD+[:#6.D5.,%PLK(.!4\"1
ME6ONG(S:667G5=E_.CCT6L2%A23=C=[JV3!U\F*=JH$_5,3)#\;:*L#4D5NP
M&L8!=;R**4%+W?@B.)<^?X3$"WBAEL4E=B5V8FD"<S']6T"E@K,O"0P&M6Q%
M]TVO@^(A"!+D>-O9_^E MSB 7;D(ZYHC([>L$!QMLL1LK%"8CIKH<LZ(#M&L
MX8BNF-\[96YGZQ"NX/.4C^%N]"Z]6EP_G%*+V9F9EXML55D[6[6$AC-"NUK%
MS(- 77"ZV@,@MG&4DDCFE\%T05R;\PLK+5?'EM+/655_$UG=/L[G9'4?<335
MAN2BWUBB2J(4:6+$TY""B2YNZ3S=(:MHBR1"]U>:B@A5;\T8-?ZNL >BE+E;
M#J6:99MT!S ["V9;7)5X&6/78IY4F.$]PRB\.&5$^<Z1"DD>\L95=8A*M#8P
M,+$K++NFZ%J]E)US!3YM2MZD];WL3KR)<H$E20H]043L97Q.-JU#*98H[YCN
MC^_-_A59312/8*E& 1?\H=4NI./=&)]+R);EFF2P<Q+LK8C7R2-57H/I<Y>(
M'OJV &JOQ-5)'/P@^T$.@JB-#^%=$K*;S;JI9:8M@BLLV3GR":UUI>Q@:591
M2"8)45?C?4%&1O\JRD\*N_A'3@1$]'TEF?\=PVADGYA,_OXT^QUF][1E6SW#
MM?HH^UNMU7,YF)+GX^U^C4EM7#.$9+#2 Q2SK49"P8*;P_N$N1#X)3U]^++[
M2;;: #H_^MY YT<_+.CL%B4\>.F$;C7XJ T>- (-[,I5,D1:Y^D0HB]4Z /=
M@B)"I+:T>M!E($I%M<(MS[K3(U7-!X5.[;$U,ACX41-TC4JP@:>+I$+S(X/)
MJL%F65T4.18AH2],13[2.!@L [)HRB+/IG+]/)E6V3)CEN(+?#UU,0$V]'SC
MI26U[]\SN3;FIE5H,?'<%%:YL;;4D9?F^F%* ]HY?#H"6VE=5G9O*9TMH4+0
M9'^H;DQ2Q+DYV*D-$ZN(34^:Q)O-*X$W2ZJ?IO\B6ZJ7PY0-9*U /CP:(CF;
M5DLADY87B(EB88+8=.I"I?!@N1&,E/KYK) ,2BSQ(P)Y1*P9.YJ:ED01"1AM
MG-#:F,&B<\&MY_AK55*A##4B<VD8.#1-IA^O8YVR8\=F0-.V<N;>K4#O2\_Z
M)_JNDPS'>X:#@4[Y;^ #\'0=386P\"\?L_(GS8M9O?B')ID@6JFCAH?8FCK;
MK+PV98'ALO4P^J(98@TI!(;XNUDA;%GBA[7C8!F=.!%31;+G\.=V9II[A?M2
M\TBE>!Q_J3?YUIKHJ#8Q-,.3W9FZ::>HP;1,.ZK+J=2=1L3I!#PJ:QZ=A*4;
M)$:0VZ;JWEDKMM;U;RS/USD3K@B7V\.2M/N2WX(<&>_[_)(3_\"=*7T\'!@G
M"_F?_N$'$;%0I\SL>%/71@W5?**#;=%1<CN&AA\\'&S1\9QX1%P,/MGBA!>E
M=:_)M>1-%LS0G\_AWKA5C8V"G.^SM+"_1&V#!DGB40-5$:+)*V:)6"R**Q(
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M33*8OEJDLW,6RE)])#TZX"H^):MD%0AY^416]%?3I$9U1O@T8QM\IH@0-;8
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M=.BKGT&\@D'YG=E9AS>UL^ZL[7S7NO_TZOWK?[W$?_QZ]MO;E_\?4$L#!!0
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M,^.: ; 5[]-MM0]B2.UO\Y:45>/,/A,U(74Q%C"GC6^W.!S4_!K'G%A8?T4
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MZ^E74;<>4I]%>;XOKC,TI)R>>-Q=!#%BZNCPL-I9A%W>I 0_N *\KKK=]R2
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MBW =MY\GC.*;CLG8G3TU1-3Q;%MZW(HBRYA<W/6384OMX#%. [1&3PBCMK0
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M%8'I4,D GF+&@\',ZQC.T,']L>NI @X$FB(F=]5-[?J 2%&7B^ZX)2/_&B_
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M47G5=]P!?H==8VZ'V2<K]H#?:?QA-Q<TY$NU;(RYW_U+QW&(68'=;=.#"2N
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MPZGLWN!I=4.HCMW_FBAU4%E*JWX)&D^-:H*&?@UZE:B "W\3*IF:5LL4)NC
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MUZH]ELXS6#K9UANXW@'LJ$W:<,2!>**T=J>^/I#7H^7[4GFM^G]02P,$%
M  @ ^(1)5%#ZO<7' P  P0X  !    !I9F8M,C R,C R,#@N>'-DO591<]HX
M$'Z^SMQ_4/W:L8U)28%".S=):9DF;28TN4Y?.L)>$Q5;<B4YD']_*]D& H8
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M>UH3VE[P_S>VGE]D @[_ U!+ P04    " #XA$E4 C5], \)  #V:@  %
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M?E00!_UP/N$Y/FC'.J8EKYZ34 !V0/TR7U!TY_.<9VM$Z:=(ZB!DY5A4 '9
M]#)?4'3G,YDOUU@L];#XF^!/:I4N-JX2WUJ@ R; O$$SG,]8OMP\OP@A67%9
MZ40)W04;[*0A#VP!O98'NW>Q!(&9RI)<*[ 0"< %&-]J'VIH@TXX3*>OU J+
M_!5;3,\$5#7)I*Y4JUUI1![TQGDZG7\U1>6I.H=KM?X 75!QY]GR=32G))A0
MCBKS@ARL WKOLP7E=IXA?T+L7D0/*MA>"QY@;!XPR=WQV2!!:U1!!RQJ'@=H
MGONEPL_O[9VMD,#R*E+Q/_'1C"MO<E24ZX!5M?1!A][@E5KR>2DA#C]M;_ "
M"S,QY!9OU"?=V'WU15=M\5;[=5@4H&VY%/UC?R] W?R]WI=N-S_,?Q[26_X/
M4$L#!!0    ( /B$250PH_@V!0P  ""3   4    :69F+3(P,C(P,C X7VQA
M8BYX;6S-G>]OV[@9Q]\/V/_ ^=YL0!W'SK5WS;5W2-/D8%R:9'7:VU8,!2W3
MCA"9S%%RXOSW(ZD?ED@^DISK2 9%ZTK?A_I2_(2D9/'1FU^VZP0]$)[&C+X=
MC \.!XC0B"UBNGH[^#0;GLQ.I],!2C-,%SAAE+P=4#;XY>>__@6)GS=_&P[1
M>4R2Q3%ZSZ+AE"[93^@2K\DQ^I50PG'&^$_H,TXV<@L[CQ/"T2E;WR<D(V)'
M?N!C]/)@/,%H..Q1[F="%XQ_^CBMRKW-LOOT>#1Z?'P\H.P!/S)^EQY$;-VO
MP%F&LTU:E7:X/2Q^\O W24SOCN5?<YP2),X738^W:?QV((];'/;QZ(#QU6AR
M>#@>_>O#Q2RZ)6L\C*D\;Q$9E%&R%%O<^/7KUR.UMY0:RNV<)^4QCD:EG:ID
ML3=NT=><I/%QJNQ=L AGJMD[#X- A?S?L)0-Y:;A>#(\&A]LT\6@//GJ#'*6
MD(]DB50UC[.G>X%2&DL2!L6V6TZ6=C,)YR,9/Z)DA3.RD =Z+0\T?B4/]%VQ
M^0+/23) 4BGX .OUNE%6$31R;?::\)@MSNCS7.O1GNR+WQV>_8D*U..=5^&&
M93AYEOEZI'/;E^1Y9WP7Y_Y,BWZ>/.],UR+_+[8ST_+>I]=^7A.Y\4)\:E@D
MVTP,8&11FI1%M/3 Z@AJ8"C*KDIG4:/<1/;FC)MUER.C*G.)T[DJ>),.5QC?
MBP-,QB.29&FY92BW# _'1?_]7;'YJQPAR9K0[#3!:7JUG&4LNCO9QFEY-%75
MMX,>^I%>#1EYPLNZ8!YUG)!",8J8&,[NLV&2G_H\?,G9NI>-XLRQ'N*OR;PJ
M/S_5P@)0D8:,DY1M>$3V:NEZ;?J>U<+A.A$1<MI&Z/#3;/"SDB&V1$J(ODCI
M?]^,=D5[)$I, =>,*F,?R'I..%!GB\XE0:#-.CF&*!AB(&<&*4I7<I)+_S0I
M\7(I6U_\.?Q1M?WT_/SKC$3C@Q]>BL$_$B#/"(T9OV092=]OB%!^;X5AGT 7
M=.Q?$8E+_RCO_.QM50=*!*/Q ?KA)2KB45X 4B4@402293A@[<?#0Z@*K]IA
MZQ/IE+;^56G@UAT6#F^]O0+ B?A6XEY],^*^]<SJ!L]W$U=HX"]$7N90#8/6
MB9-2>&>IU9:!32E"7Y0L."S$Y0.9BH^=,^V:T L>AE$K(I4J/$QT:RVH2"E2
MVF_+2TJB@Q5[&"U(K%#YXWOY<9A_5'R(_WY]SZ*-XEJ4JE7*W.V"!<B4)$#?
MY[W= 4-Z:Y<2)#4>&OE$''PA#9PG>&6I@K;?53-;;97MW-@91$/;'.DM76F0
M%/ELZO<DC7A\+V_)M]6E(7/>\!:31OO7-&%A8!J#::AI/7;R'\DJ3C.NOJ>I
M1J"6+@W0NQX&6FWKXX)5' 0X?1R"(T<]"%51'EDZH72#DX_DGO$VA)HRU^38
M3.K U#5!<6(Q!N*1:U$N]DC%/S>89X0G3YU@&$K7; !6=3PT65"$V+V!D%1R
M_YS<<$S36'9FG:"84N>7(8!9XY)$TP7%"F .OE2I]/YIF=V2))'/^6#:W;'8
MQ*Z)@0WKS)C*H*@![8'<J A4A(2%SMF#G+6+J5//"M?T/@$R;+<Q5(F#Q4AW
MV),D%89DG$>::H\9=7!D*%T3!%C5V=%D05%C]P;RDLN1TH<!RAE=],*DTOF!
M1+-I1Z00!0A(TUD7'D+M&X[S.(UPDOLY%]OTKV,ZM*XA >WJH!C"H&"!W('
MY $E-RK$.S3_)ICW0Z:F] .,8=6.2R4+$!;=6Q<J4N\-E-,-YPWG\.@#2UVA
MTF6V9 72!0%+ASGCN;A<WH#%XVAT1K,X>Y)K:"XWEB>7[!)7?$#F2B[T_4'P
M )C2.<AE2.I0+O36^N6W"C23BY? *NDRMQ38339):&H"HL%J#"!BIU5KR;Q1
M<2IZ*8Z3*5V0[6_D":R;H7/+!6"S"88F"H@,NS, C4*,E!H)N3<XKGF\QOQI
M%D<=PX8I=(L'9+3)AZX*"!# &D!(H4:SZ:GO4>4&;Z<+ 6R\C/,UH1VD@'JW
MP'38;G(#B /"I]TA0)$(0LTHWS!-:<3X/:L]+G'*-J(S?#IE"WC&TA'E%JQ>
M56CBU1H2$&1]? *H-4)?Y,^T(";7\ZL"D"S!&W4GBX4X66GQST5,R1@\!U:M
M6\):[#:YL@@#H@EV!S!4*%^4'Y",05<T)' F>U1WXA^<25]P)D&#,WD..#>/
M+"!PCO:H[I%_<([Z@G,4-#A'SP)'-+[W/N=4?+SB-^S1]L WJ/2"C6G5"LU.
M%AXRAK<N8&2 G-_($-^HJ,G6%;_F["&F$3R-AN1>H %,6\G1M.'A8S?8Q5 U
M22[C?(-43-8[?UE*F9_>IFG2WM7DFO! :1KK[&1RM6\LKEF:X>0_\7WK1;I=
M[ 41JV$K* UE>+C8['5!D\<@$>3KHKO 5GX!8EVNINUW]BVUS5;UU71]9Q @
MV!R9R5GRNRNYR$=32U8YP4#/T-SMK*$MIJIVKNT+HYE-0T8KJ]]OH?'U"RVS
M02;7MXS"#Q>8$E>M#9DK6US?'T2K Z;TEE<RI'0>[]S+K'2IO2NO[7,VTNMV
MJH&]W!%$"^MNC&&[W.^A17_G<2:.+E-[;6CQS9#M&41 YZJE6VV6K6X5!4%
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M'   9' Q-C8X-35?97@P,S Q+FAT;5!+ 0(4 Q0    ( /B$250G[(!>QE\
M &YD @ 3              "  3B%  !D<#$V-C@U-5]E>#$P,#$N:'1M4$L!
M A0#%     @ ^(1)5&CXI)FZ!P  71T  !,              ( !+^4  &1P
M,38V.#4U7V5X.3DP,2YH=&U02P$"% ,4    " #XA$E44/J]Q<<#  #!#@
M$               @ $:[0  :69F+3(P,C(P,C X+GAS9%!+ 0(4 Q0    (
M /B$250"-7TP#PD  /9J   4              "  0_Q  !I9F8M,C R,C R
M,#A?9&5F+GAM;%!+ 0(4 Q0    ( /B$250PH_@V!0P  ""3   4
M      "  5#Z  !I9F8M,C R,C R,#A?;&%B+GAM;%!+ 0(4 Q0    ( /B$
M2505]PK<1P@  (IE   4              "  8<& 0!I9F8M,C R,C R,#A?
=<')E+GAM;%!+!08     "  (  0"    #P$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
